| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone binding | MBTD1 CHD3 PSME4 CHD6 TAF1L USP49 SMARCA5 L3MBTL2 BAZ1B CHD8 SFMBT2 BRD2 CBX6 SCMH1 BRD4 SMARCA4 PHF14 KDM4A CBX8 | 2.83e-11 | 265 | 202 | 19 | GO:0042393 |
| GeneOntologyMolecularFunction | chromatin binding | MBTD1 STAG1 CHD3 HP1BP3 UBTF FOXO4 DLX2 CHD6 TAF1L SMARCA5 L3MBTL2 FAAP24 CHD8 TFAM SFMBT2 ORC1 BRD2 CBX6 SCMH1 BRD4 H1-6 EXO1 SMARCA4 KAT6B PRDM15 PHF10 STAG3 TOP2A EP300 CBX8 | 8.61e-11 | 739 | 202 | 30 | GO:0003682 |
| GeneOntologyMolecularFunction | modification-dependent protein binding | MBTD1 CCDC38 PSME4 TAF1L HDAC6 ANK3 L3MBTL2 CHD8 XRCC1 BRD2 CBX6 BRD4 SMARCA4 KDM4A EP300 CBX8 | 3.40e-10 | 206 | 202 | 16 | GO:0140030 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 4.43e-08 | 11 | 202 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 CHD3 ERVK-7 ERVK-10 CHD6 REV1 SMARCA5 CHD8 XRCC1 LIG1 ERVK-8 EXO1 SMARCA4 TOP2A | 4.82e-07 | 262 | 202 | 14 | GO:0140097 |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 5.93e-07 | 31 | 202 | 6 | GO:0140033 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 9.40e-06 | 14 | 202 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.17e-05 | 30 | 202 | 5 | GO:0070577 | |
| GeneOntologyMolecularFunction | histone modifying activity | CHEK1 JADE1 TAF1L USP49 HDAC6 BAZ1B KDM4A KAT6B PHF10 EP300 KDM4B | 2.26e-05 | 229 | 202 | 11 | GO:0140993 |
| GeneOntologyMolecularFunction | methylated histone binding | 2.67e-05 | 86 | 202 | 7 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 3.10e-05 | 88 | 202 | 7 | GO:0140034 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.38e-05 | 37 | 202 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.38e-05 | 37 | 202 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.38e-05 | 37 | 202 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 3.86e-05 | 38 | 202 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.86e-05 | 38 | 202 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 5.32e-05 | 21 | 202 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 9.87e-05 | 46 | 202 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 1.49e-04 | 27 | 202 | 4 | GO:0001091 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.62e-04 | 51 | 202 | 5 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.33e-04 | 55 | 202 | 5 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 3.51e-04 | 60 | 202 | 5 | GO:0034212 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase regulator activity | 4.16e-04 | 35 | 202 | 4 | GO:0055106 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 4.24e-04 | 15 | 202 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 5.46e-04 | 66 | 202 | 5 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 5.46e-04 | 66 | 202 | 5 | GO:0001098 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 6.63e-04 | 104 | 202 | 6 | GO:0016407 | |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 7.68e-04 | 41 | 202 | 4 | GO:0140463 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 CHD3 ERVK-7 ERVK-10 PNPT1 CHD6 NOP2 REV1 SMARCA5 CHD8 XRCC1 LIG1 ERVK-8 EXO1 SMARCA4 TOP2A | 9.02e-04 | 645 | 202 | 16 | GO:0140640 |
| GeneOntologyMolecularFunction | p53 binding | 1.10e-03 | 77 | 202 | 5 | GO:0002039 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.17e-03 | 78 | 202 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.24e-03 | 79 | 202 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase kinase activity | 1.49e-03 | 6 | 202 | 2 | GO:0008349 | |
| GeneOntologyMolecularFunction | histone H3K9me2/H3K9me3 demethylase activity | 1.49e-03 | 6 | 202 | 2 | GO:0140684 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.55e-03 | 83 | 202 | 5 | GO:1990841 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.87e-03 | 127 | 202 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | mRNA 5'-UTR binding | 1.99e-03 | 25 | 202 | 3 | GO:0048027 | |
| GeneOntologyMolecularFunction | histone reader activity | 2.23e-03 | 26 | 202 | 3 | GO:0140566 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.63e-03 | 136 | 202 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.63e-03 | 136 | 202 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.04e-03 | 140 | 202 | 6 | GO:0001221 | |
| GeneOntologyMolecularFunction | RNA polymerase I general transcription initiation factor activity | 3.50e-03 | 9 | 202 | 2 | GO:0001181 | |
| GeneOntologyMolecularFunction | anaphase-promoting complex binding | 3.50e-03 | 9 | 202 | 2 | GO:0010997 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 3.50e-03 | 9 | 202 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 3.80e-03 | 102 | 202 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 4.02e-03 | 64 | 202 | 4 | GO:0140296 | |
| GeneOntologyMolecularFunction | ubiquitin ligase inhibitor activity | 4.34e-03 | 10 | 202 | 2 | GO:1990948 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 4.45e-03 | 33 | 202 | 3 | GO:0050681 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 4.55e-03 | 152 | 202 | 6 | GO:0016779 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MBTD1 DLGAP5 FAM47C CHD3 POGZ CHEK1 JADE1 INO80D HP1BP3 TASOR2 HMG20A PSME4 UBTF MKI67 AHR CHD6 TAF1L USP49 SMARCA5 HDAC6 L3MBTL2 ARID4A BAZ1B CHD8 KANSL3 RYBP BRD2 SLF2 CBX6 SCMH1 BRD4 EPC1 H1-6 SMARCA4 PHF14 KDM4A KAT6B PHF10 EP300 CBX8 KDM4B | 1.57e-15 | 999 | 197 | 41 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | MBTD1 FAM47C CHD3 CHEK1 JADE1 INO80D HP1BP3 TASOR2 HMG20A PSME4 MKI67 CHD6 TAF1L USP49 SMARCA5 HDAC6 L3MBTL2 ARID4A BAZ1B CHD8 KANSL3 RYBP BRD2 SLF2 CBX6 SCMH1 BRD4 EPC1 H1-6 SMARCA4 PHF14 KDM4A KAT6B PHF10 EP300 CBX8 KDM4B | 3.91e-14 | 896 | 197 | 37 | GO:0006325 |
| GeneOntologyBiologicalProcess | chromatin remodeling | FAM47C CHD3 CHEK1 JADE1 INO80D HP1BP3 TASOR2 CHD6 TAF1L USP49 SMARCA5 HDAC6 ARID4A BAZ1B CHD8 RYBP BRD2 SCMH1 BRD4 EPC1 H1-6 SMARCA4 KDM4A KAT6B PHF10 EP300 CBX8 KDM4B | 5.32e-10 | 741 | 197 | 28 | GO:0006338 |
| GeneOntologyBiologicalProcess | DNA damage response | ERVK-6 MBTD1 USP45 ERVK-7 POGZ CHEK1 ERVK-10 INTS3 INO80D FZR1 PSME4 FBXO5 FOXO4 TIMELESS REV1 GCNA SMARCA5 FAAP24 BAZ1B XRCC1 LIG1 SLF2 BRD4 EPC1 ERVK-8 EXO1 SMARCA4 SPIDR PHF10 TOP2A EP300 CBX8 | 6.15e-10 | 959 | 197 | 32 | GO:0006974 |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 MBTD1 USP45 ERVK-7 POGZ CHEK1 ERVK-10 INTS3 INO80D FZR1 PSME4 TIMELESS REV1 GCNA SMARCA5 FAAP24 XRCC1 LIG1 SLF2 EPC1 ERVK-8 EXO1 SMARCA4 SPIDR PHF10 CBX8 | 6.64e-10 | 648 | 197 | 26 | GO:0006281 |
| GeneOntologyBiologicalProcess | cell cycle process | STAG1 TRIM75 RPS6 DLGAP5 CKAP5 CHD3 POGZ CHEK1 JADE1 INTS3 DCTN1 KIAA0753 DRG1 FZR1 FBXO5 MKI67 FOXO4 TIMELESS EXOC7 MN1 CCNL2 SMARCA5 ANK3 CENPU BAZ1B TACC2 KIF3A CTDSP2 ORC1 LIG1 USP8 SLF2 BRD4 SMARCA4 MEIOSIN PHF10 STAG3 TOP2A MYBL2 | 2.67e-09 | 1441 | 197 | 39 | GO:0022402 |
| GeneOntologyBiologicalProcess | DNA metabolic process | ERVK-6 MBTD1 USP45 ERVK-7 POGZ CHEK1 JADE1 ERVK-10 INTS3 INO80D FZR1 PSME4 FBXO5 AHR TIMELESS REV1 GCNA SMARCA5 FAAP24 XRCC1 ORC1 LIG1 SLF2 EPC1 ERVK-8 H1-6 EXO1 SMARCA4 SPIDR PHF10 TOP2A CBX8 | 1.12e-08 | 1081 | 197 | 32 | GO:0006259 |
| GeneOntologyBiologicalProcess | DNA recombination | ERVK-6 MBTD1 ERVK-7 POGZ CHEK1 ERVK-10 INTS3 INO80D TIMELESS XRCC1 LIG1 SLF2 EPC1 ERVK-8 H1-6 EXO1 SPIDR TOP2A | 1.70e-08 | 368 | 197 | 18 | GO:0006310 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | SOX5 MBTD1 CHD3 HMG20A LHX9 ZNF512B SINHCAF AHR TIMELESS DLX2 FOXJ1 SOX6 SMARCA5 MAGEL2 HDAC6 TCF21 L3MBTL2 ARID4A OSR2 CHD8 GTF2IRD1 SFMBT2 RYBP CBX6 SCMH1 EPC1 OSR1 SMARCA4 PHF14 KDM4A KAT6B SPEN ZNF281 EP300 CBX8 | 1.40e-07 | 1399 | 197 | 35 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | SOX5 MBTD1 CHD3 HMG20A LHX9 ZNF512B SINHCAF AHR TIMELESS DLX2 FOXJ1 SOX6 SMARCA5 MAGEL2 HDAC6 TCF21 L3MBTL2 ARID4A OSR2 CHD8 GTF2IRD1 SFMBT2 RYBP CBX6 SCMH1 EPC1 OSR1 SMARCA4 PHF14 KDM4A KAT6B SPEN ZNF281 EP300 CBX8 | 1.78e-07 | 1413 | 197 | 35 | GO:1902679 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | STAG1 RPS6 DLGAP5 CKAP5 CHEK1 JADE1 INTS3 DCTN1 DRG1 FZR1 FBXO5 MKI67 FOXO4 EXOC7 SMARCA5 ANK3 BAZ1B TACC2 CTDSP2 ORC1 LIG1 USP8 BRD4 SMARCA4 PHF10 MYBL2 | 1.81e-07 | 854 | 197 | 26 | GO:1903047 |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | MBTD1 INO80D TIMELESS XRCC1 SLF2 EPC1 SMARCA4 SPIDR PHF10 CBX8 | 1.19e-06 | 143 | 197 | 10 | GO:0045739 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | NOLC1 STAG1 RPS6 DLGAP5 CKAP5 CHEK1 JADE1 INTS3 DCTN1 DRG1 FZR1 FBXO5 MKI67 FOXO4 EXOC7 SMARCA5 ANK3 BAZ1B TACC2 CTDSP2 ORC1 LIG1 USP8 BRD4 SMARCA4 PHF10 MYBL2 | 1.41e-06 | 1014 | 197 | 27 | GO:0000278 |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | RPS6 DLGAP5 CHEK1 JADE1 INTS3 DCTN1 DRG1 FZR1 FBXO5 MKI67 FOXO4 TIMELESS EXOC7 MN1 CCNL2 SMARCA5 BAZ1B CTDSP2 ORC1 SLF2 BRD4 SMARCA4 MEIOSIN PHF10 | 1.90e-06 | 845 | 197 | 24 | GO:0010564 |
| GeneOntologyBiologicalProcess | DNA replication | ERVK-6 ERVK-7 CHEK1 JADE1 ERVK-10 INO80D FBXO5 TIMELESS REV1 SMARCA5 ORC1 LIG1 ERVK-8 EXO1 | 1.95e-06 | 312 | 197 | 14 | GO:0006260 |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | DLGAP5 POGZ HP1BP3 UBTF AHR TAF1L SMARCA5 BRD2 H1-6 SMARCA4 KAT6B EP300 | 5.19e-06 | 249 | 197 | 12 | GO:0065004 |
| GeneOntologyBiologicalProcess | DNA integration | 5.39e-06 | 13 | 197 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | embryo development | SOX5 NOLC1 MBTD1 RPS6 RPS7 CHEK1 INO80D SEMA4C SULF1 TIMELESS DLX2 DLX5 NOP2 SOX6 SMARCA5 TCF21 TCOF1 CENPU OSR2 CHD8 GTF2IRD1 THOC5 PPP4R4 KIF3A OTX2 BRD2 BRD4 OSR1 SMARCA4 ZNF281 TOP2A EP300 | 6.21e-06 | 1437 | 197 | 32 | GO:0009790 |
| GeneOntologyBiologicalProcess | rRNA metabolic process | NOLC1 RSL1D1 RPS6 RPS7 KRI1 POLR1G UBTF NOP2 NOL8 TCOF1 UTP23 SMARCA4 | 1.41e-05 | 275 | 197 | 12 | GO:0016072 |
| GeneOntologyBiologicalProcess | regulation of DNA repair | MBTD1 CHEK1 INO80D TIMELESS XRCC1 SLF2 EPC1 SMARCA4 SPIDR PHF10 CBX8 | 1.63e-05 | 234 | 197 | 11 | GO:0006282 |
| GeneOntologyBiologicalProcess | chordate embryonic development | SOX5 NOLC1 MBTD1 RPS7 CHEK1 SEMA4C SULF1 DLX2 NOP2 SOX6 TCOF1 CENPU OSR2 CHD8 THOC5 PPP4R4 KIF3A OTX2 BRD2 BRD4 OSR1 SMARCA4 EP300 | 1.95e-05 | 906 | 197 | 23 | GO:0043009 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | MBTD1 RPS6 DLGAP5 CHEK1 JADE1 INTS3 DCTN1 INO80D DRG1 PNPT1 FZR1 FBXO5 MKI67 FOXO4 TIMELESS EXOC7 MN1 CCNL2 SMARCA5 BAZ1B CTDSP2 ORC1 SLF2 BRD4 EPC1 SMARCA4 MEIOSIN PHF10 | 2.49e-05 | 1256 | 197 | 28 | GO:0051726 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | CHD3 HMG20A ZNF512B SINHCAF AHR TIMELESS DLX2 FOXJ1 SOX6 MAGEL2 TCF21 ARID4A OSR2 CHD8 GTF2IRD1 RYBP CBX6 EPC1 OSR1 SMARCA4 PHF14 SPEN ZNF281 EP300 CBX8 | 2.54e-05 | 1053 | 197 | 25 | GO:0000122 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | SOX5 NOLC1 MBTD1 RPS7 CHEK1 SEMA4C SULF1 DLX2 NOP2 SOX6 TCOF1 CENPU OSR2 CHD8 THOC5 PPP4R4 KIF3A OTX2 BRD2 BRD4 OSR1 SMARCA4 EP300 | 2.88e-05 | 929 | 197 | 23 | GO:0009792 |
| GeneOntologyBiologicalProcess | chromosome organization | STAG1 DLGAP5 POGZ INO80D DRG1 FBXO5 SMARCA5 BAZ1B CHD8 XRCC1 SLF2 H1-6 EXO1 SMARCA4 KDM4A PHF10 STAG3 TOP2A MYBL2 | 3.37e-05 | 686 | 197 | 19 | GO:0051276 |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 3.54e-05 | 95 | 197 | 7 | GO:2000781 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell lineage commitment | 4.64e-05 | 8 | 197 | 3 | GO:2000330 | |
| GeneOntologyBiologicalProcess | positive regulation of gastrulation | 4.64e-05 | 8 | 197 | 3 | GO:2000543 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | RPS6 CHEK1 JADE1 INTS3 FZR1 FBXO5 FOXO4 TIMELESS SMARCA5 BAZ1B CTDSP2 ORC1 BRD4 | 4.79e-05 | 362 | 197 | 13 | GO:0010948 |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 4.82e-05 | 42 | 197 | 5 | GO:0070316 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 5.53e-05 | 178 | 197 | 9 | GO:0006261 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SGSM1 POGZ AHR PLAG1 FOXO4 DLX2 CHD6 DLX5 FOXJ1 SOX6 SMARCA5 TCF21 ARID4A OSR2 BAZ1B CHD8 ATF6B KANSL3 OTX2 BRD4 EPC1 OSR1 SMARCA4 ELF1 KAT6B PRDM15 TOP2A EP300 MYBL2 | 5.86e-05 | 1390 | 197 | 29 | GO:0045944 |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 6.06e-05 | 44 | 197 | 5 | GO:0045023 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 type immune response | 6.20e-05 | 23 | 197 | 4 | GO:2000318 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | STAG1 DLGAP5 CKAP5 CHD3 CHEK1 DNAL1 DCTN1 KIAA0753 DRG1 FSIP2 FBXO5 FOXJ1 CCNL2 CFAP91 HDAC6 ANK3 TACC2 KIF3A MYBL2 | 6.44e-05 | 720 | 197 | 19 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | MBTD1 CHEK1 INO80D SEMA4C TIMELESS HYOU1 HDAC6 XRCC1 ATF6B SLF2 BRD4 EPC1 SMARCA4 SPIDR PHF10 EP300 CBX8 | 6.45e-05 | 598 | 197 | 17 | GO:0080135 |
| GeneOntologyBiologicalProcess | double-strand break repair | MBTD1 POGZ CHEK1 INTS3 TIMELESS XRCC1 LIG1 SLF2 EPC1 SMARCA4 SPIDR PHF10 | 7.00e-05 | 324 | 197 | 12 | GO:0006302 |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | FAM47C POLR1G UBTF AHR TAF1L SMARCA5 TFAM GTF2E2 SMARCA4 EP300 | 7.93e-05 | 231 | 197 | 10 | GO:0006352 |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | 8.22e-05 | 146 | 197 | 8 | GO:2000779 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 8.43e-05 | 188 | 197 | 9 | GO:0000724 | |
| GeneOntologyBiologicalProcess | organelle assembly | STAG1 TMEM237 RPS6 DLGAP5 POGZ DNAL1 CCDC38 DCTN1 KIAA0753 DRG1 FSIP2 FBXO5 CASKIN1 SCFD1 NOP2 FOXJ1 DCDC2 CFAP91 HDAC6 CEP162 FHOD3 KIF3A EP300 RUFY4 MYBL2 | 8.91e-05 | 1138 | 197 | 25 | GO:0070925 |
| GeneOntologyBiologicalProcess | negative regulation of mitotic chromosome condensation | 9.08e-05 | 2 | 197 | 2 | GO:1905213 | |
| GeneOntologyBiologicalProcess | regulation of mitotic chromosome condensation | 9.08e-05 | 2 | 197 | 2 | GO:1903379 | |
| GeneOntologyBiologicalProcess | chromosome condensation | 9.27e-05 | 48 | 197 | 5 | GO:0030261 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 9.27e-05 | 48 | 197 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | recombinational repair | 1.07e-04 | 194 | 197 | 9 | GO:0000725 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | MBTD1 CHEK1 JADE1 INO80D FBXO5 AHR TIMELESS SMARCA5 XRCC1 SLF2 EPC1 H1-6 SMARCA4 SPIDR PHF10 CBX8 | 1.09e-04 | 564 | 197 | 16 | GO:0051052 |
| GeneOntologyBiologicalProcess | transcription by RNA polymerase I | 1.10e-04 | 79 | 197 | 6 | GO:0006360 | |
| GeneOntologyBiologicalProcess | regulation of G2/M transition of mitotic cell cycle | 1.26e-04 | 116 | 197 | 7 | GO:0010389 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 cell lineage commitment | 1.34e-04 | 11 | 197 | 3 | GO:2000328 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | RPS6 DLGAP5 CHEK1 JADE1 INTS3 FZR1 FBXO5 FOXO4 TIMELESS MN1 CTDSP2 ORC1 BRD4 SMARCA4 PHF10 | 1.37e-04 | 516 | 197 | 15 | GO:1901987 |
| GeneOntologyBiologicalProcess | chromosome segregation | STAG1 DLGAP5 DRG1 FBXO5 MKI67 SMARCA5 CENPU BAZ1B BRD4 SMARCA4 PHF10 STAG3 TOP2A MYBL2 | 1.60e-04 | 465 | 197 | 14 | GO:0007059 |
| GeneOntologyBiologicalProcess | sister chromatid segregation | STAG1 DLGAP5 DRG1 FBXO5 SMARCA5 BAZ1B SMARCA4 PHF10 TOP2A MYBL2 | 1.73e-04 | 254 | 197 | 10 | GO:0000819 |
| GeneOntologyBiologicalProcess | stem cell differentiation | SOX5 NOLC1 RPS7 CHD3 SEMA4C FOXO4 SOX6 L3MBTL2 TCOF1 OSR1 ZNF281 | 1.82e-04 | 306 | 197 | 11 | GO:0048863 |
| GeneOntologyBiologicalProcess | microtubule-based process | STAG1 DLGAP5 CKAP5 CHD3 CHEK1 DNAL1 CCDC38 DCTN1 LYST DNAH14 KIAA0753 DRG1 FSIP2 FBXO5 FOXJ1 CCNL2 CFAP91 HDAC6 ANK3 TACC2 KIF3A H1-6 MYBL2 | 2.02e-04 | 1058 | 197 | 23 | GO:0007017 |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 2.08e-04 | 31 | 197 | 4 | GO:0060765 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | RPS6 CHEK1 JADE1 INTS3 FZR1 FBXO5 FOXO4 TIMELESS CTDSP2 ORC1 BRD4 | 2.10e-04 | 311 | 197 | 11 | GO:1901988 |
| GeneOntologyBiologicalProcess | mitotic G2/M transition checkpoint | 2.49e-04 | 59 | 197 | 5 | GO:0044818 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | DLGAP5 INO80D FBXO5 SMARCA5 BAZ1B XRCC1 SLF2 SMARCA4 PHF10 TOP2A | 2.50e-04 | 266 | 197 | 10 | GO:0033044 |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 2.57e-04 | 218 | 197 | 9 | GO:0071897 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G2/M phase transition | 2.68e-04 | 131 | 197 | 7 | GO:1902749 | |
| GeneOntologyBiologicalProcess | embryonic skeletal limb joint morphogenesis | 2.71e-04 | 3 | 197 | 2 | GO:0036023 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell differentiation | 2.89e-04 | 14 | 197 | 3 | GO:2000321 | |
| GeneOntologyBiologicalProcess | spindle organization | 3.14e-04 | 224 | 197 | 9 | GO:0007051 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 3.33e-04 | 179 | 197 | 8 | GO:0031023 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | FAM47C CHEK1 TASOR2 SMARCA5 HDAC6 ARID4A SCMH1 EPC1 SMARCA4 EP300 CBX8 | 3.48e-04 | 330 | 197 | 11 | GO:0040029 |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | MBTD1 INO80D TIMELESS SMARCA5 XRCC1 SLF2 EPC1 SMARCA4 SPIDR PHF10 CBX8 | 3.75e-04 | 333 | 197 | 11 | GO:0051054 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase I | 4.17e-04 | 37 | 197 | 4 | GO:0045943 | |
| GeneOntologyBiologicalProcess | nuclear division | STAG1 TRIM75 DLGAP5 CHEK1 DRG1 FZR1 FBXO5 MKI67 SMARCA5 BAZ1B MEIOSIN STAG3 TOP2A MYBL2 | 4.26e-04 | 512 | 197 | 14 | GO:0000280 |
| GeneOntologyBiologicalProcess | DNA ligation | 4.38e-04 | 16 | 197 | 3 | GO:0006266 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | DLGAP5 CHEK1 JADE1 INTS3 FZR1 FBXO5 FOXO4 CTDSP2 ORC1 BRD4 SMARCA4 PHF10 | 5.09e-04 | 402 | 197 | 12 | GO:1901990 |
| GeneOntologyBiologicalProcess | negative regulation of chromosome condensation | 5.38e-04 | 4 | 197 | 2 | GO:1902340 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal stem cell differentiation | 5.38e-04 | 4 | 197 | 2 | GO:2000741 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | RPS6 CHEK1 JADE1 INTS3 FZR1 FBXO5 FOXO4 TIMELESS SMARCA5 BAZ1B CTDSP2 ORC1 BRD4 | 5.44e-04 | 464 | 197 | 13 | GO:0045786 |
| GeneOntologyBiologicalProcess | positive regulation of cell fate commitment | 6.30e-04 | 18 | 197 | 3 | GO:0010455 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase I promoter | 6.30e-04 | 18 | 197 | 3 | GO:0006361 | |
| GeneOntologyBiologicalProcess | negative regulation of ubiquitin-protein transferase activity | 6.30e-04 | 18 | 197 | 3 | GO:0051444 | |
| GeneOntologyBiologicalProcess | mitotic spindle organization | 6.31e-04 | 151 | 197 | 7 | GO:0007052 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | STAG1 DLGAP5 DRG1 FBXO5 SMARCA5 BAZ1B SMARCA4 PHF10 STAG3 TOP2A MYBL2 | 6.55e-04 | 356 | 197 | 11 | GO:0098813 |
| GeneOntologyBiologicalProcess | G2/M transition of mitotic cell cycle | 6.57e-04 | 152 | 197 | 7 | GO:0000086 | |
| GeneOntologyBiologicalProcess | cilium organization | TMEM237 DNAL1 CCDC38 DCTN1 KIAA0753 FSIP2 CEP78 FOXJ1 DCDC2 CFAP91 HDAC6 CEP162 KIF3A | 6.89e-04 | 476 | 197 | 13 | GO:0044782 |
| GeneOntologyBiologicalProcess | negative regulation of G2/M transition of mitotic cell cycle | 7.59e-04 | 75 | 197 | 5 | GO:0010972 | |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 7.66e-04 | 203 | 197 | 8 | GO:0045814 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle G2/M phase transition | 8.55e-04 | 77 | 197 | 5 | GO:1902750 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | TMEM237 JADE1 SULF1 DLX5 DCDC2 SFRP4 CHD8 USP8 SMARCA4 PRDM15 ALPK2 | 8.58e-04 | 368 | 197 | 11 | GO:0030111 |
| GeneOntologyBiologicalProcess | regulation of gastrulation | 8.68e-04 | 20 | 197 | 3 | GO:0010470 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase III | 8.68e-04 | 20 | 197 | 3 | GO:0045945 | |
| GeneOntologyBiologicalProcess | metanephric mesenchymal cell differentiation | 8.91e-04 | 5 | 197 | 2 | GO:0072162 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of microtubule cytoskeleton polarity | 8.91e-04 | 5 | 197 | 2 | GO:0030951 | |
| GeneOntologyBiologicalProcess | regulation of glucose mediated signaling pathway | 8.91e-04 | 5 | 197 | 2 | GO:1902659 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 9.07e-04 | 78 | 197 | 5 | GO:2000036 | |
| GeneOntologyBiologicalProcess | urogenital system development | 9.61e-04 | 79 | 197 | 5 | GO:0001655 | |
| GeneOntologyBiologicalProcess | rRNA transcription | 9.63e-04 | 46 | 197 | 4 | GO:0009303 | |
| GeneOntologyBiologicalProcess | centrosome cycle | 1.03e-03 | 164 | 197 | 7 | GO:0007098 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 1.04e-03 | 47 | 197 | 4 | GO:2000316 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | DLGAP5 CKAP5 CHEK1 DCTN1 INO80D DRG1 FZR1 FBXO5 CASKIN1 MKI67 SCFD1 DCDC2 SMARCA5 MAGEL2 HDAC6 BAZ1B FHOD3 XRCC1 LIMK1 SLF2 SMARCA4 MEIOSIN PHF10 TOP2A EP300 | 1.05e-03 | 1342 | 197 | 25 | GO:0033043 |
| GeneOntologyBiologicalProcess | cell cycle phase transition | RPS6 DLGAP5 CHEK1 JADE1 INTS3 FZR1 FBXO5 FOXO4 TIMELESS MN1 CTDSP2 ORC1 BRD4 SMARCA4 PHF10 | 1.05e-03 | 627 | 197 | 15 | GO:0044770 |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 1.10e-03 | 166 | 197 | 7 | GO:0014074 | |
| GeneOntologyBiologicalProcess | cell division | SOX5 STAG1 CKAP5 POGZ DCTN1 FZR1 FBXO5 MICAL3 TIMELESS EXOC7 ANK3 THOC5 LIG1 USP8 PRDM15 TOP2A | 1.11e-03 | 697 | 197 | 16 | GO:0051301 |
| GeneOntologyBiologicalProcess | regulation of ubiquitin-protein transferase activity | 1.13e-03 | 48 | 197 | 4 | GO:0051438 | |
| GeneOntologyCellularComponent | chromatin | SOX5 MBTD1 STAG1 FAM47C CHD3 POGZ CHEK1 JADE1 VSX1 INO80D HP1BP3 LHX9 SINHCAF AHR FOXO4 TIMELESS DLX2 CHD6 DLX5 TAF1L FOXJ1 SOX6 SMARCA5 TCF21 ARID4A FAAP24 BAZ1B CHD8 XRCC1 ATF6B KANSL3 OTX2 BRD2 SLF2 CBX6 BRD4 EPC1 OSR1 H1-6 SMARCA4 TMPO ELF1 PHF14 KDM4A KAT6B PHF10 STAG3 EP300 CBX8 KDM4B | 3.64e-15 | 1480 | 203 | 50 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear body | NOLC1 STAG1 ZC3H13 SRSF11 EWSR1 CHD3 JADE1 HP1BP3 DRG1 PSME4 RBM27 MKI67 PLAG1 FOXO4 GCNA CCNL2 MKNK2 ZC3H18 API5 SFMBT2 LIMK1 UBE2O BRD2 SLF2 CBX6 EPC1 EXO1 PRDM15 | 5.74e-08 | 903 | 203 | 28 | GO:0016604 |
| GeneOntologyCellularComponent | chromosomal region | STAG1 CKAP5 CHEK1 DCTN1 MKI67 SMARCA5 CENPU BAZ1B XRCC1 THOC5 ORC1 SLF2 SMARCA4 KDM4A PHF10 STAG3 TOP2A KDM4B | 1.69e-07 | 421 | 203 | 18 | GO:0098687 |
| GeneOntologyCellularComponent | nuclear chromosome | CHEK1 INO80D SINHCAF TIMELESS SMARCA5 ARID4A BAZ1B ORC1 BRD4 H1-6 SMARCA4 SPIDR STAG3 TOP2A | 2.04e-07 | 254 | 203 | 14 | GO:0000228 |
| GeneOntologyCellularComponent | condensed chromosome | CKAP5 CHEK1 DCTN1 MKI67 SMARCA5 CENPU BAZ1B SLF2 BRD4 H1-6 SMARCA4 PHF10 STAG3 TOP2A | 1.97e-06 | 307 | 203 | 14 | GO:0000793 |
| GeneOntologyCellularComponent | chromosome, centromeric region | STAG1 CKAP5 DCTN1 MKI67 SMARCA5 CENPU BAZ1B SMARCA4 KDM4A PHF10 STAG3 TOP2A KDM4B | 3.24e-06 | 276 | 203 | 13 | GO:0000775 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NOLC1 CHD3 POLR1G INTS3 INO80D FZR1 SINHCAF AHR AFF1 TIMELESS TAF1L SMARCA5 HDAC6 ARID4A FAAP24 BAZ1B CHD8 PYM1 API5 XRCC1 ATF6B THOC5 RYBP ORC1 SNIP1 GTF2E2 CBX6 BRD4 SMARCA4 PHF10 CBX8 MYBL2 | 3.73e-06 | 1377 | 203 | 32 | GO:0140513 |
| GeneOntologyCellularComponent | heterochromatin | 5.84e-05 | 101 | 203 | 7 | GO:0000792 | |
| GeneOntologyCellularComponent | nuclear speck | ZC3H13 SRSF11 JADE1 HP1BP3 PSME4 RBM27 PLAG1 FOXO4 CCNL2 ZC3H18 API5 SFMBT2 LIMK1 BRD2 | 8.68e-05 | 431 | 203 | 14 | GO:0016607 |
| GeneOntologyCellularComponent | WICH complex | 9.38e-05 | 2 | 203 | 2 | GO:0090535 | |
| GeneOntologyCellularComponent | pericentric heterochromatin | 2.51e-04 | 32 | 203 | 4 | GO:0005721 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 3.12e-04 | 94 | 203 | 6 | GO:0000123 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 3.50e-04 | 96 | 203 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | site of DNA damage | 3.90e-04 | 137 | 203 | 7 | GO:0090734 | |
| GeneOntologyCellularComponent | site of double-strand break | 4.59e-04 | 101 | 203 | 6 | GO:0035861 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 5.37e-04 | 104 | 203 | 6 | GO:0031248 | |
| GeneOntologyCellularComponent | centrosome | RPS7 DLGAP5 CKAP5 CHD3 CHEK1 JADE1 CCDC38 DCTN1 KIAA0753 CEP78 PLAG1 EXOC7 DCDC2 HDAC6 CEP162 CENPU TACC2 KIF3A | 5.40e-04 | 770 | 203 | 18 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | RPS7 DLGAP5 CKAP5 CHD3 CHEK1 JADE1 CCDC38 DCTN1 KIAA0753 CEP78 PLAG1 EXOC7 DCDC2 HDAC6 CEP162 CENPU TACC2 KIF3A TSKS TOP2A | 6.55e-04 | 919 | 203 | 20 | GO:0005815 |
| GeneOntologyCellularComponent | acetyltransferase complex | 6.88e-04 | 109 | 203 | 6 | GO:1902493 | |
| GeneOntologyCellularComponent | fibrillar center | 8.45e-04 | 156 | 203 | 7 | GO:0001650 | |
| GeneOntologyCellularComponent | centriole | 1.49e-03 | 172 | 203 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | male germ cell nucleus | 1.51e-03 | 86 | 203 | 5 | GO:0001673 | |
| GeneOntologyCellularComponent | centriolar satellite | 1.58e-03 | 128 | 203 | 6 | GO:0034451 | |
| GeneOntologyCellularComponent | ATPase complex | 1.65e-03 | 129 | 203 | 6 | GO:1904949 | |
| GeneOntologyCellularComponent | B-WICH complex | 2.53e-03 | 8 | 203 | 2 | GO:0110016 | |
| HumanPheno | Posteriorly rotated ears | SOX5 TMEM237 POGZ KIAA0753 DRG1 MN1 RAP1B TCOF1 BAZ1B CHD8 GTF2IRD1 ORC1 LIMK1 OTX2 BRD4 KAT6B SPEN EP300 KDM4B RAI1 | 1.65e-05 | 470 | 78 | 20 | HP:0000358 |
| HumanPheno | Hyperactivity | SOX5 CHD3 POGZ FZR1 UBTF PLAG1 SOX6 DCDC2 MAGEL2 ANK3 SZT2 BAZ1B CHD8 GTF2IRD1 LIMK1 SLF2 BRD4 SMARCA4 SPEN EP300 KDM4B RAI1 | 1.88e-05 | 558 | 78 | 22 | HP:0000752 |
| HumanPheno | Wide nasal bridge | SOX5 RPS7 CHD3 RYR1 KIAA0753 DRG1 GNPAT SOX6 HYOU1 TCOF1 BAZ1B CHD8 GTF2IRD1 LIMK1 SMARCA4 KAT6B SPEN EP300 KDM4B RAI1 | 5.14e-05 | 508 | 78 | 20 | HP:0000431 |
| HumanPheno | Aplasia/Hypoplasia of the mandible | STAG1 TMEM237 RPS7 POGZ KIAA0753 PLAG1 CHD6 GNPAT SOX6 RAP1B HYOU1 HDAC6 TCOF1 BAZ1B CHD8 GTF2IRD1 ORC1 SNIP1 LIMK1 GTF2E2 OTX2 BRD4 KAT6B SPEN EP300 KDM4B RAI1 | 7.44e-05 | 845 | 78 | 27 | HP:0009118 |
| HumanPheno | Abnormal location of ears | SOX5 STAG1 TMEM237 RPS7 CHD3 POGZ RYR1 KIAA0753 DRG1 PLAG1 EXOC7 MN1 SOX6 RAP1B MAGEL2 HDAC6 TCOF1 BAZ1B CHD8 GTF2IRD1 ORC1 LIMK1 OTX2 BRD4 KAT6B SPEN EP300 KDM4B RAI1 | 7.50e-05 | 945 | 78 | 29 | HP:0000357 |
| HumanPheno | Abnormal thought pattern | SOX5 CHD3 POGZ DCTN1 DCDC2 MAGEL2 ANK3 BAZ1B CHD8 GTF2IRD1 USP8 LIMK1 BRD4 SPEN EP300 KDM4B RAI1 | 9.46e-05 | 404 | 78 | 17 | HP:5200269 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | STAG1 TMEM237 RPS7 POGZ KIAA0753 PLAG1 CHD6 GNPAT SOX6 RAP1B SFRP4 HYOU1 HDAC6 TCOF1 BAZ1B CHD8 GTF2IRD1 ORC1 SNIP1 LIMK1 GTF2E2 OTX2 BRD4 KAT6B SPEN EP300 KDM4B RAI1 | 1.13e-04 | 915 | 78 | 28 | HP:0009116 |
| HumanPheno | Attention deficit hyperactivity disorder | SOX5 CHD3 FZR1 PLAG1 SOX6 DCDC2 MAGEL2 SZT2 BAZ1B CHD8 GTF2IRD1 LIMK1 SLF2 BRD4 SPEN KDM4B RAI1 | 1.24e-04 | 413 | 78 | 17 | HP:0007018 |
| HumanPheno | Autistic behavior | STAG1 TMEM237 CHD3 POGZ FZR1 UBTF SOX6 MAGEL2 ANK3 SZT2 BAZ1B CHD8 GTF2IRD1 ADAM22 LIMK1 OTX2 SLF2 BRD4 SMARCA4 SPEN EP300 KDM4B RAI1 | 1.28e-04 | 678 | 78 | 23 | HP:0000729 |
| HumanPheno | Abnormality of mouth size | STAG1 POGZ RYR1 CHD6 SOX6 HDAC6 TCOF1 BAZ1B GTF2IRD1 ORC1 SNIP1 LIMK1 OTX2 SMARCA4 SPEN EP300 RAI1 | 1.77e-04 | 425 | 78 | 17 | HP:0011337 |
| HumanPheno | Increased nuchal translucency | 1.88e-04 | 56 | 78 | 6 | HP:0010880 | |
| HumanPheno | Micrognathia | STAG1 TMEM237 RPS7 POGZ KIAA0753 PLAG1 CHD6 GNPAT SOX6 RAP1B HYOU1 HDAC6 TCOF1 BAZ1B CHD8 GTF2IRD1 ORC1 SNIP1 LIMK1 GTF2E2 BRD4 KAT6B SPEN EP300 KDM4B RAI1 | 1.96e-04 | 843 | 78 | 26 | HP:0000347 |
| HumanPheno | Abnormality of the forehead | SOX5 TMEM237 RPS7 CHD3 POGZ RYR1 KIAA0753 DRG1 FZR1 KCNJ1 PLAG1 CHD6 DLX5 MN1 GNPAT SOX6 MAGEL2 HYOU1 HDAC6 TCOF1 SZT2 BAZ1B GTF2IRD1 ADAM22 ORC1 LIMK1 BRD4 SMARCA4 KAT6B SPEN EP300 KDM4B RAI1 | 1.97e-04 | 1208 | 78 | 33 | HP:0000290 |
| HumanPheno | Diagnostic behavioral phenotype | STAG1 TMEM237 CHD3 POGZ FZR1 CEP78 UBTF SOX6 MAGEL2 ANK3 SZT2 BAZ1B CHD8 GTF2IRD1 ADAM22 LIMK1 OTX2 SLF2 BRD4 SMARCA4 SPEN EP300 KDM4B RAI1 | 2.04e-04 | 747 | 78 | 24 | HP:0025783 |
| HumanPheno | Auditory sensitivity | 2.20e-04 | 37 | 78 | 5 | HP:0025112 | |
| HumanPheno | Auditory hypersensitivity | 2.20e-04 | 37 | 78 | 5 | HP:5200060 | |
| HumanPheno | High hypermetropia | 2.28e-04 | 82 | 78 | 7 | HP:0008499 | |
| HumanPheno | Abnormal mandible morphology | STAG1 TMEM237 RPS7 POGZ RYR1 KIAA0753 PLAG1 CHD6 EXOC7 GNPAT SOX6 RAP1B MAGEL2 SFRP4 HYOU1 HDAC6 TCOF1 BAZ1B CHD8 GTF2IRD1 ORC1 SNIP1 LIMK1 GTF2E2 OTX2 BRD4 KAT6B SPEN EP300 KDM4B RAI1 | 2.66e-04 | 1118 | 78 | 31 | HP:0000277 |
| HumanPheno | Abnormality of the jaws | SOX5 STAG1 TMEM237 RPS7 POGZ RYR1 KIAA0753 PLAG1 CHD6 EXOC7 GNPAT SOX6 RAP1B MAGEL2 SFRP4 HYOU1 HDAC6 TCOF1 BAZ1B CHD8 GTF2IRD1 ORC1 SNIP1 LIMK1 GTF2E2 OTX2 BRD4 KAT6B SPEN EP300 KDM4B RAI1 | 2.80e-04 | 1175 | 78 | 32 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | SOX5 STAG1 TMEM237 RPS7 POGZ RYR1 KIAA0753 PLAG1 CHD6 EXOC7 GNPAT SOX6 RAP1B MAGEL2 SFRP4 HYOU1 HDAC6 TCOF1 BAZ1B CHD8 GTF2IRD1 ORC1 SNIP1 LIMK1 GTF2E2 OTX2 BRD4 KAT6B SPEN EP300 KDM4B RAI1 | 2.85e-04 | 1176 | 78 | 32 | HP:0030791 |
| MousePheno | abnormal pterygoid bone morphology | 1.01e-05 | 12 | 172 | 4 | MP:0004453 | |
| Domain | Bromodomain_CS | 2.18e-07 | 26 | 193 | 6 | IPR018359 | |
| Domain | PHD | 3.48e-07 | 89 | 193 | 9 | SM00249 | |
| Domain | Znf_PHD | 4.21e-07 | 91 | 193 | 9 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.09e-07 | 95 | 193 | 9 | PS50016 | |
| Domain | ZF_PHD_1 | 6.66e-07 | 96 | 193 | 9 | PS01359 | |
| Domain | Chromodomain-like | 8.16e-07 | 32 | 193 | 6 | IPR016197 | |
| Domain | Chromo/shadow_dom | 9.89e-07 | 33 | 193 | 6 | IPR000953 | |
| Domain | CHROMO | 9.89e-07 | 33 | 193 | 6 | SM00298 | |
| Domain | MBT | 1.34e-06 | 9 | 193 | 4 | SM00561 | |
| Domain | MBT | 1.34e-06 | 9 | 193 | 4 | PS51079 | |
| Domain | - | 1.51e-06 | 55 | 193 | 7 | 1.10.30.10 | |
| Domain | BROMODOMAIN_1 | 2.01e-06 | 37 | 193 | 6 | PS00633 | |
| Domain | MBT | 2.21e-06 | 10 | 193 | 4 | PF02820 | |
| Domain | Mbt | 2.21e-06 | 10 | 193 | 4 | IPR004092 | |
| Domain | Bromodomain | 2.36e-06 | 38 | 193 | 6 | PF00439 | |
| Domain | EPHD | 2.55e-06 | 22 | 193 | 5 | PS51805 | |
| Domain | Znf_FYVE_PHD | 3.07e-06 | 147 | 193 | 10 | IPR011011 | |
| Domain | BROMODOMAIN_2 | 3.75e-06 | 41 | 193 | 6 | PS50014 | |
| Domain | Chromo_domain | 4.05e-06 | 24 | 193 | 5 | IPR023780 | |
| Domain | Bromodomain | 4.34e-06 | 42 | 193 | 6 | IPR001487 | |
| Domain | BROMO | 4.34e-06 | 42 | 193 | 6 | SM00297 | |
| Domain | - | 4.34e-06 | 42 | 193 | 6 | 1.20.920.10 | |
| Domain | HMG_box_dom | 4.73e-06 | 65 | 193 | 7 | IPR009071 | |
| Domain | Chromo | 6.17e-06 | 26 | 193 | 5 | PF00385 | |
| Domain | CHROMO_1 | 9.06e-06 | 28 | 193 | 5 | PS00598 | |
| Domain | CHROMO_2 | 9.06e-06 | 28 | 193 | 5 | PS50013 | |
| Domain | PHD | 1.24e-05 | 75 | 193 | 7 | PF00628 | |
| Domain | HMG_box | 1.73e-05 | 53 | 193 | 6 | PF00505 | |
| Domain | SNF2_N | 1.80e-05 | 32 | 193 | 5 | IPR000330 | |
| Domain | SNF2_N | 1.80e-05 | 32 | 193 | 5 | PF00176 | |
| Domain | HMG_BOX_2 | 1.93e-05 | 54 | 193 | 6 | PS50118 | |
| Domain | HMG | 1.93e-05 | 54 | 193 | 6 | SM00398 | |
| Domain | BRK | 2.12e-05 | 6 | 193 | 3 | SM00592 | |
| Domain | BRK_domain | 2.12e-05 | 6 | 193 | 3 | IPR006576 | |
| Domain | BRK | 2.12e-05 | 6 | 193 | 3 | PF07533 | |
| Domain | Znf_PHD-finger | 1.67e-04 | 79 | 193 | 6 | IPR019787 | |
| Domain | - | 2.23e-04 | 12 | 193 | 3 | 3.40.50.1010 | |
| Domain | H15 | 2.88e-04 | 13 | 193 | 3 | SM00526 | |
| Domain | Linker_histone | 2.88e-04 | 13 | 193 | 3 | PF00538 | |
| Domain | H15 | 2.88e-04 | 13 | 193 | 3 | PS51504 | |
| Domain | Distal-less_N | 3.17e-04 | 3 | 193 | 2 | IPR022135 | |
| Domain | DLL_N | 3.17e-04 | 3 | 193 | 2 | PF12413 | |
| Domain | Histone_H1/H5_H15 | 3.64e-04 | 14 | 193 | 3 | IPR005818 | |
| Domain | Znf_UBP | 3.64e-04 | 14 | 193 | 3 | IPR001607 | |
| Domain | zf-UBP | 3.64e-04 | 14 | 193 | 3 | PF02148 | |
| Domain | PIN_domain-like | 3.64e-04 | 14 | 193 | 3 | IPR029060 | |
| Domain | ZF_UBP | 3.64e-04 | 14 | 193 | 3 | PS50271 | |
| Domain | CNH | 3.64e-04 | 14 | 193 | 3 | SM00036 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 4.50e-04 | 35 | 193 | 4 | IPR002464 | |
| Domain | CNH | 4.51e-04 | 15 | 193 | 3 | PF00780 | |
| Domain | CNH | 4.51e-04 | 15 | 193 | 3 | PS50219 | |
| Domain | CNH_dom | 4.51e-04 | 15 | 193 | 3 | IPR001180 | |
| Domain | DEAH_ATP_HELICASE | 6.20e-04 | 38 | 193 | 4 | PS00690 | |
| Domain | BET | 6.29e-04 | 4 | 193 | 2 | PF17035 | |
| Domain | SCD | 6.29e-04 | 4 | 193 | 2 | PS51425 | |
| Domain | SCD | 6.29e-04 | 4 | 193 | 2 | IPR020839 | |
| Domain | STAG | 6.29e-04 | 4 | 193 | 2 | PF08514 | |
| Domain | MAPKKKK | 6.29e-04 | 4 | 193 | 2 | IPR021160 | |
| Domain | STAG | 6.29e-04 | 4 | 193 | 2 | IPR013721 | |
| Domain | NET_dom | 6.29e-04 | 4 | 193 | 2 | IPR027353 | |
| Domain | NET | 6.29e-04 | 4 | 193 | 2 | PS51525 | |
| Domain | Chromodomain_CS | 7.91e-04 | 18 | 193 | 3 | IPR023779 | |
| Domain | - | USP45 CHD3 JADE1 USP49 HDAC6 BAZ1B PHF14 KDM4A KAT6B FGD6 PHF10 KDM4B RUFY4 | 8.23e-04 | 449 | 193 | 13 | 3.30.40.10 |
| Domain | WHTH_DNA-bd_dom | 9.55e-04 | 242 | 193 | 9 | IPR011991 | |
| Domain | Znf_RING/FYVE/PHD | USP45 CHD3 JADE1 USP49 HDAC6 BAZ1B PHF14 KDM4A KAT6B FGD6 PHF10 KDM4B RUFY4 | 1.01e-03 | 459 | 193 | 13 | IPR013083 |
| Domain | Znf_FCS | 1.04e-03 | 5 | 193 | 2 | IPR012313 | |
| Domain | SLED | 1.04e-03 | 5 | 193 | 2 | IPR021987 | |
| Domain | SLED | 1.04e-03 | 5 | 193 | 2 | PF12140 | |
| Domain | CBX7_C | 1.04e-03 | 5 | 193 | 2 | PF17218 | |
| Domain | BRCT_2 | 1.04e-03 | 5 | 193 | 2 | PF16589 | |
| Domain | CBX7_C | 1.04e-03 | 5 | 193 | 2 | IPR033773 | |
| Domain | RIH_assoc-dom | 1.55e-03 | 6 | 193 | 2 | IPR013662 | |
| Domain | ZF_FCS | 1.55e-03 | 6 | 193 | 2 | PS51024 | |
| Domain | Ins145_P3_rec | 1.55e-03 | 6 | 193 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.55e-03 | 6 | 193 | 2 | PF08454 | |
| Domain | RIH_dom | 1.55e-03 | 6 | 193 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.55e-03 | 6 | 193 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.55e-03 | 6 | 193 | 2 | IPR015925 | |
| Domain | - | 1.55e-03 | 6 | 193 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.55e-03 | 6 | 193 | 2 | PF01365 | |
| Domain | - | 1.98e-03 | 218 | 193 | 8 | 1.10.10.10 | |
| Domain | DUF3585 | 2.16e-03 | 7 | 193 | 2 | IPR022735 | |
| Domain | DUF3585 | 2.16e-03 | 7 | 193 | 2 | PF12130 | |
| Domain | TUDOR | 2.65e-03 | 27 | 193 | 3 | SM00333 | |
| Domain | EPL1 | 2.86e-03 | 8 | 193 | 2 | PF10513 | |
| Domain | Enhancer_polycomb-like_N | 2.86e-03 | 8 | 193 | 2 | IPR019542 | |
| Domain | Tudor | 3.59e-03 | 30 | 193 | 3 | IPR002999 | |
| Domain | HMG_box_2 | 3.65e-03 | 9 | 193 | 2 | PF09011 | |
| Domain | MIR | 4.53e-03 | 10 | 193 | 2 | PF02815 | |
| Domain | JmjN | 4.53e-03 | 10 | 193 | 2 | SM00545 | |
| Domain | An_peroxidase | 4.53e-03 | 10 | 193 | 2 | PF03098 | |
| Domain | MIR_motif | 4.53e-03 | 10 | 193 | 2 | IPR016093 | |
| Domain | Haem_peroxidase_animal | 4.53e-03 | 10 | 193 | 2 | IPR019791 | |
| Domain | JmjN | 4.53e-03 | 10 | 193 | 2 | PF02375 | |
| Domain | Rap_GAP | 4.53e-03 | 10 | 193 | 2 | PF02145 | |
| Domain | MIR | 4.53e-03 | 10 | 193 | 2 | PS50919 | |
| Domain | MIR | 4.53e-03 | 10 | 193 | 2 | SM00472 | |
| Domain | Haem_peroxidase | 4.53e-03 | 10 | 193 | 2 | IPR010255 | |
| Domain | JMJN | 4.53e-03 | 10 | 193 | 2 | PS51183 | |
| Domain | PEROXIDASE_3 | 4.53e-03 | 10 | 193 | 2 | PS50292 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 8.84e-07 | 34 | 139 | 6 | MM15531 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.49e-06 | 37 | 139 | 6 | M27797 | |
| Pathway | REACTOME_DNA_REPAIR | USP45 CHEK1 INO80D TIMELESS REV1 SMARCA5 FAAP24 BAZ1B XRCC1 LIG1 EXO1 KDM4A SPIDR KDM4B | 1.62e-06 | 301 | 139 | 14 | MM15433 |
| Pathway | REACTOME_DNA_REPAIR | USP45 CHEK1 INO80D TIMELESS REV1 SMARCA5 FAAP24 BAZ1B XRCC1 LIG1 EXO1 KDM4A SPIDR KDM4B | 5.07e-06 | 332 | 139 | 14 | M15434 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 1.40e-05 | 146 | 139 | 9 | MM15292 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | SRSF11 CHD3 CHEK1 POLR1G INTS3 PSME4 UBTF FOXO4 TAF1L SMARCA5 HDAC6 L3MBTL2 BAZ1B TFAM KANSL3 RYBP GTF2E2 CBX6 SCMH1 EPC1 EXO1 SMARCA4 ELF1 EP300 CBX8 | 1.98e-05 | 1022 | 139 | 25 | MM15436 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 4.68e-05 | 170 | 139 | 9 | M27582 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 9.75e-05 | 25 | 139 | 4 | MM15546 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.36e-04 | 153 | 139 | 8 | MM15522 | |
| Pathway | REACTOME_CELL_CYCLE | STAG1 CKAP5 CHEK1 DCTN1 FZR1 PSME4 FBXO5 CEP78 SMARCA5 CENPU ORC1 LIG1 EXO1 TMPO STAG3 TOP2A EP300 MYBL2 | 1.60e-04 | 694 | 139 | 18 | M543 |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | 2.03e-04 | 30 | 139 | 4 | MM15173 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 3.34e-04 | 34 | 139 | 4 | M27826 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 3.40e-04 | 175 | 139 | 8 | MM14941 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | CHD3 JADE1 ARID4A KANSL3 EPC1 SMARCA4 KDM4A KAT6B EP300 KDM4B | 3.63e-04 | 272 | 139 | 10 | M29619 |
| Pathway | PID_RB_1PATHWAY | 4.46e-04 | 65 | 139 | 5 | M279 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 MBTD1 TMEM237 RSL1D1 RPS6 ZC3H13 RPS7 DLGAP5 CKAP5 SRSF11 EWSR1 CHD3 POGZ POLR1G INTS3 INO80D HP1BP3 HMG20A ZNF512B SINHCAF RBM27 UBTF MKI67 CHD6 NOP2 TAF1L NOL8 SMARCA5 L3MBTL2 TCOF1 ARID4A FAAP24 BAZ1B ZC3H18 XRCC1 GTF2IRD1 TFAM THOC5 KANSL3 RYBP ORC1 SNIP1 BRD2 SLF2 TRAM1 BRD4 EPC1 H1-6 EXO1 SMARCA4 TMPO PHF14 SPEN ZNF281 TOP2A EP300 CBX8 RAI1 MYBL2 | 8.60e-36 | 1294 | 204 | 59 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 RSL1D1 ZC3H13 DLGAP5 CKAP5 CHD3 POGZ POLR1G INTS3 MKI67 AFF1 MICAL3 TIMELESS SCFD1 NOP2 MN1 SMARCA5 HDAC6 TCOF1 ARID4A CAST BAZ1B ZC3H18 GTF2IRD1 MICALL1 KANSL3 LIG1 SH2D4A BRD2 BRD4 ZFP91 EXO1 SMARCA4 TMPO ELF1 PHF14 KAT6B SPEN PHF10 TOP2A KDM4B MYBL2 | 3.39e-28 | 774 | 204 | 42 | 15302935 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | STAG1 DLGAP5 CHD3 POGZ HP1BP3 HMG20A ZNF512B FSIP2 UBTF MKI67 TIMELESS CHD6 NOP2 SMARCA5 L3MBTL2 ARID4A BAZ1B CHD8 ZC3H18 XRCC1 UBE2O BRD2 SCMH1 BRD4 ZFP91 SMARCA4 TMPO ELF1 PHF14 KDM4A SPEN ZNF281 PRDM15 TOP2A CBX8 KDM4B RAI1 MYBL2 | 1.00e-27 | 608 | 204 | 38 | 36089195 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 RSL1D1 ZC3H13 RPS7 DLGAP5 KRI1 SRSF11 EWSR1 CHD3 POGZ HP1BP3 TASOR2 HMG20A ZNF512B PRAM1 RBM27 UBTF MKI67 NOP2 TAF1L NOL8 SMARCA5 ARID4A LIN28B DNAJC8 CAST BAZ1B CHD8 ZC3H18 API5 XRCC1 TFAM GTF2E2 BRD2 SLF2 BRD4 SMARCA4 TMPO PHF14 SPEN ZNF281 TOP2A CBX8 RAI1 MYBL2 | 1.14e-27 | 954 | 204 | 45 | 36373674 |
| Pubmed | NOLC1 RSL1D1 CHD3 POGZ ZNF512B UBTF MKI67 SMARCA5 TCOF1 BAZ1B ZC3H18 BRD2 BRD4 SMARCA4 PHF14 SPEN TOP2A RAI1 | 1.12e-21 | 103 | 204 | 18 | 32744500 | |
| Pubmed | SOX5 NOLC1 MBTD1 RSL1D1 KRI1 EWSR1 CHD3 POGZ EDC4 VSX1 INO80D HP1BP3 HMG20A ZNF512B SINHCAF RBM27 UBTF MKI67 CHD6 NOP2 TAF1L SOX6 SMARCA5 L3MBTL2 ARID4A BAZ1B CHD8 ZC3H18 XRCC1 TFAM KANSL3 RYBP UBE2O BRD2 EPC1 ZFP91 SMARCA4 ELF1 SPEN ZNF281 PHF10 EP300 MYBL2 | 6.35e-19 | 1429 | 204 | 43 | 35140242 | |
| Pubmed | SOX5 EWSR1 POGZ LHX9 UBTF MKI67 AHR PLAG1 FOXO4 DLX5 TCF21 OSR2 BAZ1B TACC2 GTF2IRD1 TFAM CTDSP2 LIMK1 OTX2 BRD2 BRD4 OSR1 SMARCA4 ELF1 PHF14 KDM4A KAT6B PHF10 KDM4B MYBL2 | 2.90e-17 | 709 | 204 | 30 | 22988430 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | KRI1 EWSR1 CHD3 RBM27 MKI67 NOP2 TAF1L NOL8 SMARCA5 RAP1B BAZ1B CHD8 ZC3H18 XRCC1 GTF2E2 BRD4 SMARCA4 TMPO SPEN ZNF281 TOP2A | 3.54e-17 | 283 | 204 | 21 | 30585729 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | NOLC1 RPS6 CHD3 POGZ INTS3 HP1BP3 HMG20A CEP78 UBTF MKI67 SMARCA5 BAZ1B CHD8 ZC3H18 XRCC1 TFAM BRD2 CBX6 SCMH1 BRD4 SMARCA4 TMPO ZNF281 TOP2A CBX8 | 1.49e-15 | 533 | 204 | 25 | 30554943 |
| Pubmed | MBTD1 CHD3 CHD6 SMARCA5 HDAC6 BAZ1B CHD8 RYBP CBX6 EPC1 SMARCA4 KDM4A KAT6B PHF10 EP300 KDM4B | 1.55e-15 | 157 | 204 | 16 | 30186101 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SOX5 MBTD1 POGZ ZNF512B MKI67 SMARCA5 HYOU1 L3MBTL2 ARID4A BAZ1B CHD8 TFAM OTX2 EPC1 SMARCA4 SPEN ZNF281 PHF10 TOP2A EP300 RAI1 | 2.68e-15 | 351 | 204 | 21 | 38297188 |
| Pubmed | NOLC1 RSL1D1 RPS6 ZC3H13 RPS7 CKAP5 KRI1 EWSR1 POGZ EDC4 HP1BP3 TASOR2 PNPT1 UBTF MKI67 NOP2 SMARCA5 HYOU1 TCOF1 BAZ1B CHD8 ZC3H18 UBE2O SMARCA4 SPEN RAI1 | 1.84e-14 | 653 | 204 | 26 | 22586326 | |
| Pubmed | NOLC1 MBTD1 CHD3 POGZ CHEK1 POLR1G INO80D HMG20A DRG1 ZNF512B FBXO5 AHR IQCM CCNL2 SMARCA5 HDAC6 TCOF1 BAZ1B CHD8 ZC3H18 TFAM SNIP1 BRD2 BRD4 EPC1 ZFP91 SMARCA4 KAT6B ZNF281 PHF10 TOP2A EP300 RAI1 | 2.08e-14 | 1116 | 204 | 33 | 31753913 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | NOLC1 RSL1D1 RPS6 ZC3H13 RPS7 KRI1 EWSR1 CHD3 HP1BP3 ZNF512B UBTF MKI67 NOP2 SMARCA5 TCOF1 BAZ1B ZC3H18 API5 BRD2 SMARCA4 TMPO PHF14 SPEN TOP2A RAI1 | 2.65e-14 | 605 | 204 | 25 | 28977666 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 RSL1D1 RPS6 DLGAP5 CKAP5 CHD3 EDC4 DCTN1 HP1BP3 ZNF512B RBM27 UBTF MKI67 NOP2 NOL8 SMARCA5 L3MBTL2 TCOF1 CAST BAZ1B PYM1 TACC2 AKAP12 USP8 GTF2E2 UBE2O SMARCA4 TMPO ZNF281 TOP2A | 4.33e-14 | 934 | 204 | 30 | 33916271 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 RSL1D1 RPS7 CKAP5 KRI1 CHD3 POLR1G HP1BP3 DRG1 CEP78 RBM27 UBTF MKI67 EXOC7 NOP2 NOL8 SMARCA5 CENPU BAZ1B TACC2 XRCC1 TFAM EXO1 SMARCA4 TMPO TOP2A CBX8 | 8.24e-14 | 759 | 204 | 27 | 35915203 |
| Pubmed | NOLC1 RSL1D1 CKAP5 EWSR1 CHD3 POGZ CHEK1 EDC4 INO80D DRG1 PRAM1 RBM27 UBTF MKI67 NOP2 HYOU1 DNAJC8 CHD8 XRCC1 KANSL3 LIG1 BRD4 ZFP91 SMARCA4 TMPO ELF1 SPEN ZNF281 TOP2A EP300 RAI1 MYBL2 | 9.04e-14 | 1103 | 204 | 32 | 34189442 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NOLC1 STAG1 RSL1D1 CHD3 POGZ EDC4 HP1BP3 DRG1 ITPR2 MKI67 NOP2 TCOF1 BAZ1B CHD8 ZC3H18 XRCC1 KAT6B SPEN ZNF281 | 2.14e-13 | 341 | 204 | 19 | 32971831 |
| Pubmed | SOX5 ZC3H13 CHD3 POGZ JADE1 HMG20A UBTF AHR PLAG1 SOX6 SMARCA5 BAZ1B TFAM ATF6B CTDSP2 LIMK1 OTX2 BRD2 BRD4 OSR1 ELF1 PHF14 KDM4A KAT6B PHF10 KDM4B MYBL2 | 3.59e-13 | 808 | 204 | 27 | 20412781 | |
| Pubmed | NOLC1 TRIM75 CHD3 INTS3 TASOR2 HMG20A UBTF CHD6 CHD8 PYM1 ZC3H18 RYBP SNIP1 LIG1 BRD2 BRD4 SMARCA4 PHF14 SPEN ZNF281 TOP2A | 7.58e-13 | 469 | 204 | 21 | 27634302 | |
| Pubmed | RSL1D1 DLGAP5 CKAP5 EDC4 KIAA0753 ZNF512B RBM27 MICAL3 CHD6 NOP2 ARID4A CEP162 XRCC1 KIF3A UBE2O BRD2 EPC1 ZFP91 SPEN PRDM15 EP300 CBX8 KDM4B RAI1 | 8.47e-13 | 645 | 204 | 24 | 25281560 | |
| Pubmed | NOLC1 PHACTR2 STAG1 NHSL2 RSL1D1 RPS6 SIPA1L3 RPS7 SRSF11 CHD3 DCTN1 LYST CXorf65 HP1BP3 TASOR2 ACSM3 PXDN CHD6 SMARCA5 TTC24 RAP1B HYOU1 DUOX2 TFAM SFMBT2 PPP4R4 RYBP USP8 BRD2 H1-6 TMPO PHF14 SPEN TOP2A RAI1 | 9.47e-13 | 1442 | 204 | 35 | 35575683 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | NOLC1 RSL1D1 RPS7 KRI1 CHD3 POGZ HMG20A UBTF NOP2 SMARCA5 RAP1B BAZ1B ZC3H18 TFAM ZFP91 TMPO PHF14 TOP2A | 1.34e-12 | 330 | 204 | 18 | 33301849 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NOLC1 STAG1 RSL1D1 SIPA1L3 CKAP5 POGZ CHEK1 EDC4 DCTN1 TASOR2 FZR1 FBXO5 CEP78 MKI67 MICAL3 TIMELESS NOP2 HDAC6 L3MBTL2 DNAJC8 CENPU TACC2 AKAP12 KANSL3 ORC1 SH2D4A SMARCA4 TMPO PHF10 TOP2A MYBL2 | 1.73e-12 | 1155 | 204 | 31 | 20360068 |
| Pubmed | NOLC1 TMEM237 RSL1D1 ZC3H13 KRI1 DCTN1 HP1BP3 KIAA0753 DRG1 ITPR2 ZNF512B PNPT1 UBTF SCFD1 NOP2 NOL8 HYOU1 ANK3 L3MBTL2 TCOF1 DNAJC8 BAZ1B PYM1 TFAM ATF6B THOC5 AKAP12 MICALL1 GTF2E2 UBE2O BRD2 DNAJC14 MAP4K5 TRAM1 TMPO | 2.26e-12 | 1487 | 204 | 35 | 33957083 | |
| Pubmed | NOLC1 RPS6 ZC3H13 POGZ HP1BP3 SMARCA5 HDAC6 DNAJC8 BAZ1B CHD8 ZC3H18 SNIP1 BRD2 SMARCA4 SPEN TOP2A | 2.36e-12 | 251 | 204 | 16 | 31076518 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | RPS7 CHD3 POGZ EDC4 DCTN1 HMG20A RBM27 EXOC7 SMARCA5 CHD8 ZC3H18 XRCC1 BRD2 BRD4 ZFP91 PHF14 TOP2A CBX8 RAI1 | 2.72e-12 | 394 | 204 | 19 | 27248496 |
| Pubmed | NOLC1 RSL1D1 ZC3H13 DLGAP5 POLR1G RBM27 MKI67 TIMELESS EXOC7 NOP2 SMARCA5 HDAC6 TCOF1 CHD8 TACC2 LIG1 SH2D4A EPC1 ELF1 SPEN TOP2A | 2.86e-12 | 503 | 204 | 21 | 16964243 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 RSL1D1 RPS6 ZC3H13 SIPA1L3 RPS7 CKAP5 KRI1 EWSR1 EDC4 HP1BP3 TASOR2 DRG1 ITPR2 FZR1 RBM27 UBTF MKI67 NOP2 NOL8 SMARCA5 RAP1B HYOU1 BAZ1B ZC3H18 TFAM THOC5 SMARCA4 TMPO SPEN TOP2A CBX8 | 2.93e-12 | 1257 | 204 | 32 | 36526897 |
| Pubmed | RSL1D1 RPS6 ZC3H13 RPS7 KRI1 SRSF11 EWSR1 CHD3 POLR1G DCTN1 HP1BP3 ZNF512B RBM27 UBTF MKI67 NOP2 NOL8 SMARCA5 TCOF1 BAZ1B ZC3H18 TFAM TRAM1 ZFP91 SMARCA4 TOP2A | 6.77e-12 | 847 | 204 | 26 | 35850772 | |
| Pubmed | NOLC1 MBTD1 USP45 CNST RSL1D1 ZC3H13 DLGAP5 CHD3 JADE1 DCTN1 KIAA0753 SINHCAF PSME4 KCNJ1 UBTF AFF1 TIMELESS DCDC2 RAP1B HYOU1 HDAC6 ANK3 MAP4K3 CEP162 CAST BAZ1B PYM1 TACC2 AKAP12 | 1.05e-11 | 1084 | 204 | 29 | 11544199 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | EWSR1 JADE1 VSX1 HMG20A LHX9 ZNF512B UBTF AHR TIMELESS DLX2 DLX5 FOXJ1 SOX6 SMARCA5 TCF21 GTF2E2 OTX2 CBX6 SCMH1 PHF14 SPEN PHF10 EP300 KDM4B RAI1 MYBL2 | 1.46e-11 | 877 | 204 | 26 | 20211142 |
| Pubmed | RPS6 CKAP5 CHD3 DCTN1 PXDN DENND6B PLAG1 NOP2 CCNL2 L3MBTL2 UTP23 BAZ1B CHD8 SMARCA4 TOP2A EP300 ALPK2 | 1.57e-11 | 332 | 204 | 17 | 37433992 | |
| Pubmed | NOLC1 RSL1D1 RPS7 DLGAP5 CKAP5 HP1BP3 UBTF MKI67 NOP2 SMARCA5 TCOF1 PYM1 XRCC1 TFAM BRD2 BRD4 SMARCA4 TMPO TOP2A | 1.91e-11 | 441 | 204 | 19 | 31239290 | |
| Pubmed | SRSF11 POLR1G ARHGEF17 HP1BP3 TASOR2 MICAL3 RAP1B HYOU1 ANK3 DNAJC8 PYM1 XRCC1 TFAM THOC5 BRD4 ZFP91 TOP2A RAI1 | 3.68e-11 | 403 | 204 | 18 | 35253629 | |
| Pubmed | NOLC1 DLGAP5 POGZ JADE1 ZNF512B PSME4 RBM27 SULF1 CASKIN1 SCFD1 SZT2 CEP162 CHD8 MICALL1 KANSL3 UBE2O KDM4A KAT6B KDM4B RAI1 | 5.68e-11 | 529 | 204 | 20 | 14621295 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | RPS7 SRSF11 CHD3 POGZ TASOR2 MKI67 NOL8 SMARCA5 TCOF1 CHD8 GTF2E2 SMARCA4 TMPO PHF14 TOP2A | 8.61e-11 | 271 | 204 | 15 | 32433965 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | NOLC1 RSL1D1 KRI1 RBM27 MKI67 NOP2 NOL8 TCOF1 BAZ1B ZC3H18 BRD4 TOP2A | 8.70e-11 | 148 | 204 | 12 | 32538781 |
| Pubmed | STAG1 CNST RSL1D1 SIPA1L3 CKAP5 EWSR1 POGZ DCTN1 HMG20A ZNF512B SULF1 DENND6B CHD6 EXOC7 SOX6 CFAP91 HDAC6 ANK3 TCOF1 ADAM22 KIF3A USP8 LIMK1 UBE2O BRD2 DNAJC14 SLF2 SMARCA4 KDM4A EP300 | 1.23e-10 | 1285 | 204 | 30 | 35914814 | |
| Pubmed | TMEM237 RSL1D1 SIPA1L3 KRI1 SRSF11 EWSR1 CHD3 POGZ HP1BP3 DRG1 PNPT1 CEP78 RBM27 MKI67 AHR NOP2 SMARCA5 RAP1B TCOF1 LIN28B PYM1 TFAM THOC5 KANSL3 SNIP1 GTF2E2 ZFP91 SMARCA4 TMPO PHF10 CBX8 | 1.28e-10 | 1371 | 204 | 31 | 36244648 | |
| Pubmed | PHACTR2 CKAP5 RYR1 MKI67 FOXJ1 HDAC6 MAP4K3 CAST XRCC1 GTF2IRD1 ORC1 MAP4K5 BRD4 TMPO TSKS SPEN | 1.35e-10 | 329 | 204 | 16 | 17474147 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 RSL1D1 RPS6 ZC3H13 RPS7 KRI1 SRSF11 EWSR1 POLR1G INTS3 HP1BP3 DRG1 RBM27 MKI67 CHD6 SCFD1 NOP2 SMARCA5 HYOU1 TCOF1 UTP23 BAZ1B CHD8 KANSL3 SNIP1 LIG1 H1-6 SMARCA4 TMPO TOP2A | 2.26e-10 | 1318 | 204 | 30 | 30463901 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 ZC3H13 RPS7 SRSF11 EWSR1 POGZ HP1BP3 HMG20A DRG1 ZNF512B PNPT1 RBM27 CHD6 SMARCA5 HDAC6 TCOF1 ZC3H18 GTF2IRD1 TFAM THOC5 BRD2 BRD4 SMARCA4 TMPO SPEN ZNF281 CBX8 | 2.70e-10 | 1082 | 204 | 27 | 38697112 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 RSL1D1 RPS6 CKAP5 SRSF11 EWSR1 CHD3 EDC4 HP1BP3 DRG1 ITPR2 ZNF512B UBTF MKI67 NOP2 SMARCA5 HYOU1 TCOF1 BAZ1B XRCC1 TFAM BRD2 SMARCA4 TMPO SPEN TOP2A | 4.13e-10 | 1024 | 204 | 26 | 24711643 |
| Pubmed | 4.26e-10 | 72 | 204 | 9 | 31248990 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | RPS6 RPS7 DLGAP5 CKAP5 EWSR1 TASOR2 SMARCA5 BAZ1B CHD8 BRD2 BRD4 SMARCA4 TMPO ZNF281 PHF10 TOP2A EP300 | 4.27e-10 | 411 | 204 | 17 | 35182466 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SIPA1L3 JADE1 EDC4 DCTN1 LYST TNFRSF21 RYR1 ITPR2 FZR1 PSME4 CASKIN1 MICAL3 DLX2 SZT2 CHD8 GTF2IRD1 CTDSP2 MICALL1 KANSL3 ORC1 BRD2 DNAJC14 BRD4 SPEN EP300 RAI1 MYBL2 | 4.27e-10 | 1105 | 204 | 27 | 35748872 |
| Pubmed | POGZ EDC4 DCTN1 RBM27 SMARCA5 ANK3 TCOF1 DNAJC8 CAST BAZ1B CHD8 GTF2E2 UBE2O BRD4 SMARCA4 TMPO SPEN TOP2A EP300 | 7.65e-10 | 549 | 204 | 19 | 38280479 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 RSL1D1 RPS6 RPS7 DLGAP5 KRI1 SRSF11 EWSR1 POLR1G SINHCAF RBM27 UBTF MKI67 NOP2 NOL8 SMARCA5 TCOF1 BAZ1B ORC1 LIG1 BRD2 SMARCA4 TMPO PHF14 TOP2A | 1.01e-09 | 989 | 204 | 25 | 36424410 |
| Pubmed | SIPA1L3 CKAP5 EDC4 POLR1G INO80D HMG20A DRG1 SEMA4C PXDN RBM27 CHD6 TAF1L NOL8 DNAJC8 UTP23 BAZ1B CHD8 PYM1 API5 XRCC1 TFAM ORC1 SNIP1 GTF2E2 BRD2 TRAM1 ZFP91 PHF14 SPEN ZNF281 CBX8 | 1.08e-09 | 1497 | 204 | 31 | 31527615 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | MBTD1 STAG1 CKAP5 POGZ INTS3 DCTN1 FOXO4 DLX5 FOXJ1 SMARCA5 HDAC6 L3MBTL2 ARID4A XRCC1 KANSL3 EPC1 SMARCA4 SPIDR SPEN PRDM15 TOP2A EP300 MYBL2 | 1.61e-09 | 857 | 204 | 23 | 25609649 |
| Pubmed | NOLC1 CHD3 POLR1G HP1BP3 HMG20A RBM27 UBTF MKI67 SMARCA5 DNAJC8 BAZ1B CHD8 ZC3H18 API5 XRCC1 THOC5 KANSL3 GTF2E2 BRD2 BRD4 ZFP91 SMARCA4 PHF14 TOP2A EP300 | 1.67e-09 | 1014 | 204 | 25 | 32416067 | |
| Pubmed | MBTD1 RSL1D1 POGZ RBM27 UBTF L3MBTL2 CHD8 BRD2 BRD4 EPC1 SMARCA4 ELF1 SPEN ZNF281 MYBL2 | 1.89e-09 | 339 | 204 | 15 | 30415952 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | NOLC1 STAG1 CKAP5 SRSF11 CHD3 CHEK1 EDC4 INTS3 DCTN1 DRG1 EXOC7 SMARCA5 CHD8 API5 BRD2 BRD4 SMARCA4 TMPO TOP2A | 1.99e-09 | 582 | 204 | 19 | 20467437 |
| Pubmed | EDC4 HP1BP3 UBTF NOP2 SMARCA5 BAZ1B CHD8 BRD2 SMARCA4 TMPO SPEN TOP2A | 2.10e-09 | 195 | 204 | 12 | 19454010 | |
| Pubmed | NOLC1 RSL1D1 RPS6 ZC3H13 RPS7 KRI1 SRSF11 EWSR1 POLR1G HP1BP3 RBM27 NOP2 SMARCA5 TCOF1 LIN28B ZC3H18 THOC5 SNIP1 TMPO SPEN TOP2A | 2.63e-09 | 731 | 204 | 21 | 29298432 | |
| Pubmed | NOLC1 RSL1D1 RPS6 RPS7 KRI1 POLR1G HP1BP3 RBM27 MKI67 NOP2 NOL8 SMARCA5 L3MBTL2 CENPU UTP23 SMARCA4 TOP2A | 4.84e-09 | 483 | 204 | 17 | 36912080 | |
| Pubmed | 4.88e-09 | 42 | 204 | 7 | 35705031 | ||
| Pubmed | MBTD1 JADE1 EDC4 DCTN1 INO80D SEMA4C SINHCAF FBXO5 UBTF AHR NOP2 CCNL2 SZT2 ARID4A LIN28B CHD8 ZC3H18 PPP4R4 GTF2E2 OTX2 BRD2 DNAJC14 BRD4 EPC1 PHF14 KDM4A PHF10 EP300 | 5.04e-09 | 1327 | 204 | 28 | 32694731 | |
| Pubmed | PDXDC1 NOLC1 RSL1D1 RPS6 RPS7 HP1BP3 TASOR2 SEMA4C MKI67 SCFD1 NOP2 NOL8 ANK3 TCOF1 CEP162 AKAP12 CTDSP2 LIG1 GTF2E2 TMPO SPEN | 7.63e-09 | 777 | 204 | 21 | 35844135 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 PHACTR2 SIPA1L3 RPS7 CKAP5 SRSF11 CHEK1 EDC4 ARHGEF17 LYST KIAA0753 FSIP2 FOXO4 CEP162 PPP4R4 MICALL1 USP8 LIMK1 SLF2 BRD4 EXO1 FGD6 | 9.02e-09 | 861 | 204 | 22 | 36931259 |
| Pubmed | RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma. | RSL1D1 RPS6 POGZ RBM27 NOP2 TCOF1 ZC3H18 API5 THOC5 TMPO CBX8 | 1.27e-08 | 183 | 204 | 11 | 28186131 |
| Pubmed | NOLC1 MBTD1 PHACTR2 ZC3H13 SRSF11 ERVK-10 DNAH14 TASOR2 PXDN SULF1 MICAL3 ERVK-25 CCNL2 FAAP24 CHD8 TACC2 ZC3H18 THOC5 CTDSP2 BRD2 MAP4K5 EPC1 EXO1 KDM4A PRDM15 EP300 | 1.41e-08 | 1215 | 204 | 26 | 15146197 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RSL1D1 CKAP5 EDC4 DCTN1 HP1BP3 SCFD1 SMARCA5 HYOU1 TCOF1 ZC3H18 API5 AKAP12 LIG1 BRD2 BRD4 SMARCA4 TMPO SPEN TOP2A | 1.71e-08 | 665 | 204 | 19 | 30457570 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 RSL1D1 RPS6 RPS7 CKAP5 KRI1 POGZ EDC4 CCDC38 DCTN1 DRG1 UBTF MKI67 SCFD1 NOP2 SMARCA5 RAP1B HYOU1 TCOF1 DNAJC8 BAZ1B DUOX2 API5 UBE2O SMARCA4 TMPO SPEN TOP2A | 2.30e-08 | 1425 | 204 | 28 | 30948266 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | NOLC1 RSL1D1 ZC3H13 SIPA1L3 CKAP5 SRSF11 REV1 ANK3 ZC3H18 SFMBT2 SNIP1 ZFP91 TMPO SPEN | 3.49e-08 | 361 | 204 | 14 | 26167880 |
| Pubmed | RPS6 CKAP5 KRI1 HP1BP3 UBTF TCOF1 BAZ1B ZC3H18 TFAM SMARCA4 SPEN TOP2A | 3.52e-08 | 251 | 204 | 12 | 28077445 | |
| Pubmed | 4.44e-08 | 57 | 204 | 7 | 21555454 | ||
| Pubmed | RSL1D1 RPS6 ZC3H13 RPS7 KRI1 SRSF11 HP1BP3 DRG1 CEP78 RBM27 MKI67 NOP2 LIN28B PYM1 ZC3H18 TFAM THOC5 SNIP1 TOP2A | 5.11e-08 | 713 | 204 | 19 | 29802200 | |
| Pubmed | NOLC1 STAG1 RSL1D1 RPS7 POGZ HP1BP3 HMG20A MKI67 NOP2 SMARCA5 RAP1B TCOF1 BAZ1B API5 TFAM THOC5 TMPO TOP2A | 6.90e-08 | 652 | 204 | 18 | 31180492 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 RSL1D1 ZC3H13 RPS7 SRSF11 EWSR1 PNPT1 RBM27 UBTF NOP2 NOL8 TCOF1 LIN28B PYM1 ZC3H18 API5 TFAM UBE2O SPEN TOP2A | 7.27e-08 | 807 | 204 | 20 | 22681889 |
| Pubmed | RSL1D1 RPS6 RPS7 CKAP5 KRI1 CHEK1 DCTN1 DRG1 FZR1 FBXO5 NOP2 RAP1B TCOF1 CAST CENPU BAZ1B PYM1 ZC3H18 TFAM SNIP1 UBE2O TMPO | 7.48e-08 | 971 | 204 | 22 | 33306668 | |
| Pubmed | Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. | 7.56e-08 | 37 | 204 | 6 | 36835656 | |
| Pubmed | NOLC1 RSL1D1 SIPA1L3 SRSF11 HP1BP3 UBTF MKI67 NOP2 SMARCA5 BAZ1B ZC3H18 API5 XRCC1 TFAM THOC5 BRD2 TMPO TOP2A | 8.28e-08 | 660 | 204 | 18 | 32780723 | |
| Pubmed | RSL1D1 RPS6 RPS7 KRI1 EWSR1 CHD3 EDC4 DCTN1 HP1BP3 DRG1 RBM27 UBTF AFF1 CHD6 SCFD1 SMARCA5 TCOF1 LIN28B DNAJC8 CHD8 TFAM UBE2O H1-6 PHF10 | 8.88e-08 | 1153 | 204 | 24 | 29845934 | |
| Pubmed | POGZ ZNF512B UBTF NOL8 REV1 BRD2 SLF2 BRD4 SMARCA4 ZNF281 MYBL2 | 9.24e-08 | 222 | 204 | 11 | 37071664 | |
| Pubmed | RSL1D1 RPS6 RPS7 POGZ DCTN1 HP1BP3 HMG20A DRG1 CEP78 UBTF BAZ1B GTF2E2 BRD2 SMARCA4 TMPO TOP2A CBX8 | 1.15e-07 | 601 | 204 | 17 | 33658012 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 RSL1D1 RPS6 RPS7 DLGAP5 CKAP5 POGZ POLR1G DCTN1 PSME4 UBTF MKI67 SCFD1 NOP2 SMARCA5 HDAC6 L3MBTL2 MAP4K3 BAZ1B CHD8 TFAM ORC1 MAP4K5 SMARCA4 ZNF281 TOP2A | 1.18e-07 | 1353 | 204 | 26 | 29467282 |
| Pubmed | RSL1D1 RPS6 KRI1 ARHGEF17 UBTF NOP2 SMARCA5 PCARE SMARCA4 TMPO TOP2A | 1.57e-07 | 234 | 204 | 11 | 36243803 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | RSL1D1 KRI1 HP1BP3 MKI67 NOP2 NOL8 SMARCA5 BAZ1B XRCC1 TFAM TMPO PHF14 RAI1 | 1.73e-07 | 349 | 204 | 13 | 25665578 |
| Pubmed | 1.99e-07 | 3 | 204 | 3 | 28262505 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | CKAP5 KRI1 DRG1 MKI67 PLAG1 DLX2 SMARCA5 HDAC6 TCOF1 KIF3A LIMK1 TOP2A EP300 | 2.31e-07 | 358 | 204 | 13 | 32460013 |
| Pubmed | RSL1D1 SIPA1L3 POLR1G HP1BP3 DRG1 MKI67 AHR NOP2 HYOU1 ANK3 TCOF1 ZC3H18 THOC5 SMARCA4 PHF10 TOP2A CBX8 | 2.44e-07 | 634 | 204 | 17 | 34591612 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | CHD3 POGZ INO80D ZNF512B SINHCAF FBXO5 L3MBTL2 KANSL3 RYBP UBE2O BRD2 CBX6 ZNF281 CBX8 MYBL2 | 2.75e-07 | 495 | 204 | 15 | 27705803 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 RSL1D1 RPS6 RPS7 CKAP5 KRI1 EWSR1 INTS3 DCTN1 HP1BP3 DRG1 PNPT1 NOP2 SMARCA5 HYOU1 HDAC6 TCOF1 CAST PYM1 TACC2 ZC3H18 USP8 GTF2E2 UBE2O SMARCA4 TOP2A | 2.80e-07 | 1415 | 204 | 26 | 28515276 |
| Pubmed | RSL1D1 RPS6 RPS7 KRI1 EWSR1 CHD3 DRG1 UBTF MKI67 NOP2 RAP1B TCOF1 BAZ1B TFAM BRD2 TMPO TOP2A | 2.84e-07 | 641 | 204 | 17 | 36057605 | |
| Pubmed | 2.91e-07 | 46 | 204 | 6 | 30419336 | ||
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | NOLC1 RPS6 EWSR1 HP1BP3 DRG1 AFF1 NOP2 CCNL2 TCOF1 ZC3H18 ADAM22 RYBP BRD2 EP300 | 3.12e-07 | 432 | 204 | 14 | 23455922 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RSL1D1 CKAP5 POGZ CEP78 RBM27 MKI67 NOP2 NOL8 HYOU1 CAST PYM1 THOC5 AKAP12 MICALL1 ZFP91 SPEN ZNF281 PHF10 | 3.22e-07 | 724 | 204 | 18 | 36232890 |
| Pubmed | NOLC1 PHACTR2 RPS7 SRSF11 DCTN1 MKI67 NOP2 SMARCA5 TCOF1 DNAJC8 GTF2E2 UBE2O BRD4 SMARCA4 TMPO | 3.64e-07 | 506 | 204 | 15 | 30890647 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 4.12e-07 | 157 | 204 | 9 | 30686591 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | PHACTR2 EWSR1 DCTN1 DNAH14 FZR1 OSBP2 SCFD1 EXOC7 NOP2 HDAC6 ARID4A CEP162 FAAP24 OSR2 XRCC1 CTDSP2 GTF2E2 SMARCA4 SPIDR ZNF281 | 6.29e-07 | 925 | 204 | 20 | 28986522 |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 6.93e-07 | 167 | 204 | 9 | 20362541 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SGSM1 SIPA1L3 SRSF11 CHD3 RBBP8NL INTS3 DNAH14 HP1BP3 TASOR2 PXDN AFF1 MICAL3 CHD6 ANK3 CAST GTF2IRD1 SFMBT2 PPP4R4 KANSL3 PHF14 SPIDR KAT6B PRDM15 EP300 KDM4B RAI1 | 7.33e-07 | 1489 | 204 | 26 | 28611215 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | SOX5 MBTD1 POGZ GNPAT XRCC1 TFAM BRD2 BRD4 EPC1 SMARCA4 TMPO EP300 KDM4B | 7.64e-07 | 398 | 204 | 13 | 35016035 |
| Pubmed | 7.82e-07 | 86 | 204 | 7 | 37253089 | ||
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 30428346 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 7.92e-07 | 4 | 204 | 3 | 10469592 | |
| Pubmed | Ank3-dependent SVZ niche assembly is required for the continued production of new neurons. | 7.92e-07 | 4 | 204 | 3 | 21745638 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 RSL1D1 RPS6 RPS7 EWSR1 POLR1G DCTN1 HP1BP3 PXDN UBTF MKI67 NOP2 SMARCA5 TCOF1 UTP23 XRCC1 SNIP1 ZFP91 SMARCA4 TOP2A | 9.33e-07 | 949 | 204 | 20 | 36574265 |
| Interaction | H3C3 interactions | STAG1 DLGAP5 CHD3 POGZ HP1BP3 HMG20A ZNF512B FSIP2 UBTF MKI67 TIMELESS CHD6 NOP2 SMARCA5 L3MBTL2 ARID4A BAZ1B CHD8 ZC3H18 UBE2O BRD2 SCMH1 BRD4 ZFP91 SMARCA4 TMPO PHF14 SPEN ZNF281 PRDM15 TOP2A CBX8 KDM4B RAI1 | 4.20e-19 | 495 | 200 | 34 | int:H3C3 |
| Interaction | H2BC8 interactions | MBTD1 STAG1 DLGAP5 CHD3 POGZ INTS3 HP1BP3 HMG20A ZNF512B UBTF MKI67 CHD6 SMARCA5 ARID4A DNAJC8 BAZ1B CHD8 XRCC1 GTF2E2 UBE2O BRD2 BRD4 ZFP91 SMARCA4 TMPO ELF1 PHF14 SPEN ZNF281 PRDM15 PHF10 TOP2A CBX8 KDM4B RAI1 MYBL2 | 7.38e-19 | 576 | 200 | 36 | int:H2BC8 |
| Interaction | SMC5 interactions | NOLC1 RSL1D1 ZC3H13 RPS7 DLGAP5 KRI1 SRSF11 EWSR1 CHD3 POGZ HP1BP3 TASOR2 HMG20A ZNF512B PRAM1 RBM27 UBTF MKI67 TIMELESS NOP2 TAF1L NOL8 SMARCA5 ARID4A LIN28B DNAJC8 CAST BAZ1B CHD8 ZC3H18 API5 XRCC1 TFAM GTF2E2 BRD2 SLF2 BRD4 SMARCA4 TMPO PHF14 SPEN ZNF281 TOP2A CBX8 RAI1 MYBL2 | 1.11e-18 | 1000 | 200 | 46 | int:SMC5 |
| Interaction | CBX3 interactions | ZC3H13 CHD3 POGZ HP1BP3 ZNF512B RBM27 UBTF MKI67 NOL8 SMARCA5 L3MBTL2 TCOF1 DNAJC8 BAZ1B CHD8 XRCC1 GTF2IRD1 RYBP LIG1 GTF2E2 UBE2O BRD2 CBX6 BRD4 ZFP91 SMARCA4 SPEN ZNF281 PHF10 TOP2A EP300 CBX8 MYBL2 | 8.82e-15 | 646 | 200 | 33 | int:CBX3 |
| Interaction | H2BC21 interactions | POGZ JADE1 INTS3 HP1BP3 HMG20A SINHCAF CEP78 MKI67 NOP2 USP49 SMARCA5 SFRP4 ARID4A BAZ1B DUOX2 CHD8 ZC3H18 XRCC1 SFMBT2 ORC1 USP8 BRD2 CBX6 BRD4 H1-6 EXO1 SMARCA4 PHF14 KAT6B PHF10 TOP2A EP300 CBX8 RAI1 | 1.21e-14 | 696 | 200 | 34 | int:H2BC21 |
| Interaction | H3-3A interactions | STAG1 CKAP5 CHD3 POGZ HP1BP3 HMG20A ZNF512B UBTF MKI67 TIMELESS SMARCA5 L3MBTL2 BAZ1B CHD8 XRCC1 BRD2 CBX6 SCMH1 BRD4 ZFP91 H1-6 SMARCA4 TMPO ELF1 PHF14 KDM4A SPEN ZNF281 PRDM15 TOP2A EP300 CBX8 KDM4B RAI1 MYBL2 | 1.76e-14 | 749 | 200 | 35 | int:H3-3A |
| Interaction | H3C1 interactions | STAG1 RSL1D1 DLGAP5 KRI1 CHD3 POGZ JADE1 POLR1G HP1BP3 ZNF512B UBTF MKI67 NOP2 SMARCA5 HDAC6 ANK3 L3MBTL2 DNAJC8 CAST BAZ1B CHD8 API5 XRCC1 GTF2E2 BRD2 CBX6 BRD4 ZFP91 H1-6 SMARCA4 TMPO KDM4A KAT6B SPEN ZNF281 TOP2A EP300 CBX8 | 2.93e-14 | 901 | 200 | 38 | int:H3C1 |
| Interaction | PARP1 interactions | NOLC1 STAG1 RSL1D1 KRI1 EWSR1 CHD3 POGZ CHEK1 HP1BP3 HMG20A ZNF512B FZR1 UBTF MKI67 AHR TIMELESS CHD6 DLX5 NOP2 NOL8 SMARCA5 HYOU1 HDAC6 L3MBTL2 DNAJC8 BAZ1B ZC3H18 XRCC1 TFAM MICALL1 RYBP LIG1 UBE2O BRD2 BRD4 SMARCA4 TMPO PHF14 ZNF281 PHF10 STAG3 TOP2A EP300 CBX8 RAI1 MYBL2 | 3.60e-14 | 1316 | 200 | 46 | int:PARP1 |
| Interaction | ZNF330 interactions | NOLC1 RSL1D1 RPS6 KRI1 CHD3 HP1BP3 HMG20A ZNF512B UBTF NOP2 NOL8 SMARCA5 DNAJC8 BAZ1B ZC3H18 XRCC1 GTF2E2 UBE2O BRD2 ZFP91 SMARCA4 PHF14 ZNF281 PRDM15 TOP2A CBX8 RAI1 | 5.50e-14 | 446 | 200 | 27 | int:ZNF330 |
| Interaction | MEN1 interactions | NOLC1 STAG1 RSL1D1 RPS6 ZC3H13 RPS7 KRI1 EWSR1 CHD3 POGZ CHEK1 EDC4 POLR1G ARHGEF17 DCTN1 HP1BP3 DRG1 ITPR2 ZNF512B UBTF MKI67 NOP2 NOL8 SMARCA5 TCOF1 BAZ1B CHD8 ZC3H18 XRCC1 TFAM KANSL3 TRAM1 ZFP91 SMARCA4 KAT6B SPEN ZNF281 TOP2A CBX8 | 3.79e-13 | 1029 | 200 | 39 | int:MEN1 |
| Interaction | TOP1 interactions | RPS6 CKAP5 SRSF11 CHD3 POGZ CHEK1 POLR1G INTS3 HP1BP3 HMG20A FZR1 MKI67 NOP2 SMARCA5 HDAC6 TCOF1 BAZ1B ZC3H18 XRCC1 THOC5 LIG1 GTF2E2 UBE2O BRD2 BRD4 EXO1 SMARCA4 PHF14 PHF10 TOP2A CBX8 RAI1 | 4.16e-13 | 696 | 200 | 32 | int:TOP1 |
| Interaction | DAXX interactions | NOLC1 RSL1D1 RPS6 KRI1 POGZ HP1BP3 TASOR2 FZR1 UBTF MKI67 SMARCA5 LIN28B UTP23 BAZ1B ZC3H18 UBE2O BRD2 CBX6 PHF14 SPEN TOP2A EP300 RAI1 | 1.02e-12 | 353 | 200 | 23 | int:DAXX |
| Interaction | TERF2IP interactions | SRSF11 CHD3 POGZ HP1BP3 TASOR2 ZNF512B RBM27 UBTF MKI67 AHR DNAJC8 CHD8 ZC3H18 XRCC1 KANSL3 ORC1 SNIP1 GTF2E2 BRD4 SMARCA4 SPEN ZNF281 PHF10 TOP2A CBX8 RAI1 MYBL2 | 8.29e-12 | 552 | 200 | 27 | int:TERF2IP |
| Interaction | NUP43 interactions | RSL1D1 ZC3H13 KRI1 CHD3 POGZ HP1BP3 TASOR2 FSIP2 UBTF MKI67 TIMELESS CHD6 L3MBTL2 SZT2 ARID4A CHD8 ZC3H18 KANSL3 SLF2 EPC1 ZFP91 SMARCA4 ELF1 SPEN ZNF281 TOP2A CBX8 MYBL2 | 2.60e-11 | 625 | 200 | 28 | int:NUP43 |
| Interaction | KRR1 interactions | RSL1D1 RPS6 RPS7 KRI1 EWSR1 CHD3 HP1BP3 FZR1 NOP2 USP49 SMARCA5 LIN28B UTP23 BAZ1B ZC3H18 TFAM SNIP1 UBE2O CBX6 H1-6 EP300 CBX8 | 3.14e-11 | 379 | 200 | 22 | int:KRR1 |
| Interaction | H2AC4 interactions | RPS7 CHD3 POGZ EDC4 HP1BP3 HMG20A RBM27 TIMELESS EXOC7 SMARCA5 HDAC6 UTP23 DUOX2 CHD8 XRCC1 BRD2 CBX6 BRD4 ZFP91 H1-6 PHF14 TOP2A EP300 CBX8 RAI1 | 4.24e-11 | 506 | 200 | 25 | int:H2AC4 |
| Interaction | BRD2 interactions | NOLC1 CHD3 POGZ POLR1G HP1BP3 UBTF IQCM SMARCA5 DNAJC8 UTP23 BAZ1B CHD8 XRCC1 RYBP SNIP1 LIG1 UBE2O BRD2 BRD4 ZFP91 SMARCA4 PHF10 TOP2A | 5.37e-11 | 429 | 200 | 23 | int:BRD2 |
| Interaction | KLF3 interactions | SOX5 MBTD1 CHD3 POGZ SINHCAF CHD6 SMARCA5 HYOU1 L3MBTL2 ARID4A TFAM RYBP OTX2 EPC1 ELF1 ZNF281 EP300 | 1.32e-10 | 228 | 200 | 17 | int:KLF3 |
| Interaction | BRD3 interactions | NOLC1 RPS6 POGZ POLR1G INO80D HP1BP3 HMG20A UBTF MKI67 CCNL2 SMARCA5 BAZ1B CHD8 XRCC1 TFAM SNIP1 BRD2 BRD4 ZFP91 SMARCA4 TMPO ZNF281 TOP2A RAI1 | 1.51e-10 | 494 | 200 | 24 | int:BRD3 |
| Interaction | RPS6 interactions | NOLC1 RSL1D1 RPS6 RPS7 KRI1 CHD3 CXorf65 HP1BP3 DRG1 ZNF512B FZR1 UBTF MKI67 CHD6 NOP2 NOL8 HDAC6 LIN28B DNAJC8 UTP23 PYM1 ZC3H18 XRCC1 SNIP1 GTF2E2 UBE2O BRD4 ZFP91 PRDM15 PHF10 TOP2A CBX8 | 1.59e-10 | 874 | 200 | 32 | int:RPS6 |
| Interaction | XRCC6 interactions | RPS6 KRI1 EWSR1 CHD3 CHEK1 POLR1G ZNF512B FZR1 RBM27 MKI67 DLX2 NOP2 TAF1L NOL8 SMARCA5 RAP1B HYOU1 HDAC6 CENPU BAZ1B CHD8 ZC3H18 XRCC1 ORC1 GTF2E2 UBE2O BRD4 SMARCA4 TMPO SPEN ZNF281 TOP2A EP300 | 1.69e-10 | 928 | 200 | 33 | int:XRCC6 |
| Interaction | RPL31 interactions | NOLC1 RSL1D1 RPS6 ZC3H13 RPS7 KRI1 EWSR1 CHD3 DRG1 ZNF512B FZR1 UBTF MKI67 NOP2 NOL8 HDAC6 TCOF1 UTP23 ZC3H18 SNIP1 UBE2O BRD2 BRD4 ZFP91 H1-6 PRDM15 PHF10 TOP2A | 1.82e-10 | 680 | 200 | 28 | int:RPL31 |
| Interaction | SRSF6 interactions | RSL1D1 RPS6 ZC3H13 KRI1 SRSF11 EWSR1 CHD3 HP1BP3 FZR1 MKI67 NOP2 NOL8 DNAJC8 CENPU UTP23 ZC3H18 SNIP1 UBE2O BRD4 H1-6 TMPO SPEN PRDM15 EP300 | 2.18e-10 | 503 | 200 | 24 | int:SRSF6 |
| Interaction | CHD4 interactions | NOLC1 RSL1D1 RPS6 RPS7 KRI1 EWSR1 CHD3 POGZ DCTN1 HP1BP3 ZNF512B UBTF MKI67 NOP2 SMARCA5 L3MBTL2 TCOF1 BAZ1B ZC3H18 API5 SNIP1 LIMK1 UBE2O BRD2 BRD4 SMARCA4 TMPO PHF14 SPEN TOP2A EP300 RAI1 MYBL2 | 2.22e-10 | 938 | 200 | 33 | int:CHD4 |
| Interaction | APEX1 interactions | NOLC1 PHACTR2 RSL1D1 KRI1 EWSR1 POGZ DCTN1 DNAH14 HP1BP3 ZNF512B FZR1 UBTF OSBP2 SCFD1 EXOC7 NOP2 NOL8 HDAC6 TCF21 TCOF1 ARID4A DNAJC8 CEP162 FAAP24 OSR2 BAZ1B XRCC1 CTDSP2 LIG1 GTF2E2 BRD2 BRD4 SMARCA4 SPIDR ZNF281 PHF10 EP300 CBX8 RAI1 | 2.26e-10 | 1271 | 200 | 39 | int:APEX1 |
| Interaction | MYBBP1A interactions | RSL1D1 RPS6 CHD3 POLR1G HP1BP3 FZR1 UBTF NOP2 SMARCA5 HDAC6 L3MBTL2 LIN28B CENPU BAZ1B ZC3H18 RYBP SNIP1 UBE2O BRD4 H1-6 SMARCA4 TMPO EP300 | 2.42e-10 | 463 | 200 | 23 | int:MYBBP1A |
| Interaction | SUZ12 interactions | NOLC1 TRIM75 RSL1D1 ZC3H13 EWSR1 CHD3 INTS3 HP1BP3 TASOR2 HMG20A ZNF512B UBTF MKI67 NOP2 SMARCA5 CHD8 PYM1 ZC3H18 TFAM UBE2O BRD2 BRD4 SMARCA4 PHF14 ZNF281 CBX8 MYBL2 | 2.68e-10 | 644 | 200 | 27 | int:SUZ12 |
| Interaction | H1-4 interactions | NOLC1 RSL1D1 RPS6 KRI1 CHD3 EDC4 HP1BP3 TASOR2 ZNF512B PRAM1 UBTF NOP2 SMARCA5 TCOF1 UTP23 BAZ1B TACC2 ZC3H18 BRD2 BRD4 H1-6 TMPO TSKS PRDM15 ALPK2 CBX8 MYBL2 | 4.02e-10 | 656 | 200 | 27 | int:H1-4 |
| Interaction | CHD3 interactions | SOX5 NOLC1 RSL1D1 RPS6 ZC3H13 RPS7 KRI1 EWSR1 CHD3 HP1BP3 ZNF512B UBTF MKI67 CHD6 NOP2 SOX6 SMARCA5 BAZ1B ZC3H18 API5 BRD2 BRD4 SMARCA4 TMPO PHF14 TOP2A EP300 RAI1 MYBL2 | 4.50e-10 | 757 | 200 | 29 | int:CHD3 |
| Interaction | RNF2 interactions | PDXDC1 NOLC1 MBTD1 RSL1D1 RPS7 EWSR1 CHD3 POGZ POLR1G HP1BP3 HMG20A SINHCAF UBTF MKI67 NOP2 SMARCA5 HYOU1 ANK3 L3MBTL2 BAZ1B THOC5 RYBP CBX6 SCMH1 BRD4 EPC1 ZFP91 SMARCA4 PHF14 TOP2A CBX8 | 5.53e-10 | 866 | 200 | 31 | int:RNF2 |
| Interaction | H1-2 interactions | RSL1D1 KRI1 CHD3 DCTN1 HP1BP3 FOXO4 NOP2 REV1 COL16A1 TCOF1 LIN28B CAST CENPU UTP23 BAZ1B ZC3H18 THOC5 LIG1 GTF2E2 UBE2O BRD2 CBX6 MAP4K5 BRD4 H1-6 TSKS PRDM15 | 5.60e-10 | 666 | 200 | 27 | int:H1-2 |
| Interaction | POLR1G interactions | NOLC1 RSL1D1 KRI1 POGZ POLR1G ZNF512B UBTF NOP2 NOL8 TCOF1 DNAJC8 CHD8 ZC3H18 XRCC1 LIG1 BRD2 BRD4 ZFP91 SMARCA4 PHF14 ZNF281 TOP2A RAI1 | 7.02e-10 | 489 | 200 | 23 | int:POLR1G |
| Interaction | RPL3 interactions | RSL1D1 RPS6 RPS7 KRI1 CHD3 POLR1G HP1BP3 DRG1 FZR1 SINHCAF NOP2 C11orf52 NOL8 HDAC6 LIN28B UTP23 ZC3H18 API5 SNIP1 OTX2 CBX6 BRD4 ZFP91 H1-6 TMPO PRDM15 TOP2A RAI1 | 7.07e-10 | 722 | 200 | 28 | int:RPL3 |
| Interaction | EED interactions | PDXDC1 NOLC1 STAG1 RSL1D1 RPS6 ZC3H13 RPS7 CKAP5 CHD3 POGZ INTS3 DCTN1 HP1BP3 TASOR2 ZNF512B PXDN SCFD1 NOP2 SMARCA5 RAP1B HYOU1 L3MBTL2 TCOF1 SZT2 DNAJC8 BAZ1B API5 XRCC1 TFAM RYBP ORC1 LIG1 BRD4 EPC1 ZFP91 SMARCA4 TMPO SPEN TOP2A CBX8 MYBL2 | 7.51e-10 | 1445 | 200 | 41 | int:EED |
| Interaction | ZBTB2 interactions | NOLC1 RSL1D1 RPS7 KRI1 CHD3 POGZ HMG20A UBTF NOP2 SMARCA5 RAP1B LIN28B BAZ1B ZC3H18 TFAM LIG1 UBE2O SH2D4A ZFP91 TMPO PHF14 TOP2A | 8.24e-10 | 450 | 200 | 22 | int:ZBTB2 |
| Interaction | E2F4 interactions | NOLC1 SRSF11 CHEK1 POLR1G ARHGEF17 HP1BP3 TASOR2 MICAL3 RAP1B HYOU1 ANK3 DNAJC8 PYM1 XRCC1 TFAM THOC5 RYBP BRD4 ZFP91 SMARCA4 TOP2A EP300 RAI1 MYBL2 | 9.05e-10 | 540 | 200 | 24 | int:E2F4 |
| Interaction | SSRP1 interactions | NOLC1 RSL1D1 ZC3H13 CHD3 JADE1 POLR1G INTS3 TIMELESS NOP2 SMARCA5 HDAC6 DNAJC8 ZC3H18 XRCC1 THOC5 SNIP1 UBE2O BRD2 BRD4 ZFP91 EXO1 SMARCA4 PHF14 PHF10 TOP2A EP300 RAI1 | 1.03e-09 | 685 | 200 | 27 | int:SSRP1 |
| Interaction | CENPA interactions | ZC3H13 KRI1 CHD3 HP1BP3 HMG20A ZNF512B UBTF CHD6 NOP2 NOL8 SMARCA5 CENPU BAZ1B BRD2 SLF2 ZFP91 PHF14 TOP2A CBX8 RAI1 | 1.25e-09 | 377 | 200 | 20 | int:CENPA |
| Interaction | KLF16 interactions | SOX5 NOLC1 MBTD1 RSL1D1 KRI1 POGZ HP1BP3 SINHCAF UBTF L3MBTL2 BAZ1B TFAM THOC5 KANSL3 BRD2 EPC1 ZFP91 ELF1 ZNF281 EP300 MYBL2 | 1.69e-09 | 425 | 200 | 21 | int:KLF16 |
| Interaction | SRPK2 interactions | NOLC1 RSL1D1 RPS6 ZC3H13 SIPA1L3 KRI1 SRSF11 HP1BP3 DRG1 RBM27 UBTF MKI67 NOP2 NOL8 ANK3 TCOF1 LIN28B DNAJC8 UTP23 ZC3H18 SNIP1 CBX6 ZFP91 TMPO SPEN TOP2A EP300 | 2.76e-09 | 717 | 200 | 27 | int:SRPK2 |
| Interaction | RBBP4 interactions | STAG1 CHD3 INTS3 HMG20A ZNF512B FZR1 SINHCAF SMARCA5 HDAC6 L3MBTL2 ARID4A DNAJC8 ZC3H18 TFAM RYBP OTX2 BRD4 SMARCA4 PHF14 SPEN TOP2A EP300 RAI1 MYBL2 | 2.92e-09 | 573 | 200 | 24 | int:RBBP4 |
| Interaction | SUPT16H interactions | RSL1D1 RPS6 ZC3H13 KRI1 EWSR1 CHD3 POLR1G DCTN1 HMG20A SMARCA5 BAZ1B ZC3H18 SNIP1 GTF2E2 UBE2O BRD2 BRD4 ZFP91 SMARCA4 PHF14 EP300 | 3.40e-09 | 442 | 200 | 21 | int:SUPT16H |
| Interaction | H2BC9 interactions | PHACTR2 USP45 RSL1D1 DLGAP5 CKAP5 SRSF11 CHD3 FSIP2 NOP2 SMARCA5 BAZ1B DUOX2 SFMBT2 SNIP1 BRD4 H1-6 TMPO KAT6B FGD6 TOP2A RAI1 | 3.98e-09 | 446 | 200 | 21 | int:H2BC9 |
| Interaction | ASF1A interactions | ZC3H13 POGZ TASOR2 HMG20A ZNF512B CHD6 SOX6 CHD8 BRD2 SMARCA4 PHF14 SPEN ZNF281 EP300 RAI1 MYBL2 | 4.09e-09 | 249 | 200 | 16 | int:ASF1A |
| Interaction | MECP2 interactions | NOLC1 RPS6 ZC3H13 RPS7 SRSF11 EWSR1 POGZ POLR1G HP1BP3 HMG20A DRG1 ZNF512B PNPT1 RBM27 MKI67 CHD6 DLX5 NOP2 NOL8 SMARCA5 HDAC6 TCOF1 UTP23 ZC3H18 GTF2IRD1 TFAM THOC5 BRD2 BRD4 H1-6 SMARCA4 TMPO PHF14 SPEN ZNF281 EP300 CBX8 | 4.18e-09 | 1287 | 200 | 37 | int:MECP2 |
| Interaction | SNRNP40 interactions | RSL1D1 ZC3H13 KRI1 EWSR1 CHD3 POGZ TASOR2 HMG20A FZR1 UBTF MKI67 NOL8 TCOF1 ZC3H18 XRCC1 SNIP1 BRD4 SMARCA4 ELF1 SPEN ZNF281 PHF10 TOP2A CBX8 MYBL2 | 4.96e-09 | 637 | 200 | 25 | int:SNRNP40 |
| Interaction | H2AZ1 interactions | MBTD1 POGZ POLR1G HP1BP3 HMG20A SMARCA5 BAZ1B CHD8 ZC3H18 RYBP BRD2 BRD4 EPC1 SMARCA4 PHF14 KDM4A PHF10 TOP2A RAI1 | 5.89e-09 | 371 | 200 | 19 | int:H2AZ1 |
| Interaction | SIRT7 interactions | NOLC1 RSL1D1 RPS6 ZC3H13 RPS7 CKAP5 KRI1 EWSR1 POGZ EDC4 HP1BP3 TASOR2 PNPT1 UBTF MKI67 NOP2 HYOU1 TCOF1 BAZ1B CHD8 ZC3H18 UBE2O BRD4 SMARCA4 SPEN TOP2A RAI1 | 6.06e-09 | 744 | 200 | 27 | int:SIRT7 |
| Interaction | NUMA1 interactions | EWSR1 CHD3 POGZ POLR1G INTS3 HP1BP3 MKI67 SMARCA5 BAZ1B ZC3H18 XRCC1 BRD2 CBX6 BRD4 SMARCA4 PHF14 PHF10 TOP2A EP300 CBX8 RAI1 | 9.61e-09 | 469 | 200 | 21 | int:NUMA1 |
| Interaction | HNRNPU interactions | RSL1D1 RPS6 RPS7 CKAP5 KRI1 SRSF11 EWSR1 CHD3 DCTN1 HP1BP3 KIAA0753 FZR1 UBTF EXOC7 NOP2 SMARCA5 MAGEL2 HDAC6 UTP23 BAZ1B ZC3H18 API5 SNIP1 MAP4K5 BRD4 TMPO PHF14 FGD6 TOP2A EP300 CBX8 KDM4B | 1.00e-08 | 1035 | 200 | 32 | int:HNRNPU |
| Interaction | RPS10 interactions | RSL1D1 RPS6 RPS7 KRI1 EWSR1 CHD3 CHEK1 HP1BP3 DRG1 FZR1 HDAC6 LIN28B UTP23 BAZ1B PYM1 ZC3H18 THOC5 CBX6 BRD4 ZFP91 H1-6 PRDM15 TOP2A | 1.16e-08 | 567 | 200 | 23 | int:RPS10 |
| Interaction | UBTF interactions | RPS6 EWSR1 CHD3 POLR1G UBTF SMARCA5 TCOF1 DNAJC8 UTP23 CTDSP2 UBE2O BRD2 BRD4 TMPO EP300 | 1.31e-08 | 234 | 200 | 15 | int:UBTF |
| Interaction | RSL1D1 interactions | NOLC1 RSL1D1 RPS6 RPS7 CHD3 POLR1G HP1BP3 FZR1 MKI67 NOP2 HDAC6 LIN28B CAST UTP23 ZC3H18 SNIP1 UBE2O BRD4 H1-6 PRDM15 CBX8 | 1.39e-08 | 479 | 200 | 21 | int:RSL1D1 |
| Interaction | RING1 interactions | ZC3H13 MN1 SOX6 SMARCA5 L3MBTL2 RYBP BRD2 CBX6 SCMH1 BRD4 ZFP91 TOP2A EP300 CBX8 | 1.42e-08 | 201 | 200 | 14 | int:RING1 |
| Interaction | CSNK2B interactions | NOLC1 USP45 POGZ CHEK1 JADE1 VSX1 LYST SINHCAF MICAL3 CCNL2 SMARCA5 TCOF1 CHD8 ZC3H18 XRCC1 RYBP ORC1 UBE2O BRD2 BRD4 TMPO TOP2A EP300 CBX8 | 1.57e-08 | 625 | 200 | 24 | int:CSNK2B |
| Interaction | RPL7A interactions | NOLC1 RSL1D1 RPS6 RPS7 KRI1 EWSR1 CHD3 POLR1G DRG1 FZR1 NOP2 HDAC6 DNAJC8 MKNK2 CENPU ZC3H18 SNIP1 UBE2O CBX6 BRD4 ZFP91 H1-6 TMPO PRDM15 CBX8 | 1.76e-08 | 679 | 200 | 25 | int:RPL7A |
| Interaction | NSD2 interactions | RSL1D1 RPS6 POLR1G HP1BP3 ZNF512B MKI67 SMARCA5 TCOF1 LIN28B UTP23 BAZ1B BRD2 BRD4 SMARCA4 TMPO TOP2A | 1.95e-08 | 278 | 200 | 16 | int:NSD2 |
| Interaction | PYHIN1 interactions | RSL1D1 RPS6 CKAP5 KRI1 HP1BP3 UBTF MKI67 SMARCA5 TCOF1 BAZ1B ZC3H18 TFAM SMARCA4 TMPO PHF14 SPEN TOP2A RAI1 | 2.00e-08 | 358 | 200 | 18 | int:PYHIN1 |
| Interaction | POU5F1 interactions | SOX5 RSL1D1 RPS7 CKAP5 EWSR1 CHD3 JADE1 PRAM1 SINHCAF RBM27 SMARCA5 L3MBTL2 TCOF1 API5 XRCC1 RYBP OTX2 BRD4 H1-6 SMARCA4 TMPO ZNF281 TOP2A | 2.01e-08 | 584 | 200 | 23 | int:POU5F1 |
| Interaction | CEBPA interactions | NOLC1 STAG1 RSL1D1 CKAP5 EWSR1 CHD3 POGZ CHEK1 EDC4 INO80D HP1BP3 DRG1 PRAM1 RBM27 UBTF MKI67 NOP2 HYOU1 DNAJC8 CHD8 XRCC1 THOC5 KANSL3 LIG1 BRD4 ZFP91 SMARCA4 TMPO ELF1 SPEN ZNF281 TOP2A EP300 RAI1 MYBL2 | 2.07e-08 | 1245 | 200 | 35 | int:CEBPA |
| Interaction | RPL6 interactions | NOLC1 RSL1D1 RPS6 RPS7 KRI1 CHD3 POLR1G DRG1 FZR1 NOP2 HDAC6 LIN28B DNAJC8 UTP23 ZC3H18 API5 THOC5 SNIP1 UBE2O OTX2 BRD4 H1-6 TMPO TOP2A | 2.25e-08 | 637 | 200 | 24 | int:RPL6 |
| Interaction | MYCN interactions | NOLC1 STAG1 RSL1D1 RPS6 ZC3H13 RPS7 SRSF11 EWSR1 POGZ POLR1G LYST HP1BP3 HMG20A ZNF512B PNPT1 SINHCAF UBTF MKI67 NOP2 SMARCA5 TCOF1 LIN28B DNAJC8 CENPU UTP23 BAZ1B PYM1 ZC3H18 TFAM THOC5 SNIP1 H1-6 SMARCA4 TMPO EP300 CBX8 RAI1 | 2.31e-08 | 1373 | 200 | 37 | int:MYCN |
| Interaction | DDX54 interactions | RPS6 CHD3 POLR1G DRG1 FZR1 RBM27 MKI67 NOP2 ZC3H18 TFAM SNIP1 UBE2O CBX6 ZFP91 H1-6 PHF10 EP300 CBX8 | 2.38e-08 | 362 | 200 | 18 | int:DDX54 |
| Interaction | FBL interactions | NOLC1 RSL1D1 RPS6 RPS7 KRI1 CHD3 ZNF512B FZR1 UBTF MKI67 NOP2 NOL8 SMARCA5 TCOF1 LIN28B BAZ1B ZC3H18 UBE2O BRD4 ZFP91 ZNF281 PHF10 TOP2A CBX8 | 2.39e-08 | 639 | 200 | 24 | int:FBL |
| Interaction | H2AX interactions | RPS6 KRI1 POGZ HMG20A FZR1 MKI67 TIMELESS USP49 SMARCA5 HYOU1 ARID4A BAZ1B DUOX2 CHD8 ZC3H18 XRCC1 UBE2O BRD2 SCMH1 H1-6 SMARCA4 PHF14 EP300 | 2.66e-08 | 593 | 200 | 23 | int:H2AX |
| Interaction | EBNA1BP2 interactions | RSL1D1 RPS6 CHD3 POLR1G DCTN1 DRG1 FZR1 NOP2 LIN28B MAP4K3 ZC3H18 API5 SNIP1 BRD4 H1-6 TMPO EP300 | 2.71e-08 | 324 | 200 | 17 | int:EBNA1BP2 |
| Interaction | NOLC1 interactions | NOLC1 RSL1D1 RPS6 RPS7 CHD3 POLR1G NOP2 TCOF1 MKNK2 ZC3H18 GTF2IRD1 SNIP1 UBE2O BRD2 BRD4 TMPO PHF10 | 2.84e-08 | 325 | 200 | 17 | int:NOLC1 |
| Interaction | YY1 interactions | CHD3 POGZ POLR1G INO80D SEMA4C ZNF512B SINHCAF MKI67 SMARCA5 L3MBTL2 CHD8 KANSL3 RYBP SNIP1 USP8 BRD2 BRD4 SMARCA4 ELF1 EP300 | 2.89e-08 | 454 | 200 | 20 | int:YY1 |
| Interaction | DOT1L interactions | RSL1D1 RPS6 ZC3H13 RPS7 CKAP5 KRI1 SRSF11 CHD3 POLR1G DCTN1 HP1BP3 ZNF512B RBM27 UBTF MKI67 AFF1 NOP2 NOL8 SMARCA5 TCOF1 BAZ1B ZC3H18 TFAM ORC1 TRAM1 SMARCA4 TOP2A | 3.30e-08 | 807 | 200 | 27 | int:DOT1L |
| Interaction | NAA40 interactions | NOLC1 RSL1D1 RPS6 DLGAP5 CKAP5 CHD3 EDC4 DCTN1 HP1BP3 ZNF512B RBM27 UBTF MKI67 NOP2 NOL8 SMARCA5 L3MBTL2 TCOF1 CAST BAZ1B PYM1 TACC2 AKAP12 USP8 GTF2E2 UBE2O SMARCA4 TMPO ZNF281 TOP2A | 3.67e-08 | 978 | 200 | 30 | int:NAA40 |
| Interaction | LYAR interactions | NOLC1 RSL1D1 RPS6 KRI1 CHD3 POLR1G DRG1 FZR1 UBTF MKI67 UTP23 BAZ1B ZC3H18 BRD2 BRD4 H1-6 PRDM15 EP300 | 3.75e-08 | 373 | 200 | 18 | int:LYAR |
| Interaction | HMGA1 interactions | EWSR1 POGZ INTS3 HP1BP3 HMG20A SOX6 SMARCA5 DNAJC8 BAZ1B ZC3H18 UBE2O BRD4 SMARCA4 ELF1 PHF14 SPEN PHF10 TOP2A RAI1 | 4.15e-08 | 419 | 200 | 19 | int:HMGA1 |
| Interaction | DDX18 interactions | RSL1D1 RPS6 RPS7 CHD3 POLR1G NOP2 SMARCA5 HDAC6 TCOF1 LIN28B UTP23 ZC3H18 TFAM UBE2O BRD2 BRD4 EP300 | 4.22e-08 | 334 | 200 | 17 | int:DDX18 |
| Interaction | RPL4 interactions | NOLC1 RSL1D1 RPS6 RPS7 KRI1 CHD3 POLR1G HP1BP3 DRG1 FZR1 MKI67 NOP2 NOL8 HDAC6 DNAJC8 CENPU UTP23 ZC3H18 API5 SNIP1 OTX2 BRD4 TMPO SPEN PRDM15 TOP2A | 4.34e-08 | 764 | 200 | 26 | int:RPL4 |
| Interaction | NXF1 interactions | NOLC1 RSL1D1 CHD3 POGZ EDC4 ARHGEF17 DCTN1 HP1BP3 ITPR2 PNPT1 FZR1 FBXO5 CEP78 RBM27 MKI67 OSBP2 SCFD1 EXOC7 TAF1L NOL8 HYOU1 HDAC6 CHD8 PYM1 ZC3H18 ATF6B ADAM22 SFMBT2 THOC5 GTF2E2 UBE2O OTX2 SH2D4A BRD4 KDM4A ZNF281 | 4.39e-08 | 1345 | 200 | 36 | int:NXF1 |
| Interaction | NUCKS1 interactions | EWSR1 POGZ INTS3 HP1BP3 HMG20A TIMELESS SMARCA5 BAZ1B BRD4 SMARCA4 PHF14 TOP2A EP300 RAI1 | 4.45e-08 | 220 | 200 | 14 | int:NUCKS1 |
| Interaction | FTSJ3 interactions | RSL1D1 RPS6 CHD3 POLR1G HP1BP3 DRG1 MKI67 NOP2 HDAC6 LIN28B DNAJC8 UTP23 ZC3H18 RYBP SNIP1 UBE2O CBX6 BRD4 CBX8 | 4.64e-08 | 422 | 200 | 19 | int:FTSJ3 |
| Interaction | ELF2 interactions | MBTD1 POGZ POLR1G SINHCAF L3MBTL2 ARID4A KANSL3 EPC1 ZFP91 ELF1 ZNF281 MYBL2 | 5.29e-08 | 156 | 200 | 12 | int:ELF2 |
| Interaction | REXO4 interactions | RSL1D1 RPS6 KRI1 CHD3 POLR1G HP1BP3 NOP2 SMARCA5 LIN28B UTP23 BAZ1B ZC3H18 TFAM SNIP1 H1-6 | 5.61e-08 | 261 | 200 | 15 | int:REXO4 |
| Interaction | BRIX1 interactions | NOLC1 RSL1D1 RPS6 RPS7 CHD3 POLR1G DRG1 MKI67 NOP2 HDAC6 LIN28B UTP23 ZC3H18 CBX6 BRD4 H1-6 | 5.64e-08 | 300 | 200 | 16 | int:BRIX1 |
| Interaction | MOV10 interactions | NOLC1 RSL1D1 RPS6 CHD3 POGZ EDC4 DCTN1 TNFRSF21 HMG20A FZR1 FBXO5 CEP78 MKI67 OSBP2 SCFD1 EXOC7 NOP2 NOL8 RAP1B HYOU1 LIN28B PYM1 ZC3H18 ATF6B SFMBT2 LIG1 GTF2E2 UBE2O CBX6 H1-6 PHF14 KDM4A KAT6B EP300 CBX8 | 5.72e-08 | 1297 | 200 | 35 | int:MOV10 |
| Interaction | HNF1B interactions | SOX5 EWSR1 POGZ HMG20A SINHCAF SOX6 TCOF1 RYBP OTX2 EPC1 TMPO ZNF281 EP300 | 5.85e-08 | 190 | 200 | 13 | int:HNF1B |
| Interaction | UTP23 interactions | RSL1D1 RPS6 KRI1 HP1BP3 UBTF NOP2 SMARCA5 LIN28B UTP23 BAZ1B BRD2 CBX6 H1-6 | 6.22e-08 | 191 | 200 | 13 | int:UTP23 |
| Interaction | NIFK interactions | NOLC1 RSL1D1 RPS6 KRI1 CHD3 POLR1G FZR1 UBTF MKI67 NOP2 NOL8 TCOF1 LIN28B DNAJC8 ZC3H18 UBE2O BRD2 BRD4 CBX8 | 6.47e-08 | 431 | 200 | 19 | int:NIFK |
| Interaction | DUXA interactions | 6.85e-08 | 12 | 200 | 5 | int:DUXA | |
| Interaction | DDX23 interactions | NOLC1 RSL1D1 ZC3H13 RPS7 KRI1 SRSF11 EWSR1 CHD3 ZNF512B UBTF NOP2 NOL8 TCOF1 ZC3H18 THOC5 GTF2E2 BRD2 BRD4 TOP2A EP300 | 7.20e-08 | 480 | 200 | 20 | int:DDX23 |
| Interaction | CSNK2A1 interactions | NOLC1 RSL1D1 RPS6 ZC3H13 SRSF11 CHD3 CHEK1 VSX1 POLR1G LYST HP1BP3 HMG20A LHX9 UBTF CCNL2 TCOF1 ZC3H18 XRCC1 THOC5 RYBP LIG1 UBE2O BRD2 BRD4 SMARCA4 TMPO TOP2A EP300 CBX8 | 8.09e-08 | 956 | 200 | 29 | int:CSNK2A1 |
| Interaction | ARID4B interactions | SOX5 NHSL2 CHD3 POLR1G HMG20A ZNF512B FZR1 SINHCAF SOX6 ARID4A SMARCA4 ELF1 MYBL2 | 1.01e-07 | 199 | 200 | 13 | int:ARID4B |
| Interaction | CDC5L interactions | NOLC1 RPS6 CKAP5 CHD3 CHEK1 EDC4 INTS3 DRG1 FZR1 UBTF EXOC7 NOP2 NOL8 SMARCA5 CHD8 ZC3H18 API5 ORC1 SNIP1 OTX2 BRD2 BRD4 SMARCA4 TMPO SPEN TOP2A EP300 | 1.07e-07 | 855 | 200 | 27 | int:CDC5L |
| Interaction | H2BC3 interactions | MBTD1 CHD3 POGZ EDC4 DCTN1 HMG20A FZR1 EXOC7 SMARCA5 HDAC6 DUOX2 CHD8 ZC3H18 BRD2 BRD4 PHF14 EP300 RAI1 | 1.34e-07 | 406 | 200 | 18 | int:H2BC3 |
| Interaction | RPS8 interactions | RSL1D1 RPS6 RPS7 KRI1 CHD3 HP1BP3 DRG1 FZR1 MKI67 NOP2 HDAC6 DNAJC8 UTP23 PYM1 ZC3H18 API5 SNIP1 CBX6 BRD4 ZFP91 TMPO TOP2A CBX8 | 1.36e-07 | 649 | 200 | 23 | int:RPS8 |
| Interaction | HECTD1 interactions | NOLC1 RSL1D1 RPS7 CKAP5 KRI1 CHD3 POLR1G DCTN1 HP1BP3 DRG1 CEP78 RBM27 UBTF MKI67 EXOC7 NOP2 NOL8 SMARCA5 CENPU BAZ1B TACC2 XRCC1 TFAM EXO1 SMARCA4 TMPO TOP2A EP300 CBX8 | 1.49e-07 | 984 | 200 | 29 | int:HECTD1 |
| Interaction | RPL36 interactions | RSL1D1 RPS6 RPS7 CHD3 HP1BP3 DRG1 FZR1 NOP2 NOL8 HDAC6 MAP4K3 CENPU ZC3H18 API5 SNIP1 UBE2O CBX6 BRD4 TOP2A CBX8 | 1.58e-07 | 504 | 200 | 20 | int:RPL36 |
| Interaction | NKRF interactions | RPS6 EWSR1 CHD3 POLR1G DRG1 FZR1 MKI67 ZC3H18 SNIP1 UBE2O CBX6 BRD4 H1-6 EP300 | 1.61e-07 | 244 | 200 | 14 | int:NKRF |
| Interaction | HDAC1 interactions | NOLC1 STAG1 CKAP5 CHD3 POLR1G DCTN1 HMG20A ZNF512B FZR1 SINHCAF UBTF MKI67 AFF1 FOXJ1 SOX6 CCNL2 SMARCA5 TCF21 L3MBTL2 ARID4A CHD8 THOC5 RYBP BRD4 SMARCA4 PHF14 KDM4A SPEN TOP2A EP300 RAI1 | 1.67e-07 | 1108 | 200 | 31 | int:HDAC1 |
| Interaction | RPS2 interactions | SOX5 RSL1D1 RPS6 RPS7 KRI1 CHD3 DRG1 FZR1 NOP2 HDAC6 UTP23 BAZ1B PYM1 ZC3H18 API5 SNIP1 UBE2O CBX6 BRD4 ZFP91 H1-6 TMPO TOP2A | 1.69e-07 | 657 | 200 | 23 | int:RPS2 |
| Interaction | RBM28 interactions | SOX5 RSL1D1 RPS6 CHD3 POLR1G DRG1 FZR1 NOP2 LIN28B DNAJC8 UTP23 ZC3H18 TFAM SNIP1 CBX6 ELF1 EP300 | 1.70e-07 | 368 | 200 | 17 | int:RBM28 |
| Interaction | NOP2 interactions | NOLC1 RSL1D1 RPS6 RPS7 CHD3 POLR1G HP1BP3 FZR1 NOP2 NOL8 HDAC6 UTP23 ZC3H18 SNIP1 BRD4 TOP2A EP300 CBX8 | 1.92e-07 | 416 | 200 | 18 | int:NOP2 |
| Interaction | KLF8 interactions | SOX5 NOLC1 MBTD1 POGZ UBTF L3MBTL2 BAZ1B MICALL1 KANSL3 BRD2 EPC1 ELF1 SPEN ZNF281 EP300 MYBL2 | 1.99e-07 | 329 | 200 | 16 | int:KLF8 |
| Interaction | DHX40 interactions | ZC3H13 KRI1 TASOR2 RBM27 UBTF NOP2 NOL8 SOX6 CCNL2 ZC3H18 UBE2O BRD2 BRD4 RAI1 | 2.06e-07 | 249 | 200 | 14 | int:DHX40 |
| Cytoband | Xq13.1 | 6.32e-05 | 48 | 204 | 4 | Xq13.1 | |
| Cytoband | 4q26-q27 | 1.17e-04 | 4 | 204 | 2 | 4q26-q27 | |
| Cytoband | 22q12.2 | 1.33e-04 | 58 | 204 | 4 | 22q12.2 | |
| Cytoband | 12p11 | 6.93e-04 | 9 | 204 | 2 | 12p11 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 3.22e-07 | 9 | 131 | 4 | 1263 | |
| GeneFamily | PHD finger proteins | 4.88e-05 | 90 | 131 | 6 | 88 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinase kinases | 5.14e-04 | 5 | 131 | 2 | 655 | |
| GeneFamily | Cohesin complex | 1.42e-03 | 8 | 131 | 2 | 1060 | |
| GeneFamily | Chromobox family | 1.42e-03 | 8 | 131 | 2 | 976 | |
| GeneFamily | Zinc fingers CCCH-type | 2.05e-03 | 35 | 131 | 3 | 73 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.06e-03 | 181 | 131 | 6 | 694 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NOLC1 STAG1 DLGAP5 CKAP5 CHEK1 JADE1 FBXO5 MKI67 TIMELESS L3MBTL2 TCOF1 CENPU XRCC1 AKAP12 ORC1 LIG1 LIMK1 EXO1 TOP2A MYBL2 | 1.83e-08 | 578 | 198 | 20 | M2368 |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | TMEM237 DLGAP5 CHEK1 PXDN FBXO5 CEP78 MKI67 MICAL3 TIMELESS MN1 TCOF1 FAAP24 CENPU PPP4R4 MICALL1 ORC1 EXO1 TMPO TOP2A MYBL2 | 2.42e-08 | 588 | 198 | 20 | M38992 |
| Coexpression | MORI_IMMATURE_B_LYMPHOCYTE_DN | 3.07e-08 | 91 | 198 | 9 | M18917 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NOLC1 STAG1 DLGAP5 CKAP5 CHEK1 JADE1 FBXO5 MKI67 TIMELESS L3MBTL2 TCOF1 CENPU XRCC1 AKAP12 ORC1 LIG1 LIMK1 EXO1 TOP2A MYBL2 | 3.11e-08 | 597 | 198 | 20 | MM1309 |
| Coexpression | MORI_IMMATURE_B_LYMPHOCYTE_DN | 3.71e-08 | 93 | 198 | 9 | MM1138 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | NOLC1 MBTD1 PDGFRL RSL1D1 DLGAP5 CKAP5 CHEK1 GASK1B HMG20A PNPT1 FBXO5 CEP78 SULF1 MKI67 TIMELESS NOP2 NOL8 SOX6 CENPU BAZ1B TFAM ADAM22 DNAJC14 BRD4 EXO1 SMARCA4 TMPO PHF14 ZNF281 FGD6 TOP2A | 8.14e-08 | 1407 | 198 | 31 | M14427 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | NOLC1 RPS6 RPS7 DLGAP5 SRSF11 EWSR1 CHEK1 MKI67 TIMELESS NOP2 GNPAT SMARCA5 BAZ1B TFAM LIG1 GTF2E2 EXO1 SMARCA4 TMPO KDM4A TOP2A MYBL2 | 8.27e-08 | 761 | 198 | 22 | M11961 |
| Coexpression | FISCHER_DREAM_TARGETS | NOLC1 STAG1 DLGAP5 CKAP5 EWSR1 CHEK1 JADE1 FZR1 FBXO5 CEP78 MKI67 TIMELESS SMARCA5 L3MBTL2 TCOF1 FAAP24 CENPU BAZ1B XRCC1 ORC1 SLF2 EXO1 TMPO TOP2A MYBL2 | 9.12e-08 | 969 | 198 | 25 | M149 |
| Coexpression | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU EXO1 TMPO TOP2A MYBL2 | 2.88e-07 | 154 | 198 | 10 | M3766 |
| Coexpression | HALLMARK_G2M_CHECKPOINT | NOLC1 STAG1 EWSR1 CHEK1 FBXO5 MKI67 ARID4A EXO1 TMPO TOP2A MYBL2 | 3.88e-07 | 200 | 198 | 11 | M5901 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | TMEM237 DLGAP5 CKAP5 CHEK1 JADE1 FZR1 FBXO5 MKI67 TIMELESS TCOF1 CENPU BAZ1B XRCC1 THOC5 ORC1 SNIP1 LIG1 SCMH1 EXO1 SMARCA4 STAG3 TOP2A MYBL2 | 7.63e-07 | 939 | 198 | 23 | M45768 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | DLGAP5 CKAP5 CHD3 CHEK1 PXDN FBXO5 CEP78 MKI67 TIMELESS CENPU ORC1 LIG1 SCMH1 EXO1 TOP2A MYBL2 | 8.00e-07 | 478 | 198 | 16 | M45785 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | DLGAP5 CHEK1 FBXO5 CEP78 SULF1 MKI67 TIMELESS CENPU LIG1 EXO1 TMPO TOP2A MYBL2 | 1.19e-06 | 323 | 198 | 13 | M2156 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | DLGAP5 CKAP5 CHEK1 FBXO5 CEP78 MKI67 TIMELESS CENPU ORC1 LIG1 TOP2A MYBL2 | 2.33e-06 | 290 | 198 | 12 | M45736 |
| Coexpression | HALLMARK_E2F_TARGETS | NOLC1 STAG1 DLGAP5 CHEK1 MKI67 TIMELESS LIG1 TMPO TOP2A MYBL2 | 3.12e-06 | 200 | 198 | 10 | M5925 |
| Coexpression | GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN | 3.12e-06 | 200 | 198 | 10 | M7861 | |
| Coexpression | MUELLER_PLURINET | NOLC1 EWSR1 CHEK1 FOXO4 TCOF1 ORC1 OTX2 EXO1 TMPO ZNF281 PHF10 MYBL2 | 3.19e-06 | 299 | 198 | 12 | M123 |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_DN | NOLC1 DLGAP5 MKI67 TIMELESS TCOF1 CENPU ORC1 EXO1 TMPO TOP2A MYBL2 | 3.86e-06 | 253 | 198 | 11 | M16010 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | USP45 STAG1 TMEM237 DLGAP5 CKAP5 CHEK1 JADE1 DNAL1 SINHCAF FBXO5 CEP78 RBM27 MKI67 TIMELESS MN1 DCDC2 AKAP12 ORC1 LIG1 OTX2 SLF2 SCMH1 EXO1 TMPO TOP2A MYBL2 | 5.14e-06 | 1290 | 198 | 26 | M80 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | DLGAP5 CKAP5 CHEK1 JADE1 FBXO5 CEP78 MKI67 TIMELESS KLRC2 CENPU BAZ1B XRCC1 ORC1 LIG1 SCMH1 EXO1 TOP2A MYBL2 | 6.00e-06 | 694 | 198 | 18 | M45767 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | DLGAP5 CHEK1 GASK1B PSME4 FBXO5 MKI67 TIMELESS USP49 LIN28B CENPU ORC1 LIMK1 EXO1 FGD6 TOP2A MYBL2 | 7.12e-06 | 567 | 198 | 16 | M45692 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 8.18e-06 | 176 | 198 | 9 | M39223 | |
| Coexpression | BENPORATH_CYCLING_GENES | STAG1 DLGAP5 CKAP5 HP1BP3 FZR1 SINHCAF MKI67 CENPU PYM1 ORC1 SLF2 EXO1 TMPO KDM4A ZNF281 STAG3 TOP2A | 9.48e-06 | 648 | 198 | 17 | M8156 |
| Coexpression | ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER | 1.17e-05 | 140 | 198 | 8 | M15664 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | PDXDC1 STAG1 CNST INO80D SINHCAF PSME4 RBM27 ARID4A MKNK2 CENPU TFAM CTDSP2 EPC1 ZFP91 TMPO PHF10 EP300 | 1.76e-05 | 680 | 198 | 17 | M41089 |
| Coexpression | FUJII_YBX1_TARGETS_DN | 1.78e-05 | 194 | 198 | 9 | M14340 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | NOLC1 PDGFRL RSL1D1 RPS6 DLGAP5 CKAP5 CHEK1 SINHCAF FBXO5 MKI67 TIMELESS THOC5 LIG1 SMARCA4 TMPO TOP2A | 1.82e-05 | 612 | 198 | 16 | M4772 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | DLGAP5 TNFRSF21 FZR1 FBXO5 SULF1 MKI67 CENPU OSR2 GTF2IRD1 TOP2A MYBL2 | 1.92e-05 | 300 | 198 | 11 | M45675 |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 2.18e-05 | 199 | 198 | 9 | M7254 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 2.27e-05 | 200 | 198 | 9 | M9472 | |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP | 2.27e-05 | 200 | 198 | 9 | M5069 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 2.45e-05 | 155 | 198 | 8 | M39041 | |
| Coexpression | WINNEPENNINCKX_MELANOMA_METASTASIS_UP | 3.37e-05 | 162 | 198 | 8 | M6387 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | DLGAP5 CHEK1 GASK1B FBXO5 MKI67 TIMELESS CENPU OTX2 TMPO TOP2A MYBL2 | 3.66e-05 | 322 | 198 | 11 | M39060 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 3.68e-05 | 164 | 198 | 8 | M19957 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 3.68e-05 | 164 | 198 | 8 | M13108 | |
| Coexpression | NADERI_BREAST_CANCER_PROGNOSIS_UP | 4.14e-05 | 51 | 198 | 5 | M6862 | |
| Coexpression | ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR | 4.29e-05 | 84 | 198 | 6 | M2606 | |
| Coexpression | GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN | 4.36e-05 | 168 | 198 | 8 | M13844 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | RBM27 PLAG1 SMARCA5 RAP1B SNIP1 USP8 TMPO ZNF281 TOP2A KDM4B | 4.50e-05 | 272 | 198 | 10 | M15123 |
| Coexpression | ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR | 5.25e-05 | 127 | 198 | 7 | M2608 | |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP | 5.58e-05 | 88 | 198 | 6 | M19287 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | RSL1D1 SRSF11 LYST AHR MAP4K3 MKNK2 GTF2IRD1 RYBP SNIP1 BRD2 SLF2 MAP4K5 BRD4 ELF1 KDM4A FGD6 EP300 KDM4B | 5.63e-05 | 822 | 198 | 18 | M6782 |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | EWSR1 CHEK1 FBXO5 MKI67 TIMELESS ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 6.14e-05 | 341 | 198 | 11 | M2879 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 6.33e-05 | 90 | 198 | 6 | M39250 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22 | 6.70e-05 | 11 | 198 | 3 | M11594 | |
| Coexpression | GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP | 7.38e-05 | 181 | 198 | 8 | M6814 | |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP | 7.61e-05 | 93 | 198 | 6 | MM1137 | |
| Coexpression | PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP | PHACTR2 SRSF11 GASK1B TASOR2 SULF1 AHR AKAP12 CTDSP2 RYBP FGD6 | 7.90e-05 | 291 | 198 | 10 | M41002 |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | RSL1D1 DLGAP5 CHEK1 PNPT1 SINHCAF MKI67 TIMELESS NOP2 ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 8.17e-05 | 550 | 198 | 14 | M16189 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STAG1 DLGAP5 CKAP5 PSME4 AFF1 MICAL3 MN1 SMARCA5 ARID4A BAZ1B RYBP GTF2E2 MAP4K5 PHF14 SPIDR KAT6B SPEN TOP2A | 9.40e-05 | 856 | 198 | 18 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.02e-04 | 300 | 198 | 10 | M8702 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU OTX2 TMPO TOP2A MYBL2 | 1.02e-04 | 300 | 198 | 10 | M39059 |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 1.03e-04 | 190 | 198 | 8 | M761 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | DLGAP5 CKAP5 SRSF11 CHEK1 MKI67 TIMELESS GNPAT LIG1 SMARCA4 TMPO TOP2A MYBL2 | 1.04e-04 | 426 | 198 | 12 | M9516 |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_NPCS | 1.06e-04 | 142 | 198 | 7 | M39078 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | NOLC1 RSL1D1 DLGAP5 SRSF11 CHEK1 POLR1G INTS3 FBXO5 NOL8 TTC24 FAAP24 CENPU ORC1 EXO1 TOP2A MYBL2 | 1.13e-04 | 714 | 198 | 16 | M1744 |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | RSL1D1 DLGAP5 CHEK1 PNPT1 SINHCAF MKI67 TIMELESS NOP2 ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.21e-04 | 571 | 198 | 14 | MM1100 |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN | 1.33e-04 | 197 | 198 | 8 | M8464 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN | 1.42e-04 | 199 | 198 | 8 | M8031 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN | 1.42e-04 | 199 | 198 | 8 | M8029 | |
| Coexpression | GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_DN | 1.42e-04 | 199 | 198 | 8 | M8507 | |
| Coexpression | GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP | 1.42e-04 | 199 | 198 | 8 | M8538 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP | 1.42e-04 | 199 | 198 | 8 | M5239 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | NOLC1 RSL1D1 RPS6 RPS7 SRSF11 EWSR1 MKI67 TIMELESS SCFD1 NOP2 SMARCA5 RAP1B HDAC6 TCOF1 CAST BAZ1B TFAM ADAM22 TMPO ELF1 KDM4A TOP2A EP300 MYBL2 | 1.46e-04 | 1394 | 198 | 24 | M9585 |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 1.47e-04 | 200 | 198 | 8 | M3580 | |
| Coexpression | GSE27786_LSK_VS_NEUTROPHIL_UP | 1.47e-04 | 200 | 198 | 8 | M4760 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 1.47e-04 | 200 | 198 | 8 | M5041 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN | 1.47e-04 | 200 | 198 | 8 | M6408 | |
| Coexpression | GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP | 1.47e-04 | 200 | 198 | 8 | M6832 | |
| Coexpression | GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN | 1.47e-04 | 200 | 198 | 8 | M6745 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN | PDXDC1 PDGFRL DLGAP5 CENPU AKAP12 ORC1 EXO1 SMARCA4 TMPO TOP2A MYBL2 | 1.52e-04 | 378 | 198 | 11 | M17788 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS | 1.65e-04 | 107 | 198 | 6 | M39165 | |
| Coexpression | HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP | 1.66e-04 | 68 | 198 | 5 | M41108 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 1.69e-04 | 153 | 198 | 7 | M5588 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | DLGAP5 CHEK1 FBXO5 MKI67 OSBP2 SOX6 CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.73e-04 | 450 | 198 | 12 | M45747 |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5 | 1.78e-04 | 69 | 198 | 5 | M12001 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 1.83e-04 | 155 | 198 | 7 | MM1259 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | STAG1 DLGAP5 CKAP5 KRI1 CHEK1 JADE1 EDC4 POLR1G PNPT1 FZR1 FBXO5 CEP78 MKI67 TIMELESS TCOF1 CENPU ZC3H18 XRCC1 ORC1 LIG1 GTF2E2 SCMH1 TOP2A MYBL2 | 1.99e-04 | 1423 | 198 | 24 | M45722 |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_UP | 2.09e-04 | 328 | 198 | 10 | M854 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | PHACTR2 POLR1G AHR API5 TFAM SNIP1 CBX6 MAP4K5 TRAM1 C8orf44 KAT6B | 2.43e-04 | 399 | 198 | 11 | M40939 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | RPS7 SRSF11 TASOR2 PNPT1 KLRC2 SMARCA5 RAP1B ANK3 UTP23 API5 TFAM MAP4K5 TRAM1 PHF14 PHF10 | 2.45e-04 | 687 | 198 | 15 | M41022 |
| Coexpression | WONG_EMBRYONIC_STEM_CELL_CORE | 2.48e-04 | 335 | 198 | 10 | M7079 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 2.49e-04 | 163 | 198 | 7 | M8235 | |
| Coexpression | WHITEFORD_PEDIATRIC_CANCER_MARKERS | 2.69e-04 | 117 | 198 | 6 | M7854 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | NOLC1 STAG1 DLGAP5 CKAP5 CHEK1 JADE1 EDC4 DRG1 FBXO5 CEP78 MKI67 TIMELESS REV1 TCOF1 CENPU BAZ1B XRCC1 ORC1 LIG1 SCMH1 EXO1 TOP2A MYBL2 | 2.70e-04 | 1363 | 198 | 23 | M45782 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | PDXDC1 PHACTR2 CXorf65 HP1BP3 SINHCAF PSME4 ANK3 TFAM ATF6B EPC1 ELF1 KAT6B | 2.78e-04 | 474 | 198 | 12 | M40991 |
| Coexpression | KIM_WT1_TARGETS_8HR_UP | 2.89e-04 | 167 | 198 | 7 | M8857 | |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 2.99e-04 | 168 | 198 | 7 | M18811 | |
| Coexpression | TSANG_PBMC_FLUVIRIN_PANDEMRIX_ADULT_CORR_WITH_CELL_FREQ_CD27HI_CD38HI_CD20_NEG_PLASMABLASTS_AND_CD38PLUS_OF_IGD_CD27PLUS_MEM_B_CELLS_7DY_POSITIVE | 3.16e-04 | 78 | 198 | 5 | M41196 | |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP | 3.18e-04 | 224 | 198 | 8 | M12383 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | ZC3H13 SIPA1L3 SRSF11 CHD6 ARID4A BAZ1B GTF2IRD1 USP8 BRD4 PHF14 KAT6B | 3.53e-04 | 417 | 198 | 11 | M39224 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST | 3.76e-04 | 81 | 198 | 5 | M45667 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL | 4.02e-04 | 232 | 198 | 8 | M45800 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | NOLC1 DLGAP5 CHEK1 DNAL1 PNPT1 SINHCAF PXDN FBXO5 MKI67 CENPU TFAM MAP4K5 TMPO PHF14 | 4.12e-04 | 644 | 198 | 14 | M10501 |
| Coexpression | FAN_EMBRYONIC_CTX_NSC_2 | 4.13e-04 | 233 | 198 | 8 | M39036 | |
| Coexpression | VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP | 4.17e-04 | 127 | 198 | 6 | M40952 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 5.01e-04 | 183 | 198 | 7 | M2993 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMYELOCYTE_LIKE_CELL | 5.13e-04 | 49 | 198 | 4 | M45737 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 5.17e-04 | 184 | 198 | 7 | M19988 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SOX5 NOLC1 SWT1 RSL1D1 ZC3H13 CKAP5 SRSF11 POGZ CCDC38 SINHCAF PSME4 FBXO5 RBM27 MKI67 NOL8 SOX6 USP49 SMARCA5 GARNL3 L3MBTL2 TCOF1 ARID4A DNAJC8 CENPU BAZ1B FHOD3 ORC1 LIG1 BRD4 EXO1 TMPO PHF14 ZNF281 TOP2A CBX8 KDM4B MYBL2 | 2.55e-10 | 1257 | 195 | 37 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SOX5 NOLC1 SWT1 RSL1D1 ZC3H13 CKAP5 SRSF11 POGZ CCDC38 SINHCAF PSME4 FBXO5 RBM27 MKI67 NOL8 SOX6 USP49 SMARCA5 GARNL3 L3MBTL2 TCOF1 ARID4A LIN28B DNAJC8 CENPU BAZ1B FHOD3 ORC1 LIG1 BRD4 EXO1 TMPO PHF14 ZNF281 TOP2A CBX8 KDM4B MYBL2 | 4.30e-09 | 1459 | 195 | 38 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | PDXDC1 SOX5 NOLC1 STAG1 NHSL2 RPS7 EWSR1 INTS3 DCTN1 LHX9 FZR1 CCNL2 TCF21 TCOF1 MKNK2 OSR2 BAZ1B CHD8 GTF2IRD1 BRD2 SCMH1 EXO1 SMARCA4 TMPO STAG3 TOP2A MYBL2 | 8.88e-09 | 819 | 195 | 27 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NOLC1 RSL1D1 CKAP5 SRSF11 POLR1G SINHCAF MKI67 MICAL3 NOL8 SOX6 SMARCA5 MAGEL2 GARNL3 HDAC6 TCOF1 ARID4A LIN28B CEP162 BAZ1B FHOD3 GTF2IRD1 KIF3A ORC1 OTX2 EXO1 SMARCA4 PHF14 FGD6 | 1.15e-07 | 989 | 195 | 28 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SOX5 SGSM1 ZC3H13 CKAP5 POGZ DNAL1 CCDC38 SINHCAF PSME4 FBXO5 CEP78 SULF1 MKI67 REV1 SOX6 USP49 SMARCA5 SFRP4 GARNL3 HDAC6 ARID4A CEP162 CENPU FHOD3 ORC1 LIG1 BRD4 SYT14 EXO1 PHF14 TOP2A KDM4B MYBL2 | 3.25e-07 | 1370 | 195 | 33 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SOX5 NHSL2 ZC3H13 RPS7 SRSF11 EWSR1 CHEK1 JADE1 GASK1B LHX9 UBTF NOL8 SOX6 SMARCA5 HYOU1 CHD8 KIF3A BRD2 SCMH1 EXO1 SMARCA4 STAG3 TOP2A MYBL2 | 4.12e-07 | 806 | 195 | 24 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | NOLC1 RSL1D1 POLR1G SINHCAF NOL8 MAGEL2 HDAC6 TCOF1 LIN28B ORC1 SMARCA4 | 4.83e-07 | 169 | 195 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | SOX5 NOLC1 SWT1 RSL1D1 CKAP5 POGZ JADE1 POLR1G SINHCAF FBXO5 CEP78 NOP2 NOL8 SOX6 SMARCA5 SFRP4 HDAC6 TCF21 TCOF1 CENPU FHOD3 ADAM22 AKAP12 ORC1 LIG1 UBE2O BRD4 SYT14 EXO1 ZNF281 TOP2A MYBL2 | 1.00e-06 | 1371 | 195 | 32 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | MBTD1 ZC3H13 SRSF11 EWSR1 KIAA0753 ITPR2 MKI67 SMARCA5 ARID4A BAZ1B API5 GTF2IRD1 LIG1 GTF2E2 UBE2O SLF2 TMPO FGD6 TOP2A | 1.20e-06 | 564 | 195 | 19 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | PDXDC1 NOLC1 STAG1 NHSL2 RPS7 EWSR1 INTS3 DCTN1 LHX9 FZR1 CCNL2 TCOF1 MKNK2 BAZ1B GTF2IRD1 SMARCA4 TMPO MYBL2 | 1.77e-06 | 524 | 195 | 18 | gudmap_developingGonad_e12.5_testes_k1_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | PDXDC1 SOX5 NOLC1 STAG1 NHSL2 RPS7 EWSR1 INTS3 DCTN1 LHX9 FZR1 UBTF CCNL2 HYOU1 TCOF1 MKNK2 OSR2 BAZ1B CHD8 GTF2IRD1 BRD2 SMARCA4 TMPO | 3.27e-06 | 844 | 195 | 23 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | SOX5 CKAP5 SRSF11 JADE1 DNAL1 SINHCAF RBM27 DLX2 CHD6 DLX5 NOL8 SOX6 USP49 SMARCA5 MAGEL2 GARNL3 LIN28B OSR2 FHOD3 CHD8 OTX2 OSR1 EXO1 PHF14 KAT6B | 4.03e-06 | 983 | 195 | 25 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 | NOLC1 TMEM237 RSL1D1 CKAP5 CHEK1 TASOR2 SINHCAF PSME4 FBXO5 CEP78 NOP2 NOL8 SMARCA5 HDAC6 LIN28B CEP162 CENPU FHOD3 PYM1 TFAM ORC1 SYT14 EXO1 ZNF281 KDM4B MYBL2 | 6.79e-06 | 1080 | 195 | 26 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K0 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#3 | NOLC1 RSL1D1 POLR1G SINHCAF AHR NOL8 MAGEL2 HDAC6 L3MBTL2 ORC1 | 7.38e-06 | 182 | 195 | 10 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | SOX5 SWT1 RSL1D1 CKAP5 CCDC38 KIAA0753 SINHCAF PSME4 FBXO5 MKI67 AFF1 SMARCA5 L3MBTL2 TCOF1 ARID4A DNAJC8 CENPU KIF3A ORC1 GTF2E2 UBE2O BRD4 TMPO PHF14 ZNF281 FGD6 PHF10 CBX8 | 1.15e-05 | 1252 | 195 | 28 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K3 | NOLC1 NHSL2 RSL1D1 SRSF11 EDC4 TASOR2 KIAA0753 SEMA4C PNPT1 FZR1 SINHCAF FBXO5 CEP78 NOP2 USP49 SMARCA5 HYOU1 ANK3 TCOF1 MKNK2 CENPU ATF6B ORC1 UBE2O ZFP91 EXO1 CBX8 MYBL2 | 1.27e-05 | 1259 | 195 | 28 | facebase_RNAseq_e9.5_MandArch_2500_K3 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | 1.33e-05 | 85 | 195 | 7 | GSM476664_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | SRSF11 CHD3 ITPR2 MKI67 DLX2 DLX5 MAGEL2 COL16A1 LIN28B BAZ1B FHOD3 GTF2IRD1 SLF2 OSR1 PHF14 FGD6 | 1.34e-05 | 492 | 195 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05 | NOLC1 MBTD1 TMEM237 KRI1 CHEK1 POLR1G GASK1B SINHCAF FBXO5 CEP78 SULF1 TIMELESS DLX5 MN1 FOXJ1 REV1 SMARCA5 CFAP91 LIN28B CENPU TFAM AKAP12 KIF3A ORC1 LIMK1 OTX2 CBX6 C8orf44 EXO1 TMPO CBX8 | 1.34e-05 | 1479 | 195 | 31 | PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | PHACTR2 DLGAP5 CHD3 GASK1B LHX9 SULF1 PLAG1 TCF21 SZT2 LIN28B OSR2 PPP4R4 ORC1 SH2D4A SLF2 SCMH1 OSR1 SPIDR KAT6B TOP2A CBX8 | 2.77e-05 | 831 | 195 | 21 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K3 | NOLC1 RSL1D1 SIPA1L3 CKAP5 SEMA4C FZR1 SINHCAF FBXO5 CEP78 SULF1 NOP2 SOX6 SMARCA5 HYOU1 HDAC6 ANK3 TCOF1 LIN28B CENPU PYM1 UBE2O SYT14 EXO1 PRDM15 RAI1 MYBL2 | 3.47e-05 | 1187 | 195 | 26 | facebase_RNAseq_e9.5_OlfPlac_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000 | NOLC1 RSL1D1 SRSF11 EWSR1 SEMA4C PNPT1 SINHCAF FBXO5 DLX2 DLX5 NOP2 SMARCA5 MAGEL2 TCF21 ARID4A LIN28B BAZ1B XRCC1 GTF2IRD1 ORC1 GTF2E2 SLF2 SMARCA4 | 3.75e-05 | 983 | 195 | 23 | Facebase_RNAseq_e9.5_Mandibular Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | NOLC1 TMEM237 RSL1D1 CKAP5 CHEK1 TASOR2 SINHCAF PSME4 FBXO5 CEP78 NOP2 NOL8 SMARCA5 HDAC6 LIN28B CEP162 CENPU FHOD3 PYM1 TFAM ORC1 SYT14 EXO1 ZNF281 KDM4B MYBL2 | 4.28e-05 | 1202 | 195 | 26 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500 | NOLC1 RSL1D1 SRSF11 PNPT1 SINHCAF DLX2 DLX5 NOP2 SMARCA5 MAGEL2 TCF21 LIN28B ORC1 SLF2 SMARCA4 | 4.36e-05 | 484 | 195 | 15 | Facebase_RNAseq_e9.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#1 | 5.97e-05 | 145 | 195 | 8 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.07e-05 | 191 | 195 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_1000 | |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | DLGAP5 CHEK1 PSME4 FBXO5 MKI67 AFF1 PLAG1 LIN28B AKAP12 LIG1 SMARCA4 FGD6 TOP2A | 7.80e-05 | 395 | 195 | 13 | GSM538340_500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2 | NOLC1 NHSL2 RSL1D1 CKAP5 POLR1G TASOR2 SINHCAF FBXO5 CEP78 NOP2 MN1 NOL8 SOX6 SMARCA5 ANK3 L3MBTL2 TCOF1 LIN28B MKNK2 CENPU ORC1 UBE2O SYT14 EXO1 MYBL2 | 7.93e-05 | 1175 | 195 | 25 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | PDGFRL NHSL2 KRI1 SRSF11 CHD3 ITPR2 MKI67 AHR DLX2 DLX5 MAGEL2 COL16A1 GARNL3 LIN28B OSR2 BAZ1B FHOD3 GTF2IRD1 SLF2 OSR1 PHF14 FGD6 | 9.93e-05 | 978 | 195 | 22 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K4 | SOX5 NOLC1 POLR1G TNFRSF21 PNPT1 FZR1 SINHCAF FBXO5 CEP78 NOP2 MN1 USP49 ANK3 L3MBTL2 TCOF1 MKNK2 CENPU PYM1 ORC1 UBE2O EXO1 PRDM15 RAI1 MYBL2 | 1.07e-04 | 1125 | 195 | 24 | facebase_RNAseq_e9.5_MaxArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#2 | NOLC1 RSL1D1 POLR1G SINHCAF AHR NOL8 MAGEL2 HDAC6 L3MBTL2 ORC1 MYBL2 | 1.16e-04 | 302 | 195 | 11 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | RSL1D1 CKAP5 SRSF11 SSC5D SINHCAF FBXO5 MKI67 DLX2 DLX5 DCDC2 SMARCA5 TCOF1 ARID4A BAZ1B XRCC1 GTF2IRD1 ADAM22 GTF2E2 OTX2 SLF2 FGD6 PHF10 | 1.17e-04 | 989 | 195 | 22 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | NOLC1 SWT1 DLGAP5 CHEK1 JADE1 PNPT1 FBXO5 CEP78 RBM27 NOP2 NOL8 REV1 LIN28B CENPU ORC1 GTF2E2 EXO1 STAG3 MYBL2 | 1.40e-04 | 795 | 195 | 19 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500 | SOX5 NOLC1 POLR1G TNFRSF21 PNPT1 FZR1 SINHCAF FBXO5 CEP78 DLX5 NOP2 MN1 USP49 TCF21 ANK3 L3MBTL2 TCOF1 LIN28B MKNK2 CENPU PYM1 ORC1 UBE2O EXO1 PRDM15 RAI1 MYBL2 | 1.46e-04 | 1371 | 195 | 27 | facebase_RNAseq_e9.5_MaxArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | CKAP5 MKI67 SMARCA5 ARID4A CEP162 BAZ1B GTF2IRD1 KIF3A EXO1 PHF14 FGD6 | 1.49e-04 | 311 | 195 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | DLGAP5 CHEK1 SINHCAF FBXO5 CEP78 MKI67 PLAG1 TIMELESS MN1 LIN28B LIG1 EXO1 TOP2A | 1.51e-04 | 422 | 195 | 13 | GSM538357_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SOX5 MBTD1 USP45 NHSL2 ZC3H13 RPS7 SRSF11 CHEK1 GASK1B LHX9 SULF1 SMARCA5 CHD8 KIF3A SCMH1 EXO1 SMARCA4 SPIDR STAG3 | 1.62e-04 | 804 | 195 | 19 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | SOX5 GASK1B LHX9 ITPR2 ACSM3 SULF1 PLAG1 TCF21 SZT2 PPP4R4 SH2D4A SLF2 SCMH1 OSR1 PHF14 SPIDR KAT6B TOP2A | 1.70e-04 | 740 | 195 | 18 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500 | NOLC1 RSL1D1 POLR1G SINHCAF DLX5 NOP2 NOL8 MAGEL2 HDAC6 L3MBTL2 LIN28B ORC1 OTX2 MYBL2 | 1.80e-04 | 489 | 195 | 14 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | SOX5 NOLC1 SWT1 RSL1D1 RPS7 CKAP5 CCDC38 ITPR2 SINHCAF FBXO5 MKI67 NOL8 SMARCA5 ANK3 BAZ1B FHOD3 LIG1 SLF2 BRD4 EXO1 TMPO PHF14 ZNF281 PHF10 TOP2A | 1.86e-04 | 1241 | 195 | 25 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 1.92e-04 | 129 | 195 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | NHSL2 RPS7 EWSR1 INTS3 DCTN1 LHX9 FZR1 CCNL2 MKNK2 OSR2 BAZ1B BRD2 SMARCA4 | 2.03e-04 | 435 | 195 | 13 | gudmap_developingGonad_e11.5_testes and mesonephros_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | NOLC1 RSL1D1 JADE1 POLR1G SINHCAF NOP2 NOL8 MAGEL2 L3MBTL2 TCOF1 LIN28B ORC1 OTX2 MYBL2 | 2.08e-04 | 496 | 195 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | SOX5 SGSM1 SRSF11 CHD3 DNAL1 GASK1B SSC5D SULF1 CHD6 SOX6 USP49 SMARCA5 SFRP4 GARNL3 ARID4A CENPU FHOD3 CHD8 ADAM22 OTX2 | 2.21e-04 | 893 | 195 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | MBTD1 PDGFRL DLGAP5 CKAP5 SRSF11 EWSR1 MKI67 SMARCA5 ARID4A BAZ1B GTF2IRD1 ADAM22 LIG1 UBE2O SLF2 TMPO | 2.41e-04 | 629 | 195 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_500 | 2.54e-04 | 135 | 195 | 7 | gudmap_developingGonad_e11.5_testes and mesonephros_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#3 | 2.63e-04 | 62 | 195 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | NOLC1 PDGFRL RSL1D1 CHD3 POLR1G SINHCAF AHR DLX5 NOP2 NOL8 MAGEL2 COL16A1 GARNL3 HDAC6 L3MBTL2 LIN28B OSR2 ORC1 OTX2 OSR1 MYBL2 | 2.63e-04 | 976 | 195 | 21 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | PDXDC1 SOX5 NOLC1 NHSL2 RPS7 EWSR1 INTS3 DCTN1 LHX9 FZR1 CCNL2 TCOF1 MKNK2 OSR2 BAZ1B CHD8 GTF2IRD1 BRD2 SMARCA4 | 2.95e-04 | 843 | 195 | 19 | gudmap_developingGonad_e11.5_testes_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | SOX5 SGSM1 CKAP5 SRSF11 CHD3 CEP78 SULF1 DLX2 DLX5 SOX6 USP49 SMARCA5 MAGEL2 GARNL3 ARID4A LIN28B CENPU FHOD3 CHD8 ADAM22 OTX2 | 3.02e-04 | 986 | 195 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.28e-04 | 65 | 195 | 5 | gudmap_developingGonad_e12.5_epididymis_k2_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | DLGAP5 CKAP5 CHEK1 FBXO5 MKI67 TIMELESS GTF2IRD1 AKAP12 LIG1 EXO1 TMPO TOP2A | 3.28e-04 | 398 | 195 | 12 | GSM399397_500 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | DLGAP5 CKAP5 CHEK1 FBXO5 MKI67 TIMELESS AKAP12 LIG1 EXO1 SMARCA4 TOP2A MYBL2 | 4.19e-04 | 409 | 195 | 12 | GSM399452_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | DLGAP5 CKAP5 CHEK1 FBXO5 MKI67 TIMELESS KLRC2 ORC1 LIG1 EXO1 TOP2A MYBL2 | 4.29e-04 | 410 | 195 | 12 | GSM538387_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | SOX5 NOLC1 SWT1 RSL1D1 RPS7 CKAP5 CCDC38 ITPR2 SINHCAF FBXO5 MKI67 DLX5 NOL8 SMARCA5 ANK3 LIN28B BAZ1B FHOD3 LIG1 SLF2 BRD4 EXO1 TMPO PHF14 ZNF281 PHF10 TOP2A | 4.33e-04 | 1468 | 195 | 27 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | NOLC1 RSL1D1 ZC3H13 CKAP5 CHEK1 JADE1 POLR1G SINHCAF FBXO5 CEP78 AFF1 NOP2 MN1 GNPAT NOL8 SMARCA5 TCOF1 CENPU FHOD3 LIG1 EXO1 TOP2A MYBL2 | 4.48e-04 | 1164 | 195 | 23 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | GASK1B LHX9 ITPR2 ACSM3 SULF1 AFF1 PLAG1 SZT2 PPP4R4 KIF3A ORC1 SH2D4A SLF2 SCMH1 PHF14 SPIDR KAT6B CBX8 | 4.55e-04 | 803 | 195 | 18 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.38e-04 | 200 | 195 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.39e-04 | 110 | 195 | 6 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000 | PDXDC1 NHSL2 RPS7 INTS3 DCTN1 FZR1 CCNL2 MKNK2 GTF2IRD1 BRD2 SMARCA4 | 5.44e-04 | 362 | 195 | 11 | gudmap_developingGonad_e18.5_testes_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#2 | 5.62e-04 | 73 | 195 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | SWT1 CHEK1 LYST TASOR2 RBM27 NOL8 REV1 LIN28B ADAM22 PPP4R4 ORC1 LIG1 GTF2E2 SYT14 EXO1 FGD6 STAG3 MYBL2 | 5.81e-04 | 820 | 195 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#1 | 6.32e-04 | 157 | 195 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500 | NOLC1 NHSL2 RSL1D1 CKAP5 POLR1G TASOR2 SINHCAF FBXO5 CEP78 NOP2 MN1 NOL8 SOX6 SMARCA5 TCF21 ANK3 L3MBTL2 TCOF1 LIN28B MKNK2 CENPU ORC1 UBE2O SYT14 EXO1 MYBL2 | 6.55e-04 | 1429 | 195 | 26 | facebase_RNAseq_e8.5_ParaxMesoderm_2500 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100 | 6.63e-04 | 19 | 195 | 3 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | CKAP5 SRSF11 SINHCAF DLX2 DLX5 NOL8 SOX6 USP49 SMARCA5 GARNL3 LIN28B FHOD3 OTX2 | 6.64e-04 | 493 | 195 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.82e-04 | 115 | 195 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | DLGAP5 CHD3 CHEK1 FBXO5 MKI67 AHR TACC2 GTF2IRD1 LIG1 EXO1 TOP2A | 6.97e-04 | 373 | 195 | 11 | GSM605781_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | SOX5 SRSF11 SULF1 DLX2 DLX5 SOX6 USP49 MAGEL2 GARNL3 ARID4A LIN28B FHOD3 OTX2 | 7.02e-04 | 496 | 195 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | RSL1D1 CKAP5 SRSF11 POLR1G SINHCAF NOL8 SOX6 SMARCA5 ARID4A LIN28B FHOD3 OTX2 FGD6 | 7.28e-04 | 498 | 195 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SOX5 SWT1 RSL1D1 ZC3H13 CKAP5 SINHCAF PSME4 MKI67 NOL8 SOX6 USP49 SMARCA5 DNAJC8 CEP162 CENPU FHOD3 ORC1 EXO1 PHF14 ZNF281 MYBL2 | 7.74e-04 | 1060 | 195 | 21 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_100 | 7.75e-04 | 20 | 195 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k2_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | PDXDC1 NHSL2 RPS7 INTS3 DCTN1 CCNL2 MKNK2 GTF2IRD1 BRD2 SMARCA4 TMPO | 7.77e-04 | 378 | 195 | 11 | gudmap_developingGonad_e16.5_testes_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.88e-04 | 212 | 195 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.18e-04 | 164 | 195 | 7 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#1_top-relative-expression-ranked_500 | 9.10e-04 | 167 | 195 | 7 | gudmap_developingGonad_e16.5_testes_500_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | GASK1B LHX9 ITPR2 SULF1 PLAG1 TCF21 SZT2 PPP4R4 ORC1 SH2D4A SLF2 SCMH1 OSR1 SPIDR KAT6B TOP2A CBX8 | 9.32e-04 | 783 | 195 | 17 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.70e-04 | 123 | 195 | 6 | gudmap_developingGonad_e12.5_epididymis_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | NOLC1 RSL1D1 RPS6 CHEK1 DRG1 FBXO5 AFF1 NOP2 MAGEL2 XRCC1 TFAM ORC1 SMARCA4 | 1.08e-03 | 520 | 195 | 13 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K4 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.08e-03 | 334 | 195 | 10 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CKAP5 JADE1 GASK1B RBM27 CHD6 NOL8 SOX6 SMARCA5 FHOD3 CHD8 ADAM22 EXO1 ELF1 PHF14 KAT6B | 1.08e-03 | 654 | 195 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 1.12e-03 | 85 | 195 | 5 | GSM791143_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.12e-03 | 224 | 195 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | NOLC1 DLGAP5 CHEK1 JADE1 PNPT1 FBXO5 CEP78 RBM27 NOP2 NOL8 LIN28B CENPU SFMBT2 ORC1 EXO1 STAG3 MYBL2 | 1.16e-03 | 799 | 195 | 17 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_200 | 1.18e-03 | 23 | 195 | 3 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NHSL2 ZC3H13 RPS7 SRSF11 CHEK1 LHX9 UBTF DLX5 DCDC2 SMARCA5 COL16A1 OSR2 CHD8 KIF3A BRD2 SCMH1 SMARCA4 | 1.19e-03 | 801 | 195 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.21e-03 | 339 | 195 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | DLGAP5 CHEK1 FBXO5 MKI67 LIN28B AKAP12 ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.23e-03 | 400 | 195 | 11 | GSM538358_500 |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.23e-03 | 176 | 195 | 7 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | MBTD1 DLGAP5 EWSR1 MKI67 SOX6 ARID4A BAZ1B LIG1 GTF2E2 UBE2O ZFP91 TMPO TOP2A EP300 | 1.25e-03 | 595 | 195 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SOX5 SWT1 RSL1D1 ZC3H13 CKAP5 SINHCAF ACSM3 PSME4 MKI67 DLX5 NOL8 SOX6 USP49 SMARCA5 SFRP4 LIN28B DNAJC8 CEP162 CENPU FHOD3 ORC1 EXO1 PHF14 ZNF281 MYBL2 | 1.25e-03 | 1414 | 195 | 25 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | ZC3H13 SRSF11 GASK1B LHX9 UBTF SMARCA5 CHD8 BRD2 EXO1 SMARCA4 STAG3 | 1.30e-03 | 403 | 195 | 11 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | PDXDC1 NOLC1 NHSL2 RPS7 EWSR1 INTS3 FZR1 CCNL2 HYOU1 TCOF1 MKNK2 BAZ1B SMARCA4 | 1.35e-03 | 533 | 195 | 13 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | NOLC1 RSL1D1 ZC3H13 CKAP5 CHEK1 JADE1 POLR1G SINHCAF FBXO5 CEP78 AFF1 NOP2 MN1 GNPAT NOL8 SMARCA5 TCOF1 LIN28B CENPU FHOD3 LIG1 EXO1 TOP2A MYBL2 | 1.42e-03 | 1347 | 195 | 24 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | PDXDC1 NHSL2 RPS7 INTS3 DCTN1 LHX9 FZR1 UBTF CCNL2 TCF21 MKNK2 OSR2 GTF2IRD1 BRD2 OSR1 SMARCA4 STAG3 | 1.42e-03 | 814 | 195 | 17 | gudmap_developingGonad_e18.5_testes_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.45e-03 | 181 | 195 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#4 | 1.45e-03 | 133 | 195 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_500 | PDXDC1 RPS7 INTS3 DCTN1 LHX9 CCNL2 MKNK2 OSR2 BRD2 SMARCA4 STAG3 | 1.46e-03 | 409 | 195 | 11 | gudmap_developingGonad_e16.5_testes_500 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.50e-03 | 349 | 195 | 10 | gudmap_developingGonad_P2_testes_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | PDXDC1 NHSL2 RPS7 INTS3 DCTN1 LHX9 UBTF CCNL2 TCF21 MKNK2 OSR2 CHD8 GTF2IRD1 BRD2 SMARCA4 TMPO STAG3 | 1.51e-03 | 819 | 195 | 17 | gudmap_developingGonad_e16.5_testes_1000 |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | DLGAP5 EWSR1 CHEK1 SINHCAF FBXO5 MKI67 TIMELESS DLX2 CENPU ORC1 EXO1 TOP2A MYBL2 | 2.32e-12 | 183 | 199 | 13 | f20b0d71f857ac35868fd80531050ad8b6091716 |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | TMEM237 DLGAP5 FBXO5 MKI67 TIMELESS SFRP4 CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 7.85e-11 | 193 | 199 | 12 | cf680afddc08b6481f1b3eee9c57acfaebeac6f0 |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | RPS6 DNAH14 SINHCAF FBXO5 SULF1 MKI67 PLAG1 SOX6 TACC2 TMPO FGD6 TOP2A | 8.34e-11 | 194 | 199 | 12 | 5759c83308df017f1faae248e9b85388e25254f0 |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.06e-10 | 198 | 199 | 12 | bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86 |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.19e-10 | 200 | 199 | 12 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.19e-10 | 200 | 199 | 12 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | DLGAP5 CHEK1 IL21 MKI67 TIMELESS CENPU ORC1 EXO1 TMPO TOP2A MYBL2 | 4.65e-10 | 176 | 199 | 11 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DLGAP5 CHEK1 FBXO5 MKI67 CENPU ORC1 LIG1 EXO1 STAG3 TOP2A MYBL2 | 6.64e-10 | 182 | 199 | 11 | 11494a66d986297b837332ee9d382b71b9f22591 |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | DLGAP5 CHEK1 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 9.37e-10 | 188 | 199 | 11 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU LIG1 EXO1 TMPO TOP2A MYBL2 | 9.91e-10 | 189 | 199 | 11 | fd8834d1feb7f63911c5fa51efb1f679a8baddeb |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.05e-09 | 190 | 199 | 11 | c3c65d1f24e0ebdbb9adb617bed299a668f423f5 |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | DLGAP5 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.11e-09 | 191 | 199 | 11 | 50854384fdaa0efa2e3227659d544ed09ac102f2 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.31e-09 | 194 | 199 | 11 | f39a471293ecc5c5967b00e772b8f48ebc9affbe |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Pro-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TMPO TOP2A | 1.31e-09 | 194 | 199 | 11 | 3590ff471f74a361ee5bf02a58e3104cd3bf7d00 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.31e-09 | 194 | 199 | 11 | f9070035553bc68106a9e0bdf4b507715a138aba |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.31e-09 | 194 | 199 | 11 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | DLGAP5 CHEK1 IL21 MKI67 CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.31e-09 | 194 | 199 | 11 | 8f313071933451780309d2174ed27d8cdc734343 |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.31e-09 | 194 | 199 | 11 | 9bbb124001fba7450f4639f47f9b720a483e7242 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.31e-09 | 194 | 199 | 11 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.31e-09 | 194 | 199 | 11 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.31e-09 | 194 | 199 | 11 | e14f66f7584909621b776292fbd52808273fd2ee |
| ToppCell | Influenza_Severe-T/NK_proliferative|World / Disease group and Cell class | DLGAP5 CHEK1 FBXO5 IL21 MKI67 TIMELESS CENPU ORC1 EXO1 TOP2A MYBL2 | 1.38e-09 | 195 | 199 | 11 | 6f079c2d7d08110a5e1822ea861b8037eb3f62c9 |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | DLGAP5 CKAP5 CHEK1 FBXO5 MKI67 CENPU LIG1 EXO1 TMPO TOP2A MYBL2 | 1.38e-09 | 195 | 199 | 11 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | DLGAP5 CHEK1 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.38e-09 | 195 | 199 | 11 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.38e-09 | 195 | 199 | 11 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DLGAP5 CHEK1 FBXO5 IL21 MKI67 CENPU ORC1 EXO1 TMPO TOP2A MYBL2 | 1.45e-09 | 196 | 199 | 11 | 9d4f0a95e49bda25864cbe27e4e86096cba5609f |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.45e-09 | 196 | 199 | 11 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | TMEM237 DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 TOP2A MYBL2 | 1.53e-09 | 197 | 199 | 11 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f |
| ToppCell | Healthy/Control-T/NK_proliferative|World / Disease group and Cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.53e-09 | 197 | 199 | 11 | 4a4d3083938783d6f5b87da02f10e501917da0b4 |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.53e-09 | 197 | 199 | 11 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Large_pre-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | DLGAP5 CHEK1 FBXO5 MKI67 CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.53e-09 | 197 | 199 | 11 | cebf47d66f425c84d3fea962e11f5bf4bfe2e60f |
| ToppCell | Healthy_donor-T/NK_proliferative|Healthy_donor / disease group, cell group and cell class (v2) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.53e-09 | 197 | 199 | 11 | b6bbf87e5823fa66b4cad6a7be4f777356887b59 |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | TMEM237 DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 TOP2A MYBL2 | 1.62e-09 | 198 | 199 | 11 | ed86b0247006befe55400c287d334d2202b470bd |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TMPO TOP2A | 1.62e-09 | 198 | 199 | 11 | 4d8591eabb543ed789f963b507a07c560c76a7c9 |
| ToppCell | distal-2-Hematologic-Proliferating_NK/T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | DLGAP5 CHEK1 CXorf65 FBXO5 MKI67 TIMELESS CENPU LIG1 EXO1 TOP2A MYBL2 | 1.62e-09 | 198 | 199 | 11 | a5fd710df5669c95fc5b5ef6e5cfafe6687c7b72 |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.62e-09 | 198 | 199 | 11 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.62e-09 | 198 | 199 | 11 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | DLGAP5 CKAP5 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.62e-09 | 198 | 199 | 11 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU LIG1 EXO1 TMPO TOP2A MYBL2 | 1.62e-09 | 198 | 199 | 11 | e86c1224f5b0890a50a25257628e90c790aae7cd |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS HYOU1 CENPU ORC1 EXO1 TOP2A MYBL2 | 1.62e-09 | 198 | 199 | 11 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 11c3d9fe811a4619347f47d2b0e94066e3085625 |
| ToppCell | severe_influenza-T/NK_proliferative|severe_influenza / disease group, cell group and cell class (v2) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 638b1491c47f2884daf1c1d38a779ad8e0f59c52 |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | d44cc74d7171d96add61dae821daf774b17d4c69 |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | e98ff036d04fc78dffef156bdc0d644532274067 |
| ToppCell | remission-T/NK_proliferative|remission / disease stage, cell group and cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 TMPO TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 303a5fc43a48b05b6f2060d99eef4adc36f8d4e3 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|tumor_Lung / Location, Cell class and cell subclass | DLGAP5 CHEK1 FBXO5 MKI67 CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 2e222e2e080bc2be63d0fdf285e1790676b911ef |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU LIG1 EXO1 TMPO TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | ddae7fe7633661f15d3c79f5187415ffbfecce67 |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a |
| ToppCell | Influenza_Severe-T/NK_proliferative|Influenza_Severe / Disease group and Cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 2508c55f9ffe17b694c70f1283f41ad4a8e83c00 |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 |
| ToppCell | Dividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id | DLGAP5 CHEK1 FBXO5 MKI67 FAAP24 CENPU ORC1 EXO1 TMPO TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | 5c755b6876e164dc847ef7c723f850f227cf3a87 |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.71e-09 | 199 | 199 | 11 | df2fcaf01b1b48632f84e7355ef21d20853f0664 |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Ventral_Precursors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS DLX2 DLX5 CENPU TMPO TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | c8ea0db79b1521f8c90d0d749280c354d3907c3a |
| ToppCell | distal-Hematologic-Proliferating_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | 3835a8a9739b8cd5bf19c40765ef76907ac1ad38 |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | 6126a3bbafe2110fba0c1c4493035df4e8193d22 |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DLGAP5 CHEK1 FBXO5 MKI67 CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | 87e293c0882e2754756a2210a6c04723dc89f81b |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | 0892603e604c2a945dd720685d45970f855bd5d3 |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | e4eb915c29909cf8535a3603c68976545c05e54b |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-T/NK_proliferative|ICU-NoSEP / Disease, condition lineage and cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | f70cc9198339eab7fbc68f5d9b75dfb28c9afc89 |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-T/NK_proliferative|Multiple_Sclerosis / Disease, condition lineage and cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | 7faf1e37364203a08d2b2544979e848b41e36b1c |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 TMPO TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | cfec2f712b870797fab3b0770f16feaafd37e8d5 |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | DLGAP5 CHEK1 FBXO5 MKI67 CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | a1ef1b4824b2d56f6b2af15d698f58fc5590c392 |
| ToppCell | Biopsy_IPF-Immune-Proliferating_T_cells|Biopsy_IPF / Sample group, Lineage and Cell type | DLGAP5 CHEK1 FBXO5 IL21 MKI67 CENPU ORC1 EXO1 TMPO TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | c43d1a83b2a8ad060f3d80c9438da8b7a5e307fb |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TMPO TOP2A | 1.80e-09 | 200 | 199 | 11 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-NoSEP / Disease, Lineage and Cell Type | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | d86119766b9c4f1570cd8045313345f9be46d431 |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-T/NK_proliferative|Influenza_Severe / Disease, condition lineage and cell class | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | e1c266525ce6b42a4451b6a3b0cabf41ff5e2ee7 |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|COVID-19 / Condition, Lineage and Cell class | DLGAP5 CHEK1 FBXO5 MKI67 CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | b239c711cce967826432fdbd5f88eba98a88bb0c |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD8_T_cells|Lymphoid / Condition, Lineage and Cell class | DLGAP5 CKAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU LIG1 TMPO TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | 4556bb626ca1a00a6db13d2adb35acb8ba848f9c |
| ToppCell | (3)_MNP-(3)_DC_Monocyte_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | DLGAP5 CHEK1 FBXO5 MKI67 CENPU ORC1 LIG1 EXO1 TMPO TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | d94fe9bd6ee7c1fed14666f24de41bda014e299b |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TMPO TOP2A | 1.80e-09 | 200 | 199 | 11 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-T/NK_proliferative|Leuk-UTI / Disease, condition lineage and cell class | TMEM237 DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A | 1.80e-09 | 200 | 199 | 11 | 093e97395be23092229521cc55aaaee8befbc149 |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | CHEK1 FBXO5 CEP78 MKI67 TIMELESS CENPU ORC1 LIG1 EXO1 TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | 63cc57b9331459efbb73051d174d198a3568b938 |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type. | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU LIG1 EXO1 TMPO TOP2A MYBL2 | 1.80e-09 | 200 | 199 | 11 | 8f9e76048ae6f45218a09a95a2c4b31e8a8937b2 |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.87e-09 | 172 | 199 | 10 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | DLGAP5 CHEK1 SINHCAF FBXO5 MKI67 DLX2 CENPU ORC1 TOP2A MYBL2 | 7.32e-09 | 176 | 199 | 10 | d70fdc7bc48719776ed1e7c01118385e3a21623f |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | DLGAP5 CHEK1 SINHCAF FBXO5 MKI67 DLX2 CENPU ORC1 TOP2A MYBL2 | 7.32e-09 | 176 | 199 | 10 | a84361308e5e96f3a30246cd29e109c321ee65bf |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.61e-09 | 179 | 199 | 10 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | DLGAP5 CHEK1 MKI67 TIMELESS CENPU LIG1 EXO1 TMPO TOP2A MYBL2 | 1.01e-08 | 182 | 199 | 10 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 EXO1 TOP2A MYBL2 | 1.12e-08 | 184 | 199 | 10 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-08 | 186 | 199 | 10 | 4fe8e0bf74c7dbf73634cafdacad89020d2634d0 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo-Cycling_T|blood / Manually curated celltypes from each tissue | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 EXO1 TOP2A MYBL2 | 1.38e-08 | 188 | 199 | 10 | 714ccbcf826f26d39757931a3b8abbd952f4cddc |
| ToppCell | normal-na-Lymphocytic|normal / PBMC cell types (v2) per disease, treatment status, and sex | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 EXO1 TOP2A MYBL2 | 1.45e-08 | 189 | 199 | 10 | 1d382f8eb998c6a30e09fddc9a427afc8f5f7323 |
| ToppCell | normal-na-Lymphocytic-lymphocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 EXO1 TOP2A MYBL2 | 1.45e-08 | 189 | 199 | 10 | b83fd81ecc5ef363be7435ee12cb7079e2434af7 |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | CHEK1 MKI67 TIMELESS COL16A1 CENPU ADAM22 ORC1 LIG1 EXO1 MYBL2 | 1.45e-08 | 189 | 199 | 10 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa |
| ToppCell | normal-na-Lymphocytic-lymphocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | DLGAP5 CHEK1 FBXO5 MKI67 TIMELESS CENPU ORC1 EXO1 TOP2A MYBL2 | 1.45e-08 | 189 | 199 | 10 | 3db4177d68cab4cd16842d2ebcaca28f69300e44 |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | KRI1 SRSF11 POLR1G HP1BP3 MKI67 CCNL2 TCOF1 BAZ1B BRD4 TOP2A | 1.68e-08 | 192 | 199 | 10 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|normal_Lymph_Node / Location, Cell class and cell subclass | 1.77e-08 | 193 | 199 | 10 | 5ce93860bc60ce6ecfed3a3d985f84e28781eec1 | |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.77e-08 | 193 | 199 | 10 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| Drug | resveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | DLGAP5 SRSF11 HP1BP3 SEMA4C PSME4 FBXO5 SULF1 MKI67 TCOF1 TMPO SPEN TOP2A | 5.13e-08 | 176 | 199 | 12 | 958_DN |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | MBTD1 CHD3 POGZ LYST FZR1 SULF1 KCNJ1 BAZ1B SCMH1 SPIDR KDM4B | 1.37e-06 | 197 | 199 | 11 | 3182_DN |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | KRI1 HP1BP3 SULF1 MKI67 EXOC7 HYOU1 ARID4A BAZ1B MICALL1 SLF2 MAP4K5 | 1.44e-06 | 198 | 199 | 11 | 5314_DN |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.76e-06 | 177 | 199 | 10 | 985_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 4.16e-06 | 179 | 199 | 10 | 4585_DN | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 5.57e-06 | 185 | 199 | 10 | 1673_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | DLGAP5 SEMA4C PSME4 SULF1 MKI67 BAZ1B AKAP12 BRD4 TMPO TOP2A | 5.85e-06 | 186 | 199 | 10 | 5000_DN |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | SIPA1L3 JADE1 FZR1 SULF1 GTF2IRD1 ADAM22 SH2D4A MAP4K5 TMPO KDM4B | 7.39e-06 | 191 | 199 | 10 | 7525_DN |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | MBTD1 SIPA1L3 DLGAP5 CHEK1 SEMA4C ZNF512B SULF1 MKI67 AKAP12 BRD4 | 7.74e-06 | 192 | 199 | 10 | 2865_DN |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; MCF7; HT_HG-U133A | MBTD1 HP1BP3 FZR1 SULF1 CEP162 BAZ1B ADAM22 BRD4 SMARCA4 TMPO | 9.27e-06 | 196 | 199 | 10 | 2291_DN |
| Drug | Loracarbef [121961-22-6]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 9.70e-06 | 197 | 199 | 10 | 3532_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.24e-05 | 173 | 199 | 9 | 5987_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.68e-05 | 177 | 199 | 9 | 1069_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.68e-05 | 177 | 199 | 9 | 3227_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.80e-05 | 178 | 199 | 9 | 6276_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 3.20e-05 | 181 | 199 | 9 | 1791_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.34e-05 | 182 | 199 | 9 | 1043_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.49e-05 | 183 | 199 | 9 | 3510_DN | |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; PC3; HT_HG-U133A | 3.49e-05 | 183 | 199 | 9 | 4527_DN | |
| Drug | 2,3-bis(3'-hydroxybenzyl)butyrolactone | PHACTR2 TMEM237 DLGAP5 CKAP5 CHEK1 TNFRSF21 FBXO5 CEP78 MKI67 TIMELESS DLX2 MKNK2 CAST CENPU GTF2IRD1 ORC1 LIG1 EXO1 TMPO TOP2A KDM4B MYBL2 | 3.77e-05 | 961 | 199 | 22 | ctd:C029497 |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.13e-05 | 187 | 199 | 9 | 3244_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 4.49e-05 | 189 | 199 | 9 | 5084_DN | |
| Drug | S-2-pentyl-4-pentynoic hydroxamic acid | NOLC1 SGSM1 STAG1 CNST ARHGEF17 RYR1 SULF1 AFF1 TCOF1 UTP23 BAZ1B SFMBT2 MICALL1 RYBP OTX2 MAP4K5 EPC1 EXO1 TMPO STAG3 | 4.58e-05 | 834 | 199 | 20 | ctd:C513635 |
| Drug | Selegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; HL60; HT_HG-U133A | 4.67e-05 | 190 | 199 | 9 | 2465_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 5.07e-05 | 192 | 199 | 9 | 4104_DN | |
| Drug | Thapsigargin | NOLC1 RSL1D1 DLGAP5 CKAP5 POGZ CHEK1 EDC4 MKI67 AHR TIMELESS DLX5 SCFD1 TAF1L HYOU1 HDAC6 ARID4A CENPU UTP23 BAZ1B TFAM SFMBT2 UBE2O TRAM1 EXO1 SMARCA4 TOP2A KRTCAP2 | 5.23e-05 | 1353 | 199 | 27 | ctd:D019284 |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 5.49e-05 | 194 | 199 | 9 | 3303_DN | |
| Drug | A25618 | EWSR1 HP1BP3 UBTF AHR FOXJ1 SFRP4 HDAC6 AKAP12 RYBP ORC1 BRD4 EPC1 H1-6 SMARCA4 KDM4A KAT6B EP300 CBX8 KDM4B | 5.52e-05 | 777 | 199 | 19 | CID000005562 |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; HL60; HT_HG-U133A | 5.95e-05 | 196 | 199 | 9 | 1843_DN | |
| Drug | Tolazamide [1156-19-0]; Down 200; 12.8uM; HL60; HT_HG-U133A | 5.95e-05 | 196 | 199 | 9 | 2482_DN | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; HL60; HT_HG-U133A | 5.95e-05 | 196 | 199 | 9 | 2158_DN | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; HL60; HT_HG-U133A | SIPA1L3 INO80D KIAA0753 FZR1 FOXO4 EXOC7 GTF2IRD1 PPP4R4 KAT6B | 5.95e-05 | 196 | 199 | 9 | 2736_DN |
| Drug | Naringin hydrate [11032-30-7]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 5666_DN | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 4606_DN | |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 7185_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 1640_DN | |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; PC3; HT_HG-U133A | 6.19e-05 | 197 | 199 | 9 | 6325_DN | |
| Drug | 5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA | 6.43e-05 | 198 | 199 | 9 | 889_DN | |
| Drug | LY294002; Up 200; 10uM; PC3; HG-U133A | 6.43e-05 | 198 | 199 | 9 | 461_UP | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 6.43e-05 | 198 | 199 | 9 | 4805_DN | |
| Drug | Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A | 6.43e-05 | 198 | 199 | 9 | 7313_UP | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; HL60; HG-U133A | 6.43e-05 | 198 | 199 | 9 | 1625_DN | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 6.69e-05 | 199 | 199 | 9 | 7326_DN | |
| Drug | Dasatinib | RPS6 DLGAP5 GASK1B FBXO5 SULF1 MKI67 TIMELESS CENPU ORC1 EXO1 TMPO TOP2A ALPK2 MYBL2 | 8.56e-05 | 478 | 199 | 14 | ctd:D000069439 |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.40e-04 | 172 | 199 | 8 | 6439_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.46e-04 | 173 | 199 | 8 | 4237_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.46e-04 | 173 | 199 | 8 | 2881_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.46e-04 | 173 | 199 | 8 | 4458_DN | |
| Drug | Polychlorinated Biphenyls | SOX5 CHEK1 FBXO5 MKI67 AHR NOL8 CCNL2 CENPU BAZ1B AKAP12 KIF3A EPC1 TMPO TOP2A EP300 MYBL2 | 1.49e-04 | 633 | 199 | 16 | ctd:D011078 |
| Drug | HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.52e-04 | 174 | 199 | 8 | 909_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.52e-04 | 174 | 199 | 8 | 5745_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.58e-04 | 175 | 199 | 8 | 5935_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.58e-04 | 175 | 199 | 8 | 1058_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.64e-04 | 176 | 199 | 8 | 5976_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.71e-04 | 177 | 199 | 8 | 1645_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.71e-04 | 177 | 199 | 8 | 7047_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.71e-04 | 177 | 199 | 8 | 873_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.78e-04 | 178 | 199 | 8 | 4184_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.78e-04 | 178 | 199 | 8 | 1471_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.78e-04 | 178 | 199 | 8 | 992_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.85e-04 | 179 | 199 | 8 | 2105_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.92e-04 | 180 | 199 | 8 | 3688_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.99e-04 | 181 | 199 | 8 | 7005_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.99e-04 | 181 | 199 | 8 | 6951_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; HL60; HT_HG-U133A | 2.31e-04 | 185 | 199 | 8 | 1833_DN | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.31e-04 | 185 | 199 | 8 | 1049_DN | |
| Drug | Vitamin K 3 | PDXDC1 NOLC1 TMEM237 DLGAP5 CKAP5 KRI1 SRSF11 CHEK1 RYR1 PNPT1 SINHCAF AHR TIMELESS GNPAT ANK3 TCOF1 TACC2 AKAP12 DNAJC14 TMPO PHF10 STAG3 TOP2A RAI1 | 2.47e-04 | 1249 | 199 | 24 | ctd:D024483 |
| Drug | Cantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A | 2.49e-04 | 187 | 199 | 8 | 3075_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.49e-04 | 187 | 199 | 8 | 4989_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 2.58e-04 | 188 | 199 | 8 | 6735_DN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.58e-04 | 188 | 199 | 8 | 6451_DN | |
| Drug | resveratrol; Down 200; 50uM; MCF7; HG-U133A | 2.58e-04 | 188 | 199 | 8 | 595_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.77e-04 | 190 | 199 | 8 | 4322_DN | |
| Drug | Antimycin A [1397-94-0]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 2.87e-04 | 191 | 199 | 8 | 2261_DN | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; HL60; HT_HG-U133A | 2.87e-04 | 191 | 199 | 8 | 6136_DN | |
| Drug | 17-AAG; Down 200; 1uM; ssMCF7; HG-U133A | 2.87e-04 | 191 | 199 | 8 | 521_DN | |
| Drug | indomethacin, USP; Up 200; 100uM; PC3; HG-U133A | 2.97e-04 | 192 | 199 | 8 | 452_UP | |
| Drug | Monobenzone [103-16-2]; Down 200; 20uM; HL60; HT_HG-U133A | 2.97e-04 | 192 | 199 | 8 | 3054_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.97e-04 | 192 | 199 | 8 | 4180_UP | |
| Drug | Phenacetin [62-44-2]; Down 200; 22.4uM; HL60; HT_HG-U133A | 2.97e-04 | 192 | 199 | 8 | 2471_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 2.97e-04 | 192 | 199 | 8 | 4311_DN | |
| Drug | Phytoestrogens | 3.02e-04 | 67 | 199 | 5 | ctd:D048789 | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 3.08e-04 | 193 | 199 | 8 | 3562_DN | |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 3.08e-04 | 193 | 199 | 8 | 7084_DN | |
| Drug | Epitiostanol [2363-58-8]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.08e-04 | 193 | 199 | 8 | 4788_UP | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; HL60; HT_HG-U133A | 3.08e-04 | 193 | 199 | 8 | 1341_UP | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 3.08e-04 | 193 | 199 | 8 | 4321_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; PC3; HG-U133A | 3.08e-04 | 193 | 199 | 8 | 1958_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.18e-04 | 194 | 199 | 8 | 7322_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 3.18e-04 | 194 | 199 | 8 | 2009_DN | |
| Drug | Sulfathiazole [72-14-0]; Up 200; 15.6uM; PC3; HG-U133A | 3.30e-04 | 195 | 199 | 8 | 1883_UP | |
| Drug | Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.30e-04 | 195 | 199 | 8 | 3254_DN | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; PC3; HG-U133A | 3.30e-04 | 195 | 199 | 8 | 1932_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 3.30e-04 | 195 | 199 | 8 | 1505_DN | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.30e-04 | 195 | 199 | 8 | 3893_DN | |
| Drug | 1,5-Isoquinolinediol; Down 200; 100uM; HL60; HG-U133A | 3.30e-04 | 195 | 199 | 8 | 543_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 3.30e-04 | 195 | 199 | 8 | 1665_DN | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 3.30e-04 | 195 | 199 | 8 | 4157_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.30e-04 | 195 | 199 | 8 | 3191_DN | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; HL60; HT_HG-U133A | 3.30e-04 | 195 | 199 | 8 | 2708_DN | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 8.61e-07 | 12 | 194 | 4 | DOID:9119 (implicated_via_orthology) | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 2.34e-06 | 15 | 194 | 4 | DOID:1928 (implicated_via_orthology) | |
| Disease | Childhood Medulloblastoma | 9.17e-06 | 43 | 194 | 5 | C0278510 | |
| Disease | Melanotic medulloblastoma | 9.17e-06 | 43 | 194 | 5 | C1275668 | |
| Disease | Medullomyoblastoma | 9.17e-06 | 43 | 194 | 5 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 9.17e-06 | 43 | 194 | 5 | C0751291 | |
| Disease | Adult Medulloblastoma | 9.17e-06 | 43 | 194 | 5 | C0278876 | |
| Disease | Craniofacial Abnormalities | 9.55e-06 | 156 | 194 | 8 | C0376634 | |
| Disease | Williams Syndrome | 1.53e-05 | 8 | 194 | 3 | C0175702 | |
| Disease | Medulloblastoma | 1.94e-05 | 50 | 194 | 5 | C0025149 | |
| Disease | alkaline phosphatase measurement | NOLC1 RPS7 CHD3 VSX1 HP1BP3 ZNF512B CASKIN1 MICAL3 DLX5 SOX6 DCDC2 SFRP4 BAZ1B SLF2 MAP4K5 BRD4 ELF1 ALPK2 RAI1 | 4.44e-05 | 1015 | 194 | 19 | EFO_0004533 |
| Disease | Prostatic Neoplasms | EWSR1 CHD3 TNFRSF21 ACSM3 AHR CHD6 TAF1L NOL8 HDAC6 ARID4A XRCC1 BRD4 SPEN TOP2A | 6.28e-05 | 616 | 194 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | EWSR1 CHD3 TNFRSF21 ACSM3 AHR CHD6 TAF1L NOL8 HDAC6 ARID4A XRCC1 BRD4 SPEN TOP2A | 6.28e-05 | 616 | 194 | 14 | C0376358 |
| Disease | forced expiratory volume | CKAP5 ARHGEF17 KIAA0753 PNPT1 SSC5D SULF1 AFF1 PLAG1 MICAL3 MN1 LIN28B SCMH1 MEIOSIN FGD6 CBX8 KDM4B | 7.23e-05 | 789 | 194 | 16 | EFO_0004314 |
| Disease | peak expiratory flow | SOX5 ARHGEF17 HMG20A PNPT1 SULF1 PLAG1 MICAL3 MN1 TCF21 ANK3 ARID4A KRTCAP2 | 1.23e-04 | 498 | 194 | 12 | EFO_0009718 |
| Disease | Ectopic pregnancy | 1.28e-04 | 3 | 194 | 2 | HP_0031456 | |
| Disease | Abnormality of refraction | VSX1 DCTN1 ITPR2 AHR AFF1 PLAG1 ANK3 API5 TFAM KIF3A OTX2 MAP4K5 TRAM1 SYT14 | 1.58e-04 | 673 | 194 | 14 | HP_0000539 |
| Disease | Extra-osseous Ewing's sarcoma | 2.56e-04 | 4 | 194 | 2 | C0279980 | |
| Disease | Polyploidy | 2.56e-04 | 4 | 194 | 2 | C0032578 | |
| Disease | Malignant neoplasm of breast | RPS6 RPS7 CHEK1 KCNJ1 MKI67 AHR AFF1 TIMELESS TACC2 THOC5 AKAP12 MICALL1 EXO1 KAT6B SPEN ZNF281 TOP2A EP300 | 2.77e-04 | 1074 | 194 | 18 | C0006142 |
| Disease | cholesterol to total lipids in large LDL percentage | 5.09e-04 | 56 | 194 | 4 | EFO_0022235 | |
| Disease | Amyotrophic Lateral Sclerosis | 5.82e-04 | 58 | 194 | 4 | C0002736 | |
| Disease | sleep duration, triglyceride measurement | 6.34e-04 | 104 | 194 | 5 | EFO_0004530, EFO_0005271 | |
| Disease | leiomyoma (is_implicated_in) | 6.34e-04 | 6 | 194 | 2 | DOID:127 (is_implicated_in) | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 6.34e-04 | 6 | 194 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | response to perphenazine | 6.51e-04 | 26 | 194 | 3 | GO_0097334 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 6.63e-04 | 60 | 194 | 4 | EFO_0021898 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 7.50e-04 | 62 | 194 | 4 | EFO_0022263 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 7.97e-04 | 63 | 194 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 7.97e-04 | 63 | 194 | 4 | EFO_0022239 | |
| Disease | Neural crest tumor | 8.84e-04 | 7 | 194 | 2 | C2931189 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 8.84e-04 | 7 | 194 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | endoplasmic reticulum aminopeptidase 1 measurement | 8.84e-04 | 7 | 194 | 2 | EFO_0008119 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 1.12e-03 | 69 | 194 | 4 | EFO_0022341 | |
| Disease | cutaneous melanoma | 1.25e-03 | 121 | 194 | 5 | EFO_0000389 | |
| Disease | colorectal cancer (is_implicated_in) | 1.25e-03 | 121 | 194 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Abnormality of the face | 1.50e-03 | 9 | 194 | 2 | C4025871 | |
| Disease | uveitis | 1.50e-03 | 9 | 194 | 2 | EFO_1001231 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 1.53e-03 | 75 | 194 | 4 | EFO_0022287 | |
| Disease | cholesteryl ester measurement | 1.62e-03 | 257 | 194 | 7 | EFO_0010351 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 1.77e-03 | 78 | 194 | 4 | EFO_0022187 | |
| Disease | Developmental delay (disorder) | 1.84e-03 | 37 | 194 | 3 | C0424605 | |
| Disease | Kunitz-type protease inhibitor 2 measurement | 1.87e-03 | 10 | 194 | 2 | EFO_0008200 | |
| Disease | alopecia areata (is_marker_for) | 1.87e-03 | 10 | 194 | 2 | DOID:986 (is_marker_for) | |
| Disease | Joubert syndrome (is_implicated_in) | 1.87e-03 | 10 | 194 | 2 | DOID:0050777 (is_implicated_in) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.89e-03 | 195 | 194 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Global developmental delay | 1.90e-03 | 133 | 194 | 5 | C0557874 | |
| Disease | age at menarche | SOX5 POLR1G HMG20A OSBP2 USP49 LIN28B CAST CBX6 SCMH1 KDM4A KDM4B | 2.02e-03 | 594 | 194 | 11 | EFO_0004703 |
| Disease | Liver carcinoma | 2.04e-03 | 507 | 194 | 10 | C2239176 | |
| Disease | lung cancer (is_marker_for) | 2.15e-03 | 39 | 194 | 3 | DOID:1324 (is_marker_for) | |
| Disease | metabolic syndrome | 2.15e-03 | 200 | 194 | 6 | EFO_0000195 | |
| Disease | anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine | 2.27e-03 | 11 | 194 | 2 | EFO_0803358, EFO_0803362 | |
| Disease | Macrocephaly | 2.27e-03 | 11 | 194 | 2 | C0221355 | |
| Disease | quality of life during menstruation measurement, acne | 2.27e-03 | 11 | 194 | 2 | EFO_0003894, EFO_0009366 | |
| Disease | ciliopathy (implicated_via_orthology) | 2.31e-03 | 40 | 194 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | Congenital small ears | 2.48e-03 | 41 | 194 | 3 | C0152423 | |
| Disease | sexual dimorphism measurement | PDXDC1 SOX5 PRAM1 PNPT1 SSC5D CASKIN1 PLAG1 USP49 SFRP4 LIN28B BAZ1B GTF2IRD1 CTDSP2 RYBP SCMH1 SMARCA4 | 2.74e-03 | 1106 | 194 | 16 | EFO_0021796 |
| Disease | urate measurement, bone density | DNAH14 HMG20A ITPR2 FSIP2 SULF1 SCFD1 SFMBT2 AKAP12 SH2D4A MAP4K5 KAT6B | 2.77e-03 | 619 | 194 | 11 | EFO_0003923, EFO_0004531 |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 2.85e-03 | 43 | 194 | 3 | EFO_0022290 | |
| Disease | coffee consumption measurement, tea consumption measurement | 3.04e-03 | 44 | 194 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | nevus count, cutaneous melanoma | 3.10e-03 | 91 | 194 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | blood urea nitrogen measurement | 3.17e-03 | 452 | 194 | 9 | EFO_0004741 | |
| Disease | plasma beta-amyloid 1-42 measurement | 3.20e-03 | 13 | 194 | 2 | EFO_0005660 | |
| Disease | Fetal Alcohol Spectrum Disorders | 3.20e-03 | 13 | 194 | 2 | C2985290 | |
| Disease | Neuroblastoma | 3.67e-03 | 47 | 194 | 3 | C0027819 | |
| Disease | Birth Weight | 3.72e-03 | 14 | 194 | 2 | C0005612 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 3.72e-03 | 14 | 194 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 3.78e-03 | 156 | 194 | 5 | DOID:10283 (is_marker_for) | |
| Disease | osteoarthritis, knee | 3.99e-03 | 158 | 194 | 5 | EFO_0004616 | |
| Disease | phospholipids:total lipids ratio | 4.01e-03 | 227 | 194 | 6 | EFO_0020946 | |
| Disease | bone density | 4.31e-03 | 388 | 194 | 8 | EFO_0003923 | |
| Disease | platelet crit | STAG1 NHSL2 ITPR2 RBM27 AFF1 PLAG1 MN1 KLRC2 ZC3H18 RYBP CBX6 MAP4K5 ELF1 CBX8 | 4.33e-03 | 952 | 194 | 14 | EFO_0007985 |
| Disease | triglycerides to total lipids in medium LDL percentage | 4.37e-03 | 50 | 194 | 3 | EFO_0022334 | |
| Disease | triglycerides to total lipids in large LDL percentage | 4.62e-03 | 51 | 194 | 3 | EFO_0022331 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 4.62e-03 | 51 | 194 | 3 | EFO_0022302 | |
| Disease | coffee consumption, cups of coffee per day measurement | 4.86e-03 | 16 | 194 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 5.15e-03 | 53 | 194 | 3 | EFO_0022340 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 5.15e-03 | 53 | 194 | 3 | EFO_0022286 | |
| Disease | familial hyperlipidemia | 5.34e-03 | 106 | 194 | 4 | MONDO_0001336 | |
| Disease | Small cell carcinoma of lung | 5.43e-03 | 54 | 194 | 3 | C0149925 | |
| Disease | triglycerides in medium HDL measurement | 5.43e-03 | 54 | 194 | 3 | EFO_0022321 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 5.43e-03 | 54 | 194 | 3 | EFO_0022244 | |
| Disease | protein C measurement | 5.48e-03 | 17 | 194 | 2 | EFO_0004633 | |
| Disease | iritis | 5.48e-03 | 17 | 194 | 2 | EFO_1000997 | |
| Disease | Fetal Alcohol Syndrome | 5.48e-03 | 17 | 194 | 2 | C0015923 | |
| Disease | red blood cell density measurement | PDXDC1 RBBP8NL HMG20A CEP78 AFF1 KLRC2 SOX6 USP49 RYBP OTX2 MAP4K5 BRD4 KDM4A | 5.68e-03 | 880 | 194 | 13 | EFO_0007978 |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 6.01e-03 | 56 | 194 | 3 | EFO_0022316 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 6.01e-03 | 56 | 194 | 3 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 6.01e-03 | 56 | 194 | 3 | EFO_0022250 | |
| Disease | alpha synuclein measurement | 6.14e-03 | 18 | 194 | 2 | EFO_0009323 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 6.31e-03 | 57 | 194 | 3 | EFO_0022284 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASRKRRKPVQKTVKP | 11 | P35869 | |
| QGSKLKVSLARKKPP | 436 | Q01844 | |
| PGQSKKKIFKPEELR | 1041 | Q09472 | |
| KRKNCRGPSLIPSVK | 181 | Q9H2F5 | |
| SIPVPRGRKGKKVKS | 1526 | Q9HCK8 | |
| ASSPEQPKRKKGRKT | 166 | P32519 | |
| RSLKFRPKGKPCPKE | 216 | Q902F8 | |
| RQKSKRGRPPLKSTL | 661 | P29374 | |
| KRPDVPSLKSQKPKR | 121 | Q96CB5 | |
| PSLKSQKPKRKRITG | 126 | Q96CB5 | |
| KKKSTRKSPTFRNRP | 151 | A6NEN9 | |
| KRGPKPKTFLLKARA | 71 | O95503 | |
| LRGLKPKKAPTARKT | 131 | Q14203 | |
| NKPLKKGAKRPRVTS | 266 | O14757 | |
| AATPQPVKTKKGVKR | 276 | O60885 | |
| KQDPKKPSCKREGRA | 1771 | Q86TB3 | |
| SIKKFIPGRRKKRPD | 806 | Q02952 | |
| KTSAIKKIRNPKGPL | 61 | Q07092 | |
| KRKNTGSPDRKPSKK | 306 | Q9UIG0 | |
| PSKFILKPRPKRSKR | 211 | Q9P0K1 | |
| VKISAKKPGRKLRPI | 121 | Q71F23 | |
| PKKSSAGPKRDARQI | 466 | Q9BZZ5 | |
| PSVKEPSKTAKQKRR | 326 | Q5JTW2 | |
| LKKPSRLKTLDTKPG | 366 | Q8NEG7 | |
| NGKPKKVRKPRTIYS | 146 | Q07687 | |
| NGKPKKVRKPRTIYS | 131 | P56178 | |
| PKPKVITTKAGFLKR | 421 | Q7Z4T9 | |
| RLQKKTPAKSPGKAA | 456 | Q5SSJ5 | |
| IAKKEPVPRGKSLRS | 986 | Q7Z5J4 | |
| NRKTPVPGKARKKSS | 166 | P61224 | |
| RDGRKKKYPSPQKTR | 111 | Q9P2N5 | |
| QTPNTFPKRKKGEKR | 606 | Q14978 | |
| TKGSPRTSPKLKRKS | 911 | Q6P2E9 | |
| EDTKPKPTKRKRKGS | 1021 | Q68E01 | |
| KSQPRIKGTPNKTDK | 246 | A0A1B0GVH7 | |
| VPPTSKKKRQAGEKI | 336 | Q14571 | |
| RRYAKPIGRPKNKLK | 336 | Q8WYB5 | |
| KAPKKKSLSDPSRRG | 821 | Q96PE2 | |
| ISLRGPQADPKSRKK | 81 | Q5HY64 | |
| PRPGKAKLLGSTKKI | 26 | Q8WXD9 | |
| STVPKGEAKPKRRKK | 681 | Q6Y2X3 | |
| SRKEKKDVPKPISNG | 521 | Q8IVH8 | |
| KLGQTISRKRSPKDK | 656 | Q7RTP6 | |
| VEPPRRSGKATRKKK | 876 | Q9UJ55 | |
| RLNSKPPNIGFKKKD | 171 | Q9Y295 | |
| ILARLQGKPPTKKAK | 91 | Q05BQ5 | |
| TKTRPLRQGSKKPLL | 636 | Q969R5 | |
| RPFEEKLKKRGLSPK | 256 | Q86W26 | |
| RKRKKPLRDSNAPKS | 91 | Q9NP66 | |
| PVLTPAKVTGKSKKR | 121 | Q8N6L1 | |
| ERRPKGKTLQKRKPK | 111 | Q6ZN17 | |
| KKRFGKKAAVPTPRL | 996 | Q9NRD8 | |
| KRNIKPPTKPGSRSK | 1046 | Q5CZC0 | |
| RGRSKAPKKKPSVLP | 206 | P98177 | |
| TVQKGRPRKRKSPAL | 221 | Q9NQ69 | |
| SQPIDIPDAKKRGKK | 51 | Q9HBH9 | |
| RTKQRLPGQKPFKRS | 696 | Q6P996 | |
| KKSKGRRQPLSKLPR | 591 | O75164 | |
| KSERKKKSFGLLPPQ | 451 | O94953 | |
| SQPRKKKREAPLTGK | 461 | Q8N9T8 | |
| KLLGNKRDAKSKSPR | 846 | Q8N3F8 | |
| PLKGRAKTPVTLKQR | 201 | P42167 | |
| GSKRRPQTPKEKAKA | 1936 | P46013 | |
| PASKKQRVAPRARGK | 3026 | P46013 | |
| PGLSKTAKRNLKRKE | 81 | Q9BRP8 | |
| PPFKRKGKLSTIGKI | 26 | O75167 | |
| KRSKNPISRPLEGKK | 666 | Q76FK4 | |
| KLERPRTSKGKARPK | 666 | Q9Y496 | |
| DRKPSRGRLPSKTKK | 156 | Q8N2R0 | |
| TKGQVARAPVKPKEK | 516 | C9JSJ3 | |
| PKGSSKVKRRVRIPN | 501 | Q969R2 | |
| RSLKFRPKGKPCPKE | 976 | P63135 | |
| RAPKERKPSKKEGGT | 701 | O94880 | |
| KRKDTPTKKPVKRPG | 256 | Q9UPT5 | |
| KPTRGRLPSKTKKEF | 161 | Q8TAX0 | |
| KVPKKSLKPRTPRCA | 456 | Q13415 | |
| SKDKAATPRKDGPKR | 346 | Q8WUB8 | |
| ATPRKDGPKRSVLSK | 351 | Q8WUB8 | |
| RKRASEPGDKASKKP | 616 | Q8NC74 | |
| SKPANIRGTVKPKRR | 116 | Q6UWH4 | |
| KSQKLLRSPRKPTRK | 156 | Q9UM11 | |
| KRSAKRPSAAPIKQV | 1421 | Q14008 | |
| LNKAKFTKPRPRPKD | 906 | Q9Y4L1 | |
| KRAKKPRATTPKTVR | 151 | P22492 | |
| KRGPKPKTFLLKAQA | 71 | Q9HC52 | |
| PKPKESTTGLLKARK | 301 | O15228 | |
| RSLKFRPKGKPCPKE | 216 | P61570 | |
| RSLKFRPKGKPCPKE | 216 | Q69384 | |
| LSAPVPRGRKGKKTK | 1176 | Q8TD26 | |
| KSSPKKPRGRNIFKA | 26 | O14595 | |
| IGPLPGTKKSKKNLR | 431 | Q9UKT4 | |
| LPSALGVKKRKRGPK | 41 | Q12873 | |
| KPSPLSVKNTKRRLE | 346 | Q96S94 | |
| QTKEPSKNPLLGKKR | 136 | Q9BTP7 | |
| PRGQPTFTKKKKTIR | 881 | Q2V2M9 | |
| KKLKRKPPSTNAGRR | 101 | Q9HBE4 | |
| RPGPRQTSEKKVSDK | 176 | Q15398 | |
| KVPSKGRPAKNVETK | 241 | Q15398 | |
| GHKRKQPLPKRVAKV | 271 | Q92949 | |
| LQSPEKKARPKNGKE | 2606 | Q12955 | |
| GKAKQLPSKLPVKVR | 3941 | Q12955 | |
| PRKKEILSGTKLIKP | 551 | Q5TB80 | |
| RDNPTKKPEVRTNKK | 1861 | Q0VDD8 | |
| GTVRSAAPPQEKKRK | 266 | P20810 | |
| VQKRKSIAGPRKFPL | 2586 | Q99698 | |
| GKPSRSLTRTPEKKK | 291 | Q502W7 | |
| KGKKEKKNRTFLRPP | 231 | O75937 | |
| QRKPRKKTKPPALTK | 531 | Q53TQ3 | |
| PGSKTSKRPKIKVSL | 636 | Q9P2N6 | |
| GKRKSKTKTIVEPPR | 411 | Q96QF7 | |
| RSLKFRPKGKPCPKE | 216 | Q902F9 | |
| ATKRVPKLKKLDGTP | 166 | Q4LDG9 | |
| SKRNIKKGAVPRSIP | 31 | Q9UBN7 | |
| PRSIPNLAEVKKKGK | 41 | Q9UBN7 | |
| PAKDSSIPKRKRKRV | 891 | Q9UHL9 | |
| SGIPKRRTARKQLPK | 116 | P18858 | |
| PDPKALRLGVLKKKA | 361 | P21817 | |
| KKKVRFSVAGPSPNK | 501 | Q5SV97 | |
| PQPLKRKGKKEDVNS | 271 | Q9UHG0 | |
| FLGKDKKIPGKRSPR | 101 | Q6PJW8 | |
| GAPKAKSKPRKRLEE | 926 | Q5VVW2 | |
| RKKDKRDFPKPAING | 471 | Q9Y4K4 | |
| KSGIQFLKKPKAIRP | 16 | A6NGG8 | |
| NKVRPAKKKTSPARE | 106 | P32243 | |
| VTFNKKNPPEGKRKL | 846 | Q10571 | |
| KKVAPIQRRKKPASQ | 251 | P29084 | |
| RVQSKEPTPKVKRKG | 696 | Q5T011 | |
| SRRKKRKKISGPNPL | 191 | Q9BRU9 | |
| GKKPRTKAPKIQRLV | 166 | P62753 | |
| PIKKQRAKTSIQRGP | 306 | Q8NB59 | |
| RGVSRSPPKKKNKAS | 71 | Q8TAD8 | |
| LPKPTRKSRTKNKQK | 101 | P62081 | |
| KKRRDTKTPTQSLPK | 731 | Q6NUP7 | |
| RKSSRTLKKGPRQDP | 371 | O75509 | |
| GDQPAARTPRSKKKK | 1351 | Q13428 | |
| LRKAKKKPSPPTRSV | 561 | Q5HYW2 | |
| DPKRQQRKPKGNKSS | 16 | P26717 | |
| KQQLPPKKKRRVGTT | 1366 | Q8IZX4 | |
| EKQKRKPGLRRSPIK | 566 | P10244 | |
| KPGLRRSPIKKVRKS | 571 | P10244 | |
| KPRRGRKPKVSKAEQ | 631 | P57071 | |
| KTFRKPKQLEGLKPG | 671 | Q7Z3K3 | |
| KKSPTRPKRQAKPAA | 6 | Q8N488 | |
| PKRPRPAEFKALSKK | 306 | Q96QH2 | |
| DTVLSPTKKRKRQKG | 281 | O15446 | |
| PEARATPGSTKKRKK | 451 | O15446 | |
| TQGRRPRKNKDAPKK | 186 | Q6ZNE9 | |
| ESKKQKKRGRPPAEK | 1436 | P51532 | |
| PTKEKEKARKKPARG | 276 | O60292 | |
| RKLSSPKESKPKRVP | 91 | Q8IX21 | |
| LGRVPAKERAKSKLK | 781 | Q6IE81 | |
| AGKKKPVTENVPFRK | 491 | Q2KHM9 | |
| NLRGSKKVRPTPKNI | 551 | Q9C0C4 | |
| RKKSPRPKQAKSTRA | 171 | A1L4H1 | |
| RPKIGSSSQRPIKLK | 86 | Q5T5J6 | |
| KKELTLLGKPKRPRS | 146 | Q00059 | |
| EPKVTGKLKQRSPKL | 691 | P46087 | |
| KEPGENRIKPTNKKV | 31 | Q15198 | |
| KTISKPRASRKENGP | 591 | Q8TCS8 | |
| KGLNLPRKSSIVKRP | 406 | Q9UQ84 | |
| KPGKKRGRTPKTLIS | 276 | Q96GD3 | |
| KPRPKRTCIVDGKKL | 691 | P35712 | |
| ALSQGPISKPKRKRE | 536 | P25440 | |
| GTKQPKKPVKASARA | 601 | P51825 | |
| DKPKVKTKGRPRAAA | 641 | P51825 | |
| PKTISGKTKRNELRK | 566 | Q53FZ2 | |
| ERQKSQPRKKSPPVK | 536 | Q99941 | |
| KKTGSQTRRTLKPQP | 21 | Q96A22 | |
| QKVPSGKRKRGETKP | 16 | Q6DJT9 | |
| GKRKRGETKPRKNFP | 21 | Q6DJT9 | |
| LSRPKKKKPRTKNTP | 31 | Q96Q45 | |
| RAGPSLKTTLKPKKV | 81 | Q9NP50 | |
| NDLKASPTLGKRKKR | 151 | Q9NZR4 | |
| NRKTPVPGKARKKSS | 166 | A6NIZ1 | |
| LGKQPKKVPKRRQAA | 311 | Q9UNS1 | |
| VGKEPLKAAPKKRQL | 1156 | Q9UNS1 | |
| PTKALPEKAKRSKRP | 6 | Q70EL2 | |
| RRPEPEPSSSNKKKK | 11 | A2A3L6 | |
| KPAPEKNSKSKRGRS | 2066 | Q96T58 | |
| KKRAAKRPPKTTPVA | 61 | Q9UJ98 | |
| KKPRSPKRKLSRSPS | 356 | Q05519 | |
| KKKTIGSPKRIQSPL | 1076 | Q9UBZ9 | |
| TPRGKKRKALPASET | 401 | O76021 | |
| LGKKDARQTPKKPEA | 446 | O76021 | |
| PRTPENSAKKKLLRG | 246 | Q14159 | |
| KKKTAGRTSRSNPPK | 301 | Q6FHJ7 | |
| VRFTKRKQKVPGFPK | 316 | A6NK02 | |
| RKQKVPGFPKRFTVK | 321 | A6NK02 | |
| IPSGRKQKKIPAALK | 1311 | Q6ZV73 | |
| RSLKFRPKGKPCPKE | 976 | P10266 | |
| KPTKKTRPRKIPSVG | 1346 | Q92626 | |
| GKRKKISKPPIGESN | 666 | Q5VUG0 | |
| ASVPPSVKPKKRRKS | 1226 | Q9C0C9 | |
| SKRRKSNPKPLVLSE | 521 | Q70CQ1 | |
| AKRPKPESQGIKAKR | 221 | Q9Y2X9 | |
| ENSPAGARPKRKNKK | 301 | Q8WVM8 | |
| SLPVKPRPKKENGKS | 51 | Q9H788 | |
| TNKKPRKSPGEKSRI | 46 | Q8WVM7 | |
| RNKKGRPPLHKKRVE | 1076 | Q8WVM7 | |
| LGKRRKAPTKKSPLS | 56 | O43680 | |
| RTKKPRPPSLKKKQT | 2126 | O95359 | |
| PRRVTSRAKGIPKKK | 36 | Q9UJT2 | |
| KGKVFPKLRKRSPQG | 386 | Q2NKQ1 | |
| LCKTKLPKKRKRDPG | 1731 | Q14997 | |
| VSQKPDPAKTKNRRK | 1451 | P11388 | |
| DPAKTKNRRKRKPST | 1456 | P11388 | |
| VAPRAKSVRAKKPIK | 1506 | P11388 | |
| RRKQKTPKKFTGEQP | 421 | Q96KM6 | |
| APAVKKKPTVTKGRS | 331 | Q15629 | |
| SKPQESPKGKRKLDL | 236 | P18887 | |
| KPRPKRTCLVDGKKL | 626 | P35711 | |
| KRARKQEKSPVKTVP | 436 | Q5VWN6 | |
| VKPKDRPPSARVKKS | 716 | Q5VWN6 | |
| RETPKPRRKSGKVKE | 241 | Q96JP5 | |
| SKKRKPKVIRSDGAP | 6 | Q13769 | |
| NKRKSMTKLRGPNPK | 651 | P17480 | |
| AEKKKRGPKPSTQKR | 1021 | O60264 | |
| PEKPGNRFRTNKKAK | 391 | Q8IWU6 | |
| RGKRCPTPEIQKKST | 571 | P40818 | |
| KKKRGPRTPPITTKE | 1026 | Q5T200 | |
| RSKSPKKKLGVSVSP | 521 | Q86VM9 | |
| GAILAKISRPKKRAK | 176 | P48048 | |
| QPEGLRSLKKPDRKK | 491 | P53667 |